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ABSTRACT
Two cytochrome P4501A-dependent mechanisms of aryl hydrocarbon receptor
(AhR) agonist toxicity were examined in the marine teleost scup (Stenotomus chrysops),
alteration of arachidonic acid (AA) metabolism and production of reactive oxygen species
(ROS).
In scup hepatic microsomes, cytochrome P450s including CYP1A and CYP2B-like
proteins catalyzed regioselective metabolism of AA to eicosatrienoic and
hydroxyeicosatetraenoic acids. Benzo[a]pyrene (BP) treatment induced liver microsomal
AA metabolism, but that effect varied with season. Endogenous AA epoxides were
recovered from scup liver, heart, and kidney, and their composition in the liver was altered
by treatment with BP or 2,3,7,8-tetrachlorodibenzo-p-dioxin.
In scup and mammals, the formation of ROS was stimulated by binding of
3,3',4,4-tetrachlorobiphenyl (TCB) to CYP1A, apparently CYP1A1. Attack of that ROS
inactivated scup CYP1A. ROS release and inactivation of CYPlA were stimulated only by
substrates of CYP1A that are slowly metabolized. In vivo, 3,3',4,4',5-
pentachlorobiphenyl (PeCB) potently induced CYPlA mRNA, protein and catalytic activity
at low doses (0.01-0.1 mg/kg), suppressed induction of CYPlA protein and catalytic
activity at a high dose (1 mg/kg) and transiently induced oxidative stress in scup liver. The
suppression of CYP1A induction was organ-dependent, with hepatic CYP1A being most
susceptible to inactivation. The results suggest that ROS could be involved in the in vivo
suppression of scup liver CYP1A by planar halogenated aromatic hydrocarbons.
The reactive oxygen sensitive transcription factor, nuclear factor-KB (NF-KB), was
characterized in scup. An NF-KB consensus binding sequence bound specifically to 3
proteins in scup liver, heart and kidney. One protein was recognized by an antibody to
mammalian p50. Injection alone appeared to activate NF-KB. BP did not increase the
activation of NF-KB, and PeCB activated NF-KB in only 1 of 2 experiments.
Last, CYP1A induction in endothelial cells of the American eel (Anguilla rostrata), a
site which may be particularly susceptible to alterations in AA metabolism and ROS
production, was described. Eel liver CYPlA responded to BP, 13-naphthoflavone and
TCB in a dose-dependent fashion, and induction was correlated with hepatic inducer
concentration. Endothelial CYP1A was inducible in a number of organs and was
metabolically active. In the rete mirabile, penetration of endothelial CYP1A induction
increased with increasing dose of AhR agonists, corresponding with an increase in inducer
concentration. A transition from endothelial to epithelial staining occurred in the gill, heart
and kidney at high inducer doses.
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CHAPTER 1
Introduction and Background
INTRODUCTION
The overall goal of this research was to investigate mechanisms of toxicity of aryl
hydrocarbon receptor agonists, with particular emphasis on planar halogenated aromatic
hydrocarbons (pHAH). These studies explored two potential cytochrome P450 1A-
mediated mechanisms of toxicity, alteration of arachidonic acid metabolism and production
of reactive oxygen species. Further, cytochrome P450 1A induction in a sensitive cell
type, endothelium, was examined following either experimental or environmental
exposure.
Polychlorinated biphenyls (PCB) are ubiquitous contaminants of the global
environment. Produced mainly for the electrical industry from the 1940's to the 1970's,
their production now is banned. PCBs, along with dioxins and dibenzofurans, comprise
the group of compounds know as halogenated aromatic hydrocarbons (HAH). The planar
HAH congeners are considered to be the most toxic. While the toxicity of planar HAHs
(pHAH) is recognized and thought mainly to be a function of their interaction with the aryl
hydrocarbon receptor (AhR), the mechanisms of this toxicity are unclear.
Mono-oxygenase enzymes, particularly cytochrome P450s, are considered to be
one of the major defense mechanisms against the toxicity of xenobiotic compounds.
Cytochromes P450 (CYP), a superfamily of enzymes, is responsible for the synthesis and
degradation of many endogenous compounds, as well as for the metabolism of many
foreign compounds. These enzymes catalyze a wide range of reactions including aromatic
and aliphatic hydroxylation, epoxidation, N, 0, and S dealkylation and N, S, and P
oxidation. In general the addition of oxygen to xenobiotic compounds increases their
water-solubility and thus allows for increased excretion. Most xenobiotics are metabolized
by CYPs in families 1-4. In particular, cytochrome P4501A (CYP1A) has been
characterized for its induction and regulation by foreign chemicals via the AhR.
Paradoxically, the interaction of substrates with CYP1A also may result in
increasing the toxicity of these chemicals. First, oxidative metabolism by CYP contributes
to toxicity by activating promutagens and procarcinogens such as benzo[a]pyrene or
aflatoxin B 1. Second, studies in fish and mammals have suggested that treatment with
CYP1A inducers increases the metabolism of arachidonic acid (AA) in vivo. These
metabolites have a variety of diverse physiological functions, and alteration of AA
metabolism following CYP1A induction may have important physiological consequences.
Third, pHAH treatment is associated with AhR-dependent oxidative stress. Binding of
slowly metabolized substrates by CYP1A may uncouple the catalytic cycle, resulting
release of reactive oxygen species (ROS) that could attack any member of the cellular
machinery. Thus CYP1A may contribute to toxicity by activating chemicals, modifying
metabolism of endogenous signaling molecules and producing reactive oxygen.
CYP1A is found in a wide range of tissues and cell types. It is thought that most
metabolism of xenobiotic compounds is carried out in the liver by CYP1A. However,
studies have shown that endothelium in vertebrates from fish to mammals is a ubiquitous
site of very strong induction of CYPIA by halogenated and non-halogenated aromatic
hydrocarbons. CYP1A found in endothelial cells may represent a significant proportion of
CYP1A found in organisms as a whole. Because the endothelial cells line all blood vessels
and actually form the capillaries, it raises the question of what significance induction of
CYP1A in these cells may have.
STRUCTURE, FUNCTION AND REGULATION OF CYTOCHROMES
P450
The cytochromes P450 are a superfamily of mono-oxygenase enzymes. CYPs are
found in a wide variety of life forms, including bacteria, fungi and plants, as well as
animals. There are 115 gene families, 37 of which occur in animals (Nelson, 1997).
CYPs with less than 40% amino acid sequence identity are placed in different gene families;
those with 40-55% identity are placed in different subfamilies. The diversity of this gene
superfamily is reflected by the vast array of chemicals, endogenous and exogenous in
origin, which are substrates for these enzymes.
In general, CYPs are hydrophobic, membrane bound, heme proteins found in the
endoplasmic reticulum of many cell types. The orientation of CYP in the membrane is still
debated. Studies agree that the protein is localized toward the cytoplasmic face. Nelson
and Strobel (Nelson and Strobel, 1988) hypothesized that a CYP is held in the membrane
by an amino terminal hairpin loop, with the globular part of the protein extending into the
cytoplasm. The substrate binding site faces the membrane in this model with the heme
oriented parallel to the membrane. Edwards et al. (Edwards et al., 1991) proposed a model
in which there is only a single stranded anchor of 20-30 residues with the globular portion
of the protein in the cytoplasm, the heme being perpendicular or near perpendicular to the
membrane. They also suggest that a portion of the globular protein may rest on the
membrane itself. Still others suggest that there are four transmembrane domains and that
the active site is within the membrane (Black and Coon, 1986).
The CYP active site contains one iron protoporphyrin IX prosthetic group formed
by four pyrole rings and one iron atom. This is where the dioxygen molecule is bound,
reduced and activated (McMurry and Groves, 1986). Unlike other hemoproteins, the CYP
heme has a 5th ligand, a cysteine-thiolate (Black and Coon, 1986). This 5th ligand causes
the unusual absorbance maximum at 450 nm. When the thiolate bond is disrupted, P450 is
converted to the inactive P420 form (Parkinson, 1996). Knowledge of active site structure
is limited because of the inability to crystallize membrane-bound proteins; however, the
stereospecific nature of substrate oxidation suggests that the substrate orientation is
constrained within the active site (Miwa and Lu, 1986).
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Figure 1: The catalytic cycle of cytochrome P450. From: (Parkinson, 1996).
The reaction mechanism of CYP consists of a series of interactions with oxygen
and a substrate (Figure 1). In the resting state, the heme iron of the prosthetic group is in a
low spin state (Fe3 +). Once the substrate is bound, the iron is converted to a high spin
state and to a redox potential that favors reduction. Substrate binding is probably the first
step in most CYP cycles; however, rapid CYP reduction also can occur in the absence of
substrate (Guengerich and Johnson, 1997). The iron is reduced by electron transport from
the flavoprotein NADPH-cytochrome P450 reductase. Oxygen binds. Addition of a
proton and a second electron converts the complex to a peroxide. Donation of the second
electron is the rate limiting step in the mechanism. The oxygen-oxygen double bond is
cleaved by the introduction of a second proton. A substrate radical is formed, hydroxylated
and released (Stegeman and Hahn, 1994). Therefore, one oxygen atom oxidizes the
substrate while the other atom is reduced with two electrons to form water.
Electron transfer is essential to CYP function. Because NADPH is the major
source of electrons and is a two electron donor, the electron transfer enzyme must be able
to accept two electrons but donate only one electron at a time to CYP. NADPH-
cytochrome P450 reductase is a membrane-bound flavoprotein which contains equimolar
amounts of FAD and FMN and donates the first, if not both, electrons to CYPs. FAD is
located close to the NADPH binding site and accepts the electron from NADPH. FMN is
located near the CYP interaction site and passes the electron to CYP (Kurzban and Strobel,
1986). The rate of reduction of CYP can be increased 5-10 fold upon substrate binding
(Ingelman-Sundberg, 1986). The second electron also may be donated to CYP by
cytochrome b5, through cytochrome b5 reductase and NADH (Ortiz de Montellano, 1986).
Cytochrome P450 enzymes form two different regulatory classes. One class
metabolizes endogenous substrates and the other metabolizes exogenous substrates,
including xenobiotics. As a result there is a fundamental difference in the way that these
two classes of enzymes are regulated. Constitutively expressed CYPs may be induced by
endogenous or exogenous compounds; however, enzyme levels are generally maintained
optimally for the maintenance of a particular function (Waterman et al., 1986).
Constitutively expressed CYPs include CYP1A2, CYP2A6, CYP2B6, CYP2C, CYP2D6,
CYP2E1 and CYP3A (Gonzalez and Lee, 1996). Those CYPs which metabolize
exogenous compounds are inducible and respond to inducers with increased protein levels
and catalytic activities. These changes in protein level are usually a result of changes in
mRNA levels. These CYPs are induced by a wide variety of compounds (Table I).
CYPs can be regulated transcriptionally or post-transcriptionally. 3-
Methylcholanthrene (MC) induction of CYP1A2 is associated with mRNA stabilization
(Kimura et al., 1986). Phenobarbital (PB) induces transcription of CYP2B 1 and CYP2B2
(Waxman and Azaroff, 1992). Increases in CYP2E1 mRNA following diabetes occur due
to mRNA stabilization (Porter and Coon, 1991). However, following exposure to acetone,
CYP2E1 protein stabilization occurs because of phosphorylation prevention (Song et al.,
1986; Eliasson et al., 1990). CYP3A can be induced either by transcriptional activation
with dexamethasone (Schuetz et al., 1984) or by protein stabilization with macrolide
antibiotics (Watkins et al., 1986). Clofibrate induces transcriptional activation of CYP4A;
this may be mediated by the peroxisome-proliferator-activated receptor (Hardwick et al.,
1987). Thus, regulation is inducer-, as well as, CYP- specific.
TABLE I
Induction of selected CYP gene subfamilies (From: Stegeman and Hahn. 1994)
Abbreviations:
BNF B-naphthoflavone
DDT dichlorodiphenyltrichloroethane
PAH polynuclear aromatic hydrocarbon
PCB polychlorinated biphenyl
TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin
DEX dexamethasone
ISF isosafrole
PB phenobarbital
PCN pregnenolone-a-carbonitrile
Gene family Selected
and Protein Prominent substrates Common Inducers Mechanisms
subfamily members
CYPlA 1A1 PAH, planar PCB, PAHs, planar PCBs, Mostly
7-ethoxyresorufin BNF, chlorinated dioxins transcriptional
and furans
1A2 Acetanilide, estradiol, PAHs, planar PCBs, Transcriptional, post-
caffeine BNF, chlorinated dioxins transcriptional
and furans, ISF
CYP2B 2B1 Barbiturates, steroids Barbiturates, non-planar Transcriptional
PCBs, DDT
CYP2E 2E1 Ethanol, Ethanol, ketones, Transcriptional, post-
alkylnitrosamines starvation, diabetes transcriptional
CYP3A 3A1 Steroids PCN, DEX, macrolide Transcriptional, post-
(68-hydroxylase) antibiotics transcriptional
CYP4A 4A1 Lauric acid, arachidonic Clofibrate, phthalates, Transcriptional
acid PCBs
For CYPIA1, induction is a receptor-mediated process. The aryl hydrocarbon
receptor (AhR) is a cytosolic protein containing a ligand binding subunit and two heat
shock proteins. Recently, the hepatitis B virus X-associated protein 2 also has been shown
to be associated with the unliganded AhR (Meyer et al., 1998). Agonist binding to the
AhR initiates CYP1A1 induction. The sequence of events is as follows (Hankinson,
1995). 1. The inducer diffuses into the cell. 2. The inducer binds to the AhR protein. 3.
The ligand receptor complex is converted to a DNA binding form via the dissociation of the
heat shock proteins, translocation to the nucleus, association with the AhR nuclear
translocator (ARNT) protein and phosphorylation. 4. The ligand, receptor, ARNT
complex binds to the enhancer DNA, known as the dioxin response element (DRE).
Multiple DREs may be present in the promoter region of CYP1A (Lusska et al., 1993). 5.
The enhancer DNA is activated. The enhancer is activated by several possible mechanisms,
including altered DNA configuration, histone modification, or recruitment of additional
proteins. 6. The nucleosome is disrupted allowing increased accessibility of the
transcriptional promoter. The transcription factor binds to the promoter and enhances
mRNA and protein synthesis. This sequence of reactions leads to increased levels of
CYP1A in the cell.
CYPs may be regulated by physiological parameters, as well. In mammals, the
CYP2A, CYP2C, CYP3A, and CYP4A subfamilies are expressed in a sexually
differentiated fashion (Sundseth et al., 1992a; Sundseth and Waxman, 1992b). The
differences in expression have been attributed to the pulsatile versus continuous release of
growth hormone in males and females. Suppression of hepatic P450 content and activity
during gonadal development in females, and release of that suppression after spawning,
occurs in many teleost species (Pajor et al., 1990; Gray et al., 1991; Andersson and Forlin,
1992; Elskus et al., 1992). CYP1A, CYP2B-like and CYP3A-like proteins are suppressed
by estradiol treatment or during natural maturation of female fish (Pajor et al., 1990; Gray
et al., 1991). Estradiol regulates CYP1A at a pre-transcriptional level (Elskus et al., 1992).
Sexually differentiated expression of CYP2K mRNA and protein also has been attributed to
hormonal regulation (Buhler et al., 1994).
Even environmental factors, such as temperature, can influence CYP content. In
some species, cold acclimatized fish have higher CYP metabolic rates than warm
acclimatized fish (Carpenter et al., 1990). In killifish (Fundulus heteroclitus), warm
acclimatized fish have higher CYP1A content and EROD activity; however, cold
acclimatized fish maintain elevated CYP1A mRNA and protein levels for longer periods of
time. The data suggest that it is a post-transcriptional temperature affect (Kloepper-Sams
and Stegeman, 1992). The regulation of CYPs is not directed simply by inducers, but is
influenced by a large variety of internal and external variables.
CYTOCHROMES P450 IN TELEOST FISH
While this study focuses on the CYP1A subfamily, it is important to note that other
CYP gene families exist in fish. Procedures including protein purification, immunological
reactivity and amino acid sequencing have been used to identify and classify different CYP
genes in fish. This has lead to the description of fish CYP genes in subfamilies 1-4: 1(A),
2(B,E,K,M,N,P), 3(A), 4(T) (Stegeman, 1987; Kaplan et al., 1991; Stegeman, 1993;
Buhler et al., 1994; Yang et al., 1996; Falckh et al., 1997; Oleksiak et al., 1998a; Oleksiak
et al., 1998b). CYP from the 11(A), 17, 19, and 26 subfamilies also have been identified
in fish (Sakai et al., 1992; Tanaka et al., 1992; Takahashi et al., 1993; White et al., 1996).
Most of these CYP forms have been isolated in rainbow trout (Oncorhynchus mykiss);
however, several subfamilies have been described in scup (Stenotomus chrysops), cod
(Gadus morhua) and killifish as well. In particular, CYP1A has been found in all fish
species that have been examined to date (Stegeman and Hahn, 1994).
While the CYP1A subfamily in mammals is represented by two members, CYP1A1
and CYP1A2, most fish are thought to have only one CYP1A subfamily member. In
mammals, CYP1Al metabolizes polynuclear aromatic hydrocarbons (PAH), and CYP1A2
metabolizes aromatic amines (Parke et al., 1991). Scup CYP1A expressed in Chinese
hamster V-79 cells has catalytic properties of both mammalian CYP1A1 and CYP1A2,
consistent with the hypothesis that teleost CYP1As represent a type ancestral to both of the
mammalian genes (Morrison et al., 1995; Stegeman et al., 1996). The scup CYP1A amino
acid sequence is 57-59% similar to mammalian CYP1A1 representatives and 52-55%
similar to CYP1A2 representatives. Scup CYP1A has an 78-82% amino acid sequence
similarity to CYP1As from rainbow trout, toadfish (Ospanus tau), plaice (Plueronectes
platessa), and tomcod (Microgadus tomcod) (Morrison et al., 1995; Morrison et al., 1998).
Biochemical evidence also supports the conclusion that scup P450E, rainbow trout
P450LM4 and cod P450c are orthologous proteins and that these teleost proteins are
closely related to mammalian CYP1A1 (see (Stegeman and Kloepper-Sams, 1987;
Stegeman, 1989)). The scup, trout and cod proteins are all induced by polynuclear
aromatic hydrocarbons, PCBs and 0-naphthoflavone and are inhibited by a-
naphthoflavone. When reconstituted with epoxide hydrolase all produce high percentages
of benzo-ring dihydrodiols. All of the proteins are primary catalysts for ethoxyresorufin
and aryl hydrocarbon hydroxylase (AHH) activity and have similar spectral properties (a
maximum at 447 nm when reduced and CO-ligated). Antibodies raised against the purified
form of each protein cross-reacts with each of the other proteins, and scup CYP1A shares
21 of 25 amino acids in the N-terminal sequence with the trout protein. Finally, scup and
rat CYP1As are immunologically related. Although, only 1 of 9 antibodies raised against
scup CYP1A recognize rat CYP1A1, and 2 of 10 antibodies raised against rat CYP1Al
recognize scup CYP1A (Klotz et al., 1986).
Recently, two unique CYP1A genes were found to be expressed in MC treated
rainbow trout (Berndtson and Chen, 1994). This gene is the result of a duplication after
the divergence of fish from other vertebrates.
POLYCHLORINATED BIPHENYLS
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Figure 2. Generalized structure of polychlorinated biphenyls.
Polychlorinated biphenyls (PCB) are compounds composed of two phenyl rings
connected by a single carbon-carbon bond with various patterns of chlorine substitution.
Chlorines can be substituted in the 2-6 and 2'-6' positions, resulting in 209 possible
congeners (Figure 2, Table II).
TABLE II
Chlorination patterns and IUPAC numbers for select PCBs
Structure IUPAC No.
3-Methylcholanthrene-Type
3,3',4,4'-tetrachlorobiphenyl 77
3,4,4',5-tetrachlorobiphenyl 81
3,3',4,4',5-pentachlorobiphenyl 126
3,3',4,4',5,5'-hexachlorobiphenyl 169
Phenobarbital-Type
2,2'-dichlorobiphenyl 4
2,2',4,4'-tetrachlorobiphenyl 47
2,2',5,5'-tetrachlorobiphenyl 52
2,2',4,5,5'-pentachlorobiphenyl 101
2,2',3,3',4,4-hexachlorobiphenyl 128
2,2',3,4,4',5-hexachlorobiphenyl 138
2,2',4,4',5,5'-hexachlorobiphenyl 153
2,2',4,4',6,6-hexachlorobiphenyl 155
2,3,3',4,4',5-hexachlorobiphenyl 156
2,3,3',4',5,6-hexachlorobiphenyl 163
2,2',3,4',5,5',6-heptachlorobiphenyl 187
Mixed-Type
2,3,3',4,4'-pentachlorobiphenyl 105
2,3',4,4',5-pentachlorobiphenyl 118
2,3,3',4,4',5-hexachlorobiphenyl 156
Several properties lend PCBs to many uses; they are inflammable, chemically stable
and miscible with organic compounds. PCBs were used as organic diluents, plasticizers,
pesticide extenders, adhesives, dust reducing agents, cutting oils, flame retardants, heat
transfer fluids, dielectric fluids for transformers and capacitors, hydraulic lubricants,
sealants, and in carbonless copy paper (Safe, 1994). Of the 1.5 million metric tons of
PCBs that were produced, 65% is land-locked, 31% has been released into the
environment and 4% has been degraded or incinerated (Tanabe, 1985). Reports of PCB
residues in the environment began in the 1960's (Jensen, 1966; Risebrough et al., 1968).
PCB residues have been found in every component of the global ecosystem, including the
atmosphere, rivers, lakes, soil, marine sediment, open ocean, and fish, wildlife and human
adipose tissue, blood and milk (Safe et al., 1985; Tanabe, 1985). Of the environmental
load, 97% can be found in coastal sediments and open ocean (Tanabe, 1985).
PCBs regulate CYPs on multiple levels. Individual chlorobiphenyl (CB) congeners
can be grouped structurally by their induction of different CYP isoforms. CB congeners
with no ortho substitutions induce CYP1A1, CYP1A2 and CYP2A1 and are called MC-
type inducers (Parkinson et al., 1980; Parkinson et al., 1980). The most potent inducers
have chlorine substitutions at both para positions and at least two meta positions (i.e. CBs
77, 81, 126, 169) (Poland and Glover, 1977; Kafafi et al., 1993). Structurally diverse CB
congeners induce CYP2B1/2B2, but all effective PB-type inducers have two or more ortho
substitutions (Parkinson et al., 1980; Parkinson et al., 1980). The two most potent
CYP2B1/2B2 inducers are CBs 163 and 187 (Connor et al., 1995). CB congeners with a
mono-ortho substitution induce all five CYP forms and are called mixed-type inducers
(Parkinson et al., 1980; Parkinson et al., 1980). Mixed-type CB congeners are less potent
at inducing CYPs than the type-specific congeners (see (Safe, 1994)).
The structure activity relationships seen in fish differ somewhat from those seen in
mammals. A number of studies in a range of fish species have demonstrated that CB 77
(Franklin et al., 1980; Melancon and Lech, 1983; Gooch et al., 1989; Monosson and
Stegeman, 1991; Tyle et al., 1991; Lindstrom-Seppa et al., 1994; Newsted et al., 1995;
Otto and Moon, 1995; Huuskonen et al., 1996; Sleiderlink and Boon, 1996; White et al.,
1997a), CB 126 (Engwall et al., 1994; Newsted et al., 1995; Huuskonen et al., 1996;
Palace et al., 1996) and CB 169 (James and Little, 1981; Miranda et al., 1990; Newsted et
al., 1995) induce CYP1A in fish. Several studies have found that no P450 induction
occurs in fish following treatment with PB-type congeners (i.e. CBs 52, 128, 138, 153)
(Forlin and Lidman, 1978; James and Little, 1981; Gooch et al., 1989). However, two
studies have suggested that AHH activity is increased following treatment with PB-type
congeners (i.e. CBs 101 and 153) (Gruger et al., 1976; Da Costa and Curtis, 1995), and
one study showed an increase in total P450 and p-nitroanisole O-demethylation following
CB 153 treatment (Forlin and Lidman, 1978). There is contradictory evidence as to
whether mixed-type congeners are effective CYP inducers in fish. CB 105 was ineffective
at inducing CYPlA in scup, rainbow trout and cod (Gooch et al., 1989; Bernhoft et al.,
1994; Newsted et al., 1995). CB 118 did not induce CYP1A in scup but did induce
CYP1A in rainbow trout (Gooch et al., 1989; Skaare et al., 1991). CB 156 significantly
induced CYP1A in flounder (Platichthys flesus L.) (Beyer et al., 1997). The reasons for
the relative insensitivity of fish to PB- and mixed-type congeners is unknown.
Following induction, CBs can inhibit CYP catalytic activities. CB 77 is a
competitive inhibitor of ethoxyresorufin O-deethylation (EROD), a CYP1A catalytic
activity, in scup liver microsomes. The mono-ortho CB 156 has a limited capacity to
inhibit EROD in scup liver microsomes as well (Gooch et al., 1989). In rat liver
microsomes, CB 77 is a mixed-type inhibitor of EROD (DeMatteis et al., 1989), and CB
169 is a noncompetitive inhibitor of estradiol 2-hydroxylase activity, a CYP1A2 catalytic
activity (Voorman and Aust, 1987). Furthermore, treatment with high doses of non-ortho
CB congeners results in a decrease in CYP1A catalytic activity in vivo (Melancon and
Lech, 1983; Voorman and Aust, 1988; Miranda et al., 1990; Monosson and Stegeman,
1991; Lindstrom-Seppa et al., 1994) or in cultured cells (Sawyer and Safe, 1982; Rodman
et al., 1989; Hahn et al., 1993; Kennedy et al., 1993; Lorenzen et al., 1997). In rat liver
microsomes, CBs 4, 52 and 155 all inhibit O-demethylation of p-nitroanisole, a CYP2B
catalytic activity, with inhibitory capacity decreasing with increasing chlorination (Hesse
and Wolff, 1977).
CB 77 and other planar CB congeners that are AhR agonists also stimulate
inactivation of CYP1A. While CYP1A mRNA remains elevated in rainbow trout exposed
to high doses of CB 77 or 126 and in scup exposed to high doses of CB 77, CYP1A
activity and protein both decrease at high doses (Gooch et al., 1989; Newsted et al., 1995;
White et al., 1997a). Similar results have been described in studies of cultured chick
embryo hepatocytes and porcine aorta endothelial cells exposed to high doses of CB 77
(Lambrecht et al., 1988; Sinclair et al., 1989; Stegeman et al., 1995; Lorenzen et al.,
1997). In scup, the CB 77-dependent decrease in CYP1A was shown to be post-
transcriptional and hypothesized to result from oxidative modification of the protein (White
et al., 1997a).
The environmental significance of a CB congener can be determined by assessing
its potential for toxicity, its frequency of occurrence in the environment and its relative
abundance in animal tissues (McFarland and Clark, 1989). Exposure to PCBs can result in
hepatocellular carcinoma, immunotoxicity, wasting syndrome and reproductive, endocrine
and developmental toxicity (see (Safe, 1994)). The most toxicologically active congeners
are those having chlorine substitutions at both para positions and at least two meta positions
but no chlorine substitutions at the ortho positions (Safe et al., 1985). By comparing the
TCDD equivalency factors (TEF) of CB congeners, the coplanar congeners are most potent
in eliciting toxic effects in fish (Janz and Metcalfe, 1991; Walker and Peterson, 1991;
Newsted et al., 1995) and mammals (Safe, 1990; Tillitt et al., 1991). While these coplanar
CB congeners occur at extremely low concentrations in environmental samples, their
potential toxicity ranks them as the congeners of highest environmental concern (McFarland
and Clark, 1989). Mixed-type inducers are considered the next most toxic group of
congeners, and they are relatively abundant. PB-type inducers are most abundant in
environmental samples but are considered to have limited toxic potential.
REACTIVE OXYGEN SPECIES
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Figure 3. Oxygen chemistry.
Reactive oxygen species (ROS) are free radical species containing an unpaired
electron in an outer orbital resulting in an unstable electron configuration. Technically,
molecular oxygen is a bi-radical, as it has two unpaired electrons in the outer orbitals in the
ground state. Molecular oxygen oxidizes by accepting two electrons; however the electrons
must have parallel spins. This spin restriction is advantageous to aerobic organisms
because it slows oxygen reactions but is disadvantageous because it allows one electron
transfers. Reduction of molecular oxygen results in the formation of the superoxide radical
(02-'), which is a good reductant but a poor oxidant. Protonation of 02-" to the
perhydroxyl radical (H02) increases the oxidizing potential. Addition of a second electron
to oxygen results in the formation hydrogen peroxide (H202), which is also a product of
02- dismutation. Addition of a third electron to oxygen forms the hydroxyl radical (OH*),
the most reactive oxygen species. OH* are formed by the interaction of H202 with either
reduced iron (Fenton reaction, Fe2 + + H202 --------> Fe3 + + OH. + OH-) or with 02 -*
(Haber Weiss reaction, 02 -* + H202 -------- > 02 + OH* + OH-).
Both singlet oxygen and H202 are considered to be ROS, but are not radicals.
Singlet oxygen, a powerful oxidizer, is produced by an electron rearrangement, with
electrons in non-parallel spin or in the same orbital. While H202 is not reactive enough to
oxidize in an aqueous environment, it is biologically important because it forms OH*,
diffuses readily and crosses biological membranes.
TABLE m
Oxygen species and their reactivity (From: Yu, 1994)
Species Chemical Half Life Properties
Symbol at 37* C (Sec)
Molecular Oxygen 302 >102
Singlet Oxygen 102 1 . 10-6 Powerful oxidizing agent
Superoxide 02 -* 1. 10-6 Good reductant, poor oxidant.
Hydroxyl OH* 1 * 10-9  Extremely reactive, very low diffusion distance.
Perhydroxyl H02* Stronger oxidant, more lipid soluble than 02-'.
Alkoxyl RO* 1.10-6 Intermediate in its reactivity with lipid between
ROO* and HO.
Peroxyl ROO* 1 . 10-2 Low oxidizing ability relative to HO. but
greater diffusibility.
Hydrogen peroxide H202 Oxidant, but reactions with organic substrates
very slow, very diffusable.
Both exogenous and endogenous sources of ROS are present in cells. Exogenous
sources include radiation, ozone and hyperoxia (see (Freeman and Crapo, 1982)). A major
endogenous source of ROS is 02 -* produced during leakage of electrons by mitochondria
(see (Freeman and Crapo, 1982)). Other endogenous sources include lipid breakdown
(Girotti, 1985), production of 02 -* during inflammatory response (Baboir, 1978),
oxidative metabolism by oxidases such as monoamine oxidase (Cohen, 1985), NADPH
oxidase (Shatwell and Segal, 1996) and xanthine oxidase (McCord and Fridovich, 1968),
peroxisomes (see (Mannaerts and Veldhoven, 1993)) and CYP. Interruption of the CYP
catalytic cycle after passage of the first electron results in 02-* release and after passage of
the second electron results in H202 release (Parkinson, 1996). 02-* also can be produced
by cytochrome P450 reductase (Aust et al., 1972; Morehouse et al., 1984).
ROS can initiate radical damage to lipids, proteins and DNA (Kappus, 1987).
Oxidative damage to lipids results in a loss of membrane fluidity, a reduction in membrane
potential and an increase in ion permeability (Bagchi et al., 1989; Simonian and Coyle,
1996). Oxidation of amino acids, particularly those that are unsaturated and sulfur-
containing (i.e. tryptophan, tyrosine, phenylalanine, histidine, methionine and cysteine),
can lead to gross structural modification of proteins (Kyle et al., 1989), can result in
crosslinking and aggregate formation (Davies, 1987; Davies et al., 1987) and can mark
proteins for proteolysis (Davies et al., 1987). ROS oxidize nucleotides and cause single-
and double- strand breaks (Floyd et al., 1988; Simonian and Coyle, 1996).
ROS regulate both gene transcription and post-translational activation of certain
proteins involved in signal transduction. The tumor suppresser p53 inhibits growth and
suppresses transformation by blocking the cell cycle and preventing gene amplification
(Baker et al., 1990; Lane, 1992). Binding of p53 to DNA is controlled post-translationally
by the redox status of cysteine residues at the zinc and DNA binding regions (Rainwater et
al., 1995). Activator protein 1 (AP-1) is a complex of oncogene proteins from the Fos and
Jun families which are intermediary transcriptional regulators in signal transduction
processes leading to proliferation and transformation (Angel and Karin, 1991). Both
H202 and the antioxidant pyrrolidine dithiocarbamate induce c-fos and c-jun expression
(Meyer et al., 1994). However, H202 only moderately activates AP-1 DNA binding while
antioxidants strongly activate binding (Meyer et al., 1994). Nuclear factor-KB (NF-KB) is
a complex of homo- or heterodimers (e.g. p50 and p65) of members of the Rel family of
transcriptional activator proteins. NF-KB resides in the cytoplasm complexed with an
inhibitor IKB, and degradation of IB is required to allow translocation and DNA binding
(see (Piette et al., 1997)). Degradation of IKB has been suggested to involve ROS, as
antioxidants block NF-KB activation, and potent NF-KB activators such as tumor necrosis
factor-a, interlukin-1, phorbol 12-myristate 13-acetate (PMA), lipopolysaccharide and
okadaic acid all elevate ROS levels (Schreck et al., 1991; Schreck et al., 1992). Redox
regulation also has been suggested for the c-myb protooncogene (Guehmann et al., 1992),
Ets transcription factor (Wasylyk and Wasylyk, 1993), SP-1 transcription factor (Knoepfel
et al., 1994), glucocorticoid receptor (Esposito et al., 1995), early growth response-1
transcription factor (Huang and Adamson, 1993), thyroid transcription factors (Civitareale
et al., 1994; Arnone et al., 1995), upstream stimulatory transcription factor (Pognonec et
al., 1992), aryl hydrocarbon receptor (Ireland et al., 1995), and estrogen receptor (Hayashi
et al., 1997). Oxidants also may stimulate signal transduction by altering Ca2 +-flux and
protein phosphorylation (see (Suzuki et al., 1997)).
An antioxidant defense system has evolved to lower the steady state cellular
concentrations of ROS and to repair damage caused by ROS. Primary antioxidant defenses
include: 1) ROS scavenging compounds, both lipid- and water-soluble and 2) antioxidant
enzyme systems (Table IV) (see (Freeman and Crapo, 1982; Yu, 1994)). Secondary
defenses include lipolytic enzymes, phospholipases, proteolytic enzymes, proteases,
peptidases, DNA repair enzymes, endonucleases, exonucleases and ligase (Davies, 1986).
TABLE IV
Antioxidant defenses (From: Yu, 1994)
Category Primary Tissue Site Actions
Enzyme Systems
Cu/Zn SOD
Mn SOD
Cu SOD
Catalase
GSH Redox Cycle
GSH Peroxidase
GSH reductase
Lipid-Soluble Compounds
Vitamin E Li
1-Carotene Li
Bilirubin
Water-soluble Compounds
Vitamin C W
Uric Acid W
Glucose W
Cysteine W
GSH W
Cytosol
Mitochondria
Plasma
Peroxisomes
Cytosol
Cytosol
pid membranes
pid Membranes
Bloodstream
ide distribution
ride distribution
ide distribution
ride distribution
ride distribution
Dismutation of 02-* to H202.
Dismutation of 02-* to H202.
Dismutation of 02-* to H202.
Dismutation of H202, reduces methyl and ethyl
hydroperoxides.
Reduction of H202 and other hydroperoxides.
Reduction of low molecular weight disulfides.
Converts 02-*, OH* and lipid ROO* to less reactive
forms, breaks lipid peroxidation chain reactions.
Scavenges 02-*, reacts with ROO*.
Chain-breaking anti-oxidant. Reacts with ROO*.
Scavenges 02-* and OH*.
Scavenges 02-*, OH*, oxoheme oxidants and
ROO*.
Scavenges OH*.
Reduces organic compounds.
Reacts directly with 02-', OH* and organic free
radicals.
I- -
ARACHIDONIC ACID
Arachidonic acid (AA) is both a structural component of membranes and a
functional participant in signaling cascades. Following release from membranes by
phospholipase A2, AA is metabolized through three major pathways: cyclooxygenase,
lipoxygenase or cytochrome P450 (Needleman et al., 1986). CYP can metabolize AA to
three types of products (Figure 4). Allylic oxidation forms mid-chain conjugated dienols,
or mid-chain hydroxyeicosatetraenoic acids (5-, 8-, 9-, 11-, 12-, or 15-HETE). w-
Terminal hydroxylation forms C16- through C20-alcohols of AA (16-, 17-, 18-, 19, or 20-
HETE). Olefin epoxidation forms epoxyeicosatrienoic acids (5,6-, 8,9-, 11,12- and
14,15-EET). Mammalian CYP in families 1-4 metabolize AA (Figure 4).
Epoxygenation
CYP2Bs, CYP2Js, CYP2Cs
Human CYP1A2
Chicken CYP1A5
o-Terminal Hydroxylation
CYP2E1
CYP4s
Rat/Rabbit CYP1A1
Rat CYP1A2
Allvlic Oxidation
Figure 4. CYP-mediated arachidonic acid metabolism and the specific CYP isoforms
which favor those reactions (Oliw et al., 1982; Capdevila et al., 1990; Laethem et al.,
1993; Rifkind et al., 1994; Capdevila et al., 1995; Rifkind et al., 1995; Zeldin et al., 1995;
Wu et al., 1996; Wu et al., 1997; Zhang et al., 1997).
CYP-mediated AA metabolites can promote potent biological activities including
inhibition of platelet aggregation, neutrophil aggregation and cyclooxygenase activity
(Proctor et al., 1989), alteration of endothelial cell permeability, vascular tone, and cellular
ion flux (Schwartzman et al., 1987; Ohnishi et al., 1992; Harder et al., 1995; Campbell et
al., 1996), and stimulation of angiogenesis and peptide hormone release (Falck et al.,
1983; Harder et al., 1995). EETs, particularly 5,6- and 14,15-EET, stimulate a wide range
of effects from vasoconstriction, to vasodilation, to alteration of Ca2 + homeostasis, to
inhibition of Na+/K+-ATPases, to stimulation of peptide hormone release (see (Fitzpatrick
and Murphy, 1989)). Other physiologically relevant CYP-mediated AA metabolites include
12(R)-HETE which inhibits Na+/K+-ATPases in the cornea (Schwartzman et al., 1987)
and 19- and 20-HETE which modulate renal Na+/K+-ATPases (Escalante et al., 1990).
Investigations of AA metabolism in fish have focused on prostaglandin and HETE
formation. A variety of fish tissues have been shown to metabolize AA to prostaglandins
and hydroxy metabolites, including gills (Strivastava and Mustafa, 1984; Van Praag et al.,
1987; Beckman and Mustafa, 1992), heart (Herman et al., 1979; Strivastava and Mustafa,
1984; Brown and Bucknall, 1986), red blood cells (Cagen et al., 1983), skin (Anderson et
al., 1981), kidney, liver and stomach (Bandyopadhyay et al., 1982; Henderson et al.,
1985). Studies in gills have demonstrated that both lipoxygenases and cyclooxygenases
contribute to AA metabolism (Van Praag et al., 1987; Beckman and Mustafa, 1992). In
fish, prostaglandins may participate in the regulation of cardiovascular function (Brown
and Bucknall, 1986), hormone release (Chang et al., 1993; Hsu and Goetz, 1993; Wade
and Van Der Kraak, 1993), ovulation (Goetz et al., 1982), nervous system function
(Mustafa and Strivastava, 1989), fluid and electrolyte balance in gills and kidney (Wales
and Gaunt, 1985; Brown and Bucknall, 1986; Beckman and Mustafa, 1992) and immune
response (Rowley et al., 1995). It is likely then that CYP-mediated AA metabolism plays
an important role in the production of biologically active metabolites. However, CYP-
mediated AA metabolism has been examined only in killifish, scup, and skate (Raja
erinacea) (Zacharewski et al., 1996; Oleksiak et al., 1998a; Oleksiak et al., 1998b).
ENDOTHELIUM
Endothelial cells are those cells which line all of the blood and lymphatic vessels of
the body. In the large arteries and veins, the endothelium forms only a one-cell layer thick
lining. Endothelial cells themselves form the smallest of the blood vessels, the capillaries.
Endothelial cells can be classified on the basis of their continuity. Continuous
endothelium, found in the brain, retina, muscle, lung and adipose tissue, forms continuous
tight junctions with no breaks in the vessel wall. Discontinuous endothelium, found in the
liver, spleen and bone marrow, has gaps between cells. Fenestrated endothelium, found in
the endocrine glands, renal glomeruli and tubules and the intestinal villi, is characterized by
specialized intracellular pores that are important to transport and filtration (Gerritsen,
1987). Also, while large and small vessels share many common features, there is evidence
for differences in their nutritional requirements, in their responses to growth and migration
stimuli and in their metabolism of signaling compounds (Zetter, 1981; Gerritsen, 1987).
The functions of endothelial cells are many and diverse. First, they provide a
physical lining of the heart and blood vessels which maintains the fluidity of the blood.
Second, they maintain and control blood vessel tone. Mammalian endothelial cells produce
several vasoactive substances including the vasodilators, nitric oxide, endothelium derived
hyperpolarizing factor, and prostacyclin and the vasoconstrictor endothelin (Thiemermann,
1991; Hecker et al., 1994). They also metabolize other vasoactive compounds including
angiotensin and bradykinin (Hornig and Drexler, 1997). Some of these substance, such as
nitric oxide, actively maintain tone in the normal circulation, while others such as
prostacyclin, are more important in damage response (Vane et al., 1990). Shear stress is
an important signal that controls production of these vasoactive compounds (Ando and
Kamiya, 1993). Third, the ability of endothelial cells to relax or contract allows them to
control microvascular permeability (Crone, 1986; Miller and Sims, 1986). Fourth, they
regulate platelet clumping and clotting (Vander et al., 1990), and lymphocyte traffic
(Pearson, 1991). Last, these cells are responsible not only for repair of damaged blood
vessels but also angiogenesis (Alberts et al., 1989). Endothelial cells provide a diversity of
functions and may be referred to more appropriately as an "organ."
Considering the amount of endothelium in the body, endothelial CYP1A could
contribute significantly to total bodily CYP1A induction (Stegeman et al., 1989).
Endothelial cells can constitute between 0.5 and 1.5% of body weight depending on the
species. In comparison, the liver can constitute between 1 and 1.5% of body weight. Liver
is considered the major site of induction of CYPlA; however, endothelial CYP1A has been
shown to be strongly inducible in mammalian and fish endothelial cells (Dees et al., 1982;
Miller et al., 1989; Stegeman et al., 1989; Smolowitz et al., 1991; Farin et al., 1994;
Thirman et al., 1994; Stegeman et al., 1995). Considering the numerous and important
functions of endothelial cells and the potential for CYP1A induction, the effect of CYP1A
induction on endothelial cells is an important area of investigation.
OBJECTIVES OF THESIS RESEARCH
While the toxicity of planar halogenated aromatic hydrocarbons (pHAH) has been
recognized for many years, the mechanisms of their toxicity are uncertain. The toxicity of
these compounds has been linked to AhR mediated processes; however the processes
directly involved in pHAH toxicity are unknown. Considering the ubiquitous presence of
these compounds in the environment, investigation of their mechanisms of toxicity is of
utmost importance. I have examined two potential CYP1A-dependent mechanisms of AhR
agonist toxicity in the marine teleost Stenotomus chrysops, alteration of AA metabolism
(Chapter 2) and production of ROS (Chapters 3-6). The oxidative inactivation of scup, rat
and human CYP1As stimulated by CB 77 in vitro and its relationship to ROS production is
demonstrated (Chapter 3). The relationship of substrate structure to the oxidative
inactivation of CYP1A was investigated by comparing the effects of ortho and non-ortho
substituted PCBs in vitro (Chapter 4). Further, the ability of CB 126 to mediate
inactivation of CYP1A and oxidative stress was investigated in vivo (Chapter 5). The
reactive oxygen sensitive transcription factor, NF-KB, was characterized in scup, and its
activation by BP and CB 126 was examined (Chapter 6). Last, I have described CYP1A
induction in endothelial cells in the American eel (Anguilla rostrata)(Chapter 7).
Endothelium is a site which may be particularly susceptible to alterations in AA metabolism
and ROS production
The majority of this research was conducted in two teleost species, Stenotomus
chrysops (scup) (Figure 5), and Anguilla rostrata (American eel)(Figure 6). Scup are
marine teleosts that migrate along the Eastern coast of the United States (Morse, 1978).
This is a well characterized species that is extremely sensitive to both CYP1A induction and
inactivation. The American eel is a catadromous fish, that spawns in the Sargasso Sea and
spends the majority of its life in estuaries and rivers (Fahay, 1978). Eels may be
particularly useful for the study of in vivo induction of endothelial CYP1A because they
have a rete mirabile, a counter-current vascular structure, composed entirely of capillaries,
which increases the partial pressure of oxygen to aid its secretion into the swim bladder
(Krogh, 1959).
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Figure 5. Stenotomus chrysops. Actual adult size: 12-22 cm.
From: (www.wh.whoi.edu/photos/lineart/)
Figure 6. Anguilla rostrata. Actual adult size: 61-107 cm.
From: (www.wh.whoi.edulphotos/lineart/)
CHAPTER 2
Arachidonic Acid Metabolism in the Marine Fish Stenotomus chrysops
(scup) and the Effects of Cytochrome P4501A Induction
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Cytochrome P450-mediated arachidonic acid (AA)
metabolism was investigated in the marine fish scup,
Stenotomus chrysops. Liver microsomes incubated
with AA and NADPH produced epoxyeicosatrienoic
acids (EETs) and their hydration products (dihy-
droxyeicosatrienoic acids, DHETs), midchain conju-
gated dienols (midchain HETEs), and C1 6 - through C2 0-
alcohols of AA (to-terminal HETEs), all identified by
HPLC and GC/MS. Gravid females had 4-fold lower AA
metabolism rates than males but identical metabolite
profiles. The 5,6-EET (inferred from stable metabo-
lites) was most abundant (47% of total EETs) followed
by 14,15-, 11,12-, and 8,9-EET (27, 13, and 13%, respec-
tively). The 12-HETE represented 25% of total HETEs
followed in abundance by 16-, 15-, 11-, 19-, 20-, 8-, and
9-HETE. Antibodies against scup CYP1A and a scup
CYP2B-like protein inhibited liver microsomal AA me-
tabolism by 30 and 46%, respectively. GC/MS analysis
revealed EETs and DHETs as endogenous constituents
in scup liver; the predominant EETs were 8,9- and
14,15-EET, followed by a lesser amount of 11,12-EET.
Chiral analysis showed a preference for the S,R-enan-
tiomers of endogenous 8,9-, 11,12-, and 14,15-EET (op-
tical purities 80, 64, and 64%, respectively). Treatment
of scup with the CYPIA inducer benzo(a)pyrene (BP)
increased liver microsomal formation of EETs and
HETEs by 2.7-fold in spring and 1.7-fold in summer. BP
treatment did not affect microsomal EET regioselec-
tivity, but shifted hydroxylation in favor of 19-HETE
and induced 17-HETE formation. 2,3,7,8-Tetrachlorod-
ibenzo-p-dioxin (TCDD) treatment in summer did not
induce liver microsomal AA metabolism rates, yet BP
and TCDD both increased endogenous EET content of
1 To whom correspondence should be addressed. Fax: 508-457-
2169. E-mail: jstegeman@whoi.edu.
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liver (5- and 3-fold, respectively), with a shift to 14,15-
EET. BP treatment increased the selectivity for the
S,R-enantiomers of endogenous 8,9-, 11,12-, and 14,15-
EET (optical purities 91, 84, and 83%, respectively).
Kidney, gill, and heart microsomes all metabolized AA,
at rates 10- to 30-fold less than liver microsomes. Sim-
ilar amounts of endogenous 8,9- and 14,15-EET and
less 11,12-EET were detected in heart and kidney, and
there was a strong enantioselectivity for 8(R),9(S)-EET
in heart (optical purity 78%) but not in kidney. BP
treatment did not alter the total EET content in these
organs but did shift the regiochemical profile in heart
to favor 14,15-EET. Thus, scup liver and extrahepatic
organs metabolize AA via multiple cytochrome P450
(CYP) forms to eicosanoids in vitro and in vivo. BP or
TCDD induced endogenous AA metabolism in liver,
altering EET regioselectivity and, with BP, stereose-
lectivity. While AhR agonists alter metabolism of AA in
early diverging vertebrates expressing both CYP1A
and AhR, the magnitude of effects may depend upon
the type of inducer. o 1998 Academic Press
Key Words: arachidonic acid; cytochrome P450 1A;
Stenotomus chrysops.
Metabolism of free arachidonic acid (AA2 ) released
from cell membranes by phospholipase A2 is catalyzed
by cyclooxygenases, lipoxygenases, and cytochrome
2 Abbreviations used: AA, arachidonic acid; AhR, aryl hydrocarbon
receptor, BNF, -naphthoflavone; BP, benzo(a)pyrene; CYP, P450, cy-
tochrome P450; DHET, dihydroxyeicosatrienoic acid; EET, epoxyeico-
satrienoic acid; EROD, ethoxyresorufin O-deethylase; ETCP, 1,2-epoxy-
3,3,3-trichloropropane; HETE, hydroxyeicosatetraenoic acid; NBT-B-
CIP, nitroblue tetrazolium/5-bromo-4-chloro-3-indoyl-phosphate; PeCB,
3,3',4,4',5-pentachlorobiphenyl; PFB, pentafluorobenzyl; TCDD, 2,3,7,8-
tetrachlorodibenzo-p-dioxin; TMS, trimethylsilyl.
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P450 (P450 or CYP) monooxygenases (1). P450s can
metabolize AA to three types of products (2). Allylic
oxidation forms midchain conjugated dienols or mid-
chain hydroxyeicosatetraenoic acids (5-, 8-, 9-, 11-, 12-,
or 15-HETE). w-Terminal hydroxylation forms C16-
through C20-alcohols of AA (16-, 17-, 18-, 19-, or 20-
HETE). Olefin epoxidation forms epoxyeicosatrienoic
acids (5,6-, 8,9-, 11,12-, and 14,15-EET), which are
metabolized to dihydroxyeicosatrienoic acids (DHET)
by epoxide hydrolases. In mammals, these AA metab-
olites have potent biological activities including inhibi-
tion of platelet aggregation, neutrophil aggregation,
and cyclooxygnase activity (3); alteration of endothe-
lial cell permeability, vascular tone, and cellular ion
fluxes (4-6); and stimulation of angiogenesis (7) and
peptide hormone release (8).
P450s in gene families 1-4 have been shown to metab-
olize AA, and the product profile depends on the CYP
isoform. CYP2B, CYP2J2, and CYP2C proteins are pri-
marily epoxygenases (9, 12), CYP2E1 and CYP4A are
primarily ao-terminal hydroxylases (13, 14), while
CYP2J3 and CYP2J4 catalyze both activities (15, 16).
CYP1A proteins show varied patterns of AA metabolism.
Purified rabbit or rat CYP1A1 and rat CYP1A2 form
primarily 16- through 20-HETE and form lesser amounts
of midchain HETEs and EETs (10, 17). In contrast, re-
combinant human CYPIA2 and chicken CYP1A5 are
primarily epoxygenases (9, 18). The regio- and stereo-
chemical selectivity of EET formation also varies with the
CYP1A protein catalyzing the reaction. Thus, the major
epoxide formed by rat CYP1A1 is 14,15-EET (10), that
formed by rat and human CYP1A2 is 11,12-EET (9, 10),
and that formed by chicken CYP1A5 is 8,9-EET (18). Rat
CYP1A1 favors production of 8(S),9(R)-, 11(S),12(R)-, and
14(R),15(S)-EET enantiomers (10). Rat CYP1A2 and
chicken CYP1A5 favor 8(S),9(R)-, 11(R),12(S)-, and
14(R),15(S)-EET (10, 18).
Consistent with observations that CYP1As can me-
tabolize AA, treatment of mammals or birds with aryl
hydrocarbon receptor (AhR) agonists (CYP1A induc-
ers) alters microsomal AA metabolism. However, the
response to treatment differs among species. In chick
embryos, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
or 13-naphthoflavone (BNF) induced liver microsomal
metabolism of AA to 8,9- and 11,12-EET by 6- to 10-fold
(19). In rabbits, 3-methylcholanthrene and BNF induce
19- and 20-HETE formation by renal and hepatic mi-
crosomes by 2-fold (20). Similarly, in guinea pigs BNF
induced a 3-fold increase in formation of 19- and 20-
HETEs by lung microsomes (21), and 3,3',4,4',5-penta-
chlorobiphenyl (PeCB) induced hepatic microsomal 20-
HETE formation by 2-fold (22). In rats, BNF and PeCB
decreased liver microsomal EET formation but in-
creased 16- through 19-HETE formation (10, 22, 23).
The inconsistent effects of CYPIA induction on AA
metabolism in vitro by different tissues and species
make it difficult to determine the significance of AhR
agonist effects on AA metabolism. Moreover, although
it has been suggested that such effects in vivo could
modulate or contribute to the toxicity of TCDD (19), we
are unaware of studies that have examined effects on
endogenous EET formation.
In this study we consider whether multiple P450s
catalyze AA metabolism, and the identity of metabolic
products, in fish, the earliest diverging vertebrate
group. We also address the hypothesis that AhR ago-
nists affect AA metabolism in fish. Fish possess AhRs,
and testing this hypothesis is important in determin-
ing whether effects on AA metabolism are involved in
AhR agonist toxicity generally. Preliminary studies in-
dicated that BNF treatment of the marine teleost fish
scup (Stenotomus chrysops) and the elasmobranch
skate (Raja erinacea) induced microsomal AA metabo-
lism in those species (24). Here we examine the in vitro
metabolism of AA by hepatic and extrahepatic micro-
somes of male and female scup, both untreated and
treated with CYP1A inducers. Regiospecific and ste-
reospecific metabolism of endogenous AA is described,
providing the first demonstration that in vivo metabo-
lism of AA is altered by benzo(a)pyrene (BP) and
TCDD. The results indicate that endogenous AA me-
tabolism can be altered to a greater extent than sug-
gested by microsomal rates measured in vitro.
MATERIALS AND METHODS
Materials. 1,2-Epoxy-3,3,3-trichloropropane was kindly provided
by Dr. Bruce Hammock (U.C. Davis). Benzo(a)pyrene, triph-
enylphosphine, a-bromo-2,3,4,5,6-pentafluorotoluene, N,N-diisopro-
pylethylamine, and N,N-dimethylformamide were purchased from
Aldrich (Milwaukee, WI). Purified rabbit IgG was purchased from
Cappel (Durham, NC). 8-, 9-, 12-, and 15-HETEs were purchased
from Cayman Chemical Co. (Ann Arbor, MI). I1-14C]Arachidonic acid
was purchased from DuPont-New England Nuclear (Boston, MA).
7-Ethoxyresorufin was purchased from Molecular Probes (Eugene,
OR). 2,3,7,8-Tetrachlorodibenzo(p)dioxin was purchased from Ultra
Scientific (North Kingstown, RI). All other chemicals and reagents
were purchased from Sigma (St. Louis, MO).
Animals. S. chrysops (scup) were purchased from the Marine
Biological Laboratory (Woods Hole, MA). The fish were originally
wild-caught and had been depurated for 6 months prior to use. Fish
were held in flow-through seawater tanks at 140C and maintained on
a diet of Purina Trout Chow. The studies were performed in accor-
dance with principles and procedures outlined in the NIH Guide for
the Care and Use of Laboratory Animals.
Treatment offish. Experimental animals ranged in size from 104
to 452 g. Experiments took place in March and May (spring) and July
(summer). Fish were injected intraperitoneally with corn oil (1 ml/
kg) or with solutions of BP (10 mg/kg) or TCDD (1 pg/kg) in corn oil.
These doses were selected based on previous work that has demon-
strated the greater potency of TCDD for CYPA induction [see (25)].
Each fish was kept in a separate tank postinjection. Three days
following injection, the fish were killed by severing the spinal cord.
Body and gonad weights were recorded and used to calculate the
percent of total body weight represented by the gonads. Livers,
hearts, kidneys, and gills were harvested. Portions of organs for
endogenous metabolite assays were frozen immediately and stored
in liquid N 2.
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Microsome preparation and assays. Microsomes were prepared
from freshly collected tissue by differential centrifugation (26). Mi-
crosomes were prepared from individual livers. Equivalent portions
of kidney, heart, and gill tissue from each of the fish used in the
spring induction study were pooled before microsomes were pre-
pared. Microsomes were resuspended in 0.15 M KCI following the
initial sedimentation and resedimented. Pellets were resuspended in
buffer (50 mM Tris-Cl, pH 7.4, 1 mM dithiothreitol, 1 mM EDTA,
20% glycerol) and frozen in liquid N2 until use. Protein content was
determined using the bicinchoninic acid method, with bovine serum
albumin as a standard (27). Ethoxyresorufin O-deethylase (EROD)
activity was determined fluorometrically as previously described
(28). Dithionite-difference spectra of CO-treated microsomes were
obtained as previously described (29).
Western blotting. Immunoblotting procedures used here were mod-
ified from those previously described (30). Briefly, microsomal proteins
(10-80 pg/ane) were resolved on 12% SDS-PAGE gels and transferred
to either nitrocellulose or nylon membrane. The primary antibodies
were mouse monoclonal antibody 1-12-3 (31) against scup CYP1A (32)
and rabbit polyclonal antibody 7-94 against scup P450B (a CYP2B-like
protein) (33). PAb 7-94 does not cross-react with purified CYP1A (33)
but does cross-react weakly with CYP2N and CYP2P from the fish
Fundulus heteroclitus.3 The secondary antibody to MAb 1-12-3 was goat
anti-mouse alkaline phosphatase and to PAb 7-94 was goat anti-rabbit
alkaline phosphatase (Schleicher and Schuell, Keene, NH). Immunore-
active proteins were visualized with nitroblue tetrazolium and 5-bromo-
4-chloro-3-indoyl-phosphate (NBT-BCIP) or enhanced chemilumines-
cence (Tropix, Bedford, MA). CYP1A- and CYP2B-like proteins detected
were quantified by video image analysis by comparison to scup stan-
dards of known concentration.
Analysis of microsomal metabolites and antibody inhibition studies.
Duplicate reaction mixtures containing 0.5 IU/ml isocitrate dehydro-
genase, 2.0 mg/ml microsomal protein, and (1- 1 4 C]AA (55-57 /Ci/
pmlol; 50-70 M, final concentration) were shaken constantly at
30*C. After a 5-min temperature equilibration, NADPH (1 mM, final
concentration) was added to initiate the reaction. At various time
points, the reactions were stopped by the addition of ethyl ether, and
the organic soluble products were extracted three times. Samples
were dried under a N2 stream, separated by reverse-phase HPLC,
and quantified by on-line liquid scintillation using a Radiomatic
Flo-One l-detector (Radiomatic Instruments, Tampa, FL) as previ-
ously described (2). Determination of the regiochemistry of epoxida-
tion required greater reverse-phase separation and was performed
as previously described (34). Formation of each regioisomer was
calculated as the sum of the EET and the DHET and, in the case of
the 5,6-olefin, the &-lactone as well. For antibody inhibition experi-
ments, microsomes from freshly caught fish obtained in fall were
used. These fish had appreciable levels of CYP1A and higher levels of
CYP2B-like protein than did the fish used in the treatment experi-
ments. Normal rabbit IgG, the polyclonal antibody 118 against scup
CYPIA (30), or the polyclonal antibody 7-94 against scup P450B (33)
were added to the reaction mixtures at a protein/total P450 ratio of
4, 8, or 16 mg total IgG/nmol ofP450. After 15 min at 30*C, [1-14CIAA
was added, and the reaction was initiated with NADPH. Metabolites
were extracted, resolved, and quantified as before (2). To determine
EET chirality, 1 mM 1,2-epoxy-3,3,3-trichloropropane (ETCP), an
epoxide hydrolase inhibitor, was included in the incubation, and the
samples were resolved into individual regioisomers and enantiomers
by HPLC as described (35, 36). To resolve the hydroxylation prod-
ucts, fractions corresponding to minutes 15-23 on reverse-phase
HPLC were collected batchwise, dried under N2 , and separated by
normal-phase HPLC as described (23, 37). A UV detector (Waters
Model 990) monitored the HETE standards at 234 nm (12-, 15-, 11-,
9-, and 5-HETEs) and 210 nm (16-, 17-, 19-, and 20-HETEs). The
' M. F. Oleksiak and J. J. Stegeman, unpublished observations.
microsomal II-' 4CIHETEs were monitored by a Radiomatic Flo-One
-detector.
Quantification of endogenous EETs and DHETs in scup tissues.
Methods used to quantify endogenous EETs and DHETs in scup tissues
were similar to those used with rat and human tissues (12, 36). Briefly,
frozen tissues were homogenized in 15 ml phosphate-buffered saline
containing the peroxide-reducing agent triphenylphosphine (5-10 mg).
The homogenates were extracted twice, under acidic conditions, with 2
volume of chloroform/methanol (2:1) and once with an equal volume of
chloroform. The combined organic phases were neutralized and evapo-
rated in tubes containing mixtures of [1-14C]8,9-, 11,12-, and 14,15-EET
(55-57 pCi/mol, 80 ng each) or (1-"4C]8,9 -, 11,12-, and 14,15-DHET
(55-57 ItCilpmuol, 20 ng each) internal standards. Saponification to
recover phospholipid-bound EETs and DHETs was followed by SiO2
column purification. The eluent, containing a mixture of radiolabeled
internal standards and total endogenous EETs and DHETs, was re-
solved into individual regioisomers and enantiomers by HPLC as de-
scribed (35, 36). Individual EET pentafluorobenzyl (PFB) esters were
dissolved in dodecane and analyzed by GC/MS on a VG TRIO-1 quad-
rupole mass spectrometer (Fisons/VG, Altrincham, United Kingdom)
operating under negative-ion chemical ionization conditions (source
temperature, 1006C; ionization potential, 70 eV; filament current, 500
pA) at unit mass resolution and using methane as a bath gas. Quanti-
fications were made by selected ion monitoring of m/z 319 (loss of PFB
from endogenous EET-PFB) and m/z 321 (loss of PFB from [1-14C]-
EET-PFB internal standard). Aliquots of individual DHET-PFB-tri-
methylsilyl (TMS) ether derivatives were dissolved in dodecane and
analyzed by GC/MS as described (12). Quantifications were made by
selected ion monitoring ofm/z 481 (loss of PFB from endogenous DHET-
-PFB-TMS) and m/z 483 (loss of PFB from [1-14CJDHET-PFB-TMS
internal standard). EET-PFB/[1-14C]EET-PFB and DHET-PFB-
TMS/[1-"4CIDHET-PFB-TMS ratios were calculated from the inte-
grated values of the corresponding ion current intensities.
Other methods. [1- 14CIEET internal standards were synthesized
from [1- 14C]AA (55-57 jtCi/pmol) by nonselective epoxidation as
previously described (38). DHET and [1- 14C]DHET internal stan-
dards were prepared by chemical hydration of EETs and [1-14C]-
EETs (39). The w-terminal HETEs were synthesized as previously
described (23, 40). All synthetic EETs, DHETs, and HETEs were
purified by reverse-phase HPLC (2). Methylations were performed
using an ethereal solution of diazomethane (41). PFB esters were
formed by reaction with pentafluorobenzyl bromide as described (36).
TMS ethers were prepared using 25% (v/v) bis(trimethylsilyl)triflu-
oroacetamide in anhydrous pyridine (42).
Statistics. Statistics were calculated using SuperAnova (Abacus
Concepts, Inc., Berkeley, CA) for Macintosh. Student's t test and
single-factor ANOVAs in combination with the Tukey-Kramer mul-
tiple comparisons test were used to determine significance. All data
are reported as means t SE.
RESULTS
Characterization of Scup Liver Microsomes
Prior to use in AA metabolism studies, liver micro-
somes from variously treated fish were characterized.
Levels of total spectral P450, immunoreactive CYP1A
protein, and CYP1A catalytic activity (EROD) in liver
microsomes of control male and female fish are shown
in Table I. In spring, control female fish had less total
P450, CYP1A, and EROD activity than did males;
these values increased in summer (Table I). The con-
tent of the major protein recognized by anti-P450B
(putative CYP2B) also was less in females than in
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TABLE I
Characterization of P450 in Liver Microsomes
Total spectral P450 CYP1A EROD activity
Treatment n Sex (nmol/mg) (pmol/mg) (pmol/min/mg)
Spring
Control 3 Male 0.410 ± 0.180 1 ± 1 175 ± 112
4 Female 0.122 ± 0.034 nd 90 ± 18
Summer
Control 4 Male 0.404 : 0.065 12 ± 3 736 ± 157
3 Female 0.212 2 0.028 5 ± 0 168 ± 44
BP 5 Male 0.902 ± 0.031* 321 ± 13* 8973 ± 163*
3 Female 0.596 ± 0.123* 222 ± 46* 7364 ± 919*
TCDD 5 Male 0.725 ± 0.100* 237 ± 40* 8090 ± 960*
2 Female 0.321, 0.428" 130, 133 4668, 5995*
Note. Scup liver microsomes were characterized for their total P450 content, CYP1A content, and CYPIA catalytic activity (EROD) as
described under Materials and Methods. Values are means ± SE. Spring and summer indicate the season in which experiments took place
and fish were killed. Low levels of CYP1A detected in control fish are consistent with the fact that these fish had depurated for only 6 months.
Longer times result in a further decrease of signal. Microsomes from these fish were used to determine rates of AA metabolism and the
distribution of products. nd, not detectable.
a Individual values.
* Significantly different from control (P < 0.05, Tukey-Kramer).
males in spring (P < 0.05,417 ± 81 vs density units/mg
microsomal protein 876 ± 95 density units/mg micro-
somal protein), but not in summer. Gonad-body
weight ratios were significantly different in spring and
summer (P < 0.002, spring: 3.8 ± 0.5, n = 7; summer:
2.3 ± 0.2, n = 22). The trend of the relationship be-
tween gonad size, P450 levels, and CYPIA activity in
females is consistent with previous observations that
gonadal status affects P450s and their activity in scup
liver (43).
Treatment of male scup with either BP (10 mg/kg) or
TCDD (1 pg/kg) resulted in significant increases in
total P450 (1.8- to 2.2-fold), corresponding to the in-
crease in CYPA content (20- to 27-fold) (Fig. 1 and
Table I). EROD activity increased 11- to 12-fold follow-
ing treatment with either BP or TCDD (Table I). BP or
TCDD induced total P450 content, CYP1A immunore-
Lane
1234567
FIG. 1. Immunodetection of CYPlA in scup liver microsomes. Liver
microsomal fractions prepared from scup treated with corn oil (80
±g/lane), BP (10 pLglane), or TCDD (10 g/lane) were electropho-
resed, transferred to nitrocellulose, and immunoblottedc with MAb
1-12-3 against scup CYP1A. Lanes 1-3, corn oil; lanes 4 and 5,
BP-treated; lanes 6 and 7, TCDD-treated. Visualization by NBT-
BCIP.
active protein, and EROD activity also in female scup
(Table I). The amounts of CYP2B-like protein were not
increased and if anything were decreased by treatment
(control, 1110 ± 161; BP, 725 ± 170; TCDD, 669 ± 135
density units/mg protein).
Liver Microsomal AA Metabolism
Hepatic microsomes prepared from control male
and female fish incubated with [1-1 4C]AA, NADPH,
and an NADPH-regenerating system formed EETs,
DHETs, midchain HETEs, and w-terminal HETEs
(Fig. 2). Identity of the metabolites was verified by
coelution with authentic standards on reverse-phase
and normal-phase HPLC and by GC/MS analysis (2,
37). Epoxygenase metabolites (EETs and DHETs)
were the major products, accounting for 44 ± 2% of
total metabolites formed by both male or female liver
microsomes, regardless of season. Lesser amounts of
midchain HETEs, o-terminal HETEs, and polar me-
tabolites were produced (26 ± 2, 13 - 1, and 11 ± 2%
of total metabolites, respectively). Metabolite forma-
tion was NADPH-dependent and increased linearly
with time and protein concentration (data not
shown). The reaction rate was temperature depen-
dent, with the maximum reaction rate occurring at
30*C (data not shown), as with other scup liver P450
reactions (26).
Microsomal epoxidation of AA was highly regioselec-
tive, with a strong preference for epoxidation at the
5,6-olefin (47 ± 2% of total EETs, n = 3 summer
males). Epoxidation at the 14,15-, 11,12-, and 8,9-ole-
fins occurred less often (27 ± 1, 13 ± 1, and 13 ± 1%,
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FIG. 2. Reverse-phase HPLC chromatograms of the organic soluble arachidonic acid metabolites generated by scup liver microsomes. (A)
Untreated female scup. (B) BP-treated female scup. (C) Untreated male scup. (D) BP-treated male scup. Scup liver microsomes (2 mg/ml
protein) were incubated with [I1-1 CJAA (50-70 iLM), NADPH, and an NADPH-regenerating system at 30°C for 1 h. Products were extracted,
dried under a N2 stream, separated by reverse-phase HPLC, and quantified by on-line liquid scintillation as under Methods (2). Products
were identified based on coelution with authentic standards. A similar amount of radioactivity was injected onto the column in each case.
Data are from the spring experiment. Ordinate, radioactivity in cpm; abscissa, time in minutes.
respectively; n = 3). We were unable to determine the
stereochemistry of the epoxides as they were hydrated
to DHETs by microsomal epoxide hydrolase (17). Ad-
dition of ETCP did not completely block the activity;
DHETs still represented 24-49% of epoxygenase me-
tabolites in reactions containing ETCP. Hydroxylation
of AA also occurred in a regioselective manner (Table
II). 12-HETE was produced in the greatest amount
(23% of total HETEs) followed by lesser amounts of 19-,
15-, 20-, 11-, 8-, 9-, and 17-HETE.
Hepatic microsomal AA metabolism differed by 4.2-
fold (P < 0.05) between sexes in fish sampled in spring
(Figs. 2 and 3). In summer, the rates increased in
females, and they were not significantly different from
rates in males (135 ± 18 pmol/min/mg vs 180 ± 18
pmol/min/mg, respectively).
To investigate the contribution of individual P450s
to scup liver microsomal metabolism of AA, we per-
formed inhibition studies using PAb 118 against scup
CYPA and PAb 7-94 against scup P450B (Table III).
Metabolism was inhibited progressively by increasing
amounts of either antibody (Table III). Addition of the
anti-CYP1A and anti-P450B antibodies together re-
sulted in approximately additive inhibition, up to 70%
of microsomal AA metabolism (Table III). Epoxygenase
and hydroxylase reactions were inhibited similarly.
The results above suggest that CYP1A contributes in
part to AA metabolism in scup liver. To investigate
further a role for teleost CYP1A, we examined the
effects of CYPLA induction on microsomal metabolism
of AA. In male and female scup, BP treatment signifi-
cantly increased the total rate of formation of AA me-
0 10 20 30 40
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TABLE II
Regioselectivity of HETE Formation by Liver Microsomes
from Untreated and BP-Treated Scup
Distribution (%) of HETE formation
in microsomes from
HETE Control scup BP-treated scup
8- 6-2 1±1
9- 4±2 22
11- 11 4 16 ± 1
12- 23 ±4 19 ±3
15- 12 4 12 ± 7
16- 19 ±3 21 ± 2
17- 1±1 5±3
19- 13 ± 4 21 ± 6
20- 12 ± 4 4±t 2
Note. Scup liver microsomes (2 mg/ml protein) were incubated with
(1-14CIAA(50-70 PM), NADPH, and a NADPH-regenerating system
at 30C for 1 h. Fractions corresponding to minutes 15-23 on reverse-
phase HPLC were collected batchwise, dried under N2, and resolved
into individual regioisomers by normal-phase HPLC (23, 37). Mini-
mal amounts of 5-HETE were detected. Data are from fish in sum-
mer experiments. Values are means : SE (n = 3-5). Rate of total
HETE formation was 35 t 14 pmol/min/mg (N = 8) by control scup
liver microsomes and 63 ± 10 pmol/min/mg (N = 8) by liver micro-
somes from BP-treated scup.
tabolites, by 2.7-fold in spring and 1.7-fold in summer
(Fig. 4). Comparable increases occurred in EETs,
HETEs, and unidentified polar metabolites (Fig. 2).
Treatment did not alter significantly the regioselectiv-
ity for AA-epoxide formation by liver microsomes (data
not shown). BP-treated animals in summer showed a
2-fold induction in the formation of 19-HETE and a
5-fold induction of 17-HETE (a minor metabolite) (Ta-
ble II). In contrast to BP, TCDD treatment in summer
did not significantly induce microsomal metabolism of
AA (Fig. 4), despite significant increases in total P450,
CYP1A protein, and activity (Table I).
Endogenous EET and DHET Content of Scup Liver
EETs and DHETs were detected as endogenous con-
stituents of scup liver. Control fish livers contained 61 ±
5 ng EET/g tissue (Table IV) and 14 ± 3 ng DHET/g
tissue. The predominant EETs recovered from untreated
fish liver were 8,9- and 14,15-EET, followed by a lesser
amount of 11,12-EET (Table IV). The labile 5,6-EET
could not be quantified. BP treatment resulted in a five-
fold increase in total liver EETs with a disproportionate
increase in the amount of 14,15-EET recovered, from 31
to 64% of the total (Table IV). TCDD treatment resulted
in a threefold increase in total liver EETs, with a lesser
shift in favor of the 14,15-EET (Table IV). In liver from
untreated fish the S,R-enantiomers of 8,9-, 11,12-, and
14,15-EET were predominant (optical purity 80, 64, and
64%, respectively) (Table IV). Importantly, treatment
with BP significantly increased the selectivity for the
S,R- enantiomer of the three endogenous EETs measured
in scup liver (Table IV).
Metabolism of AA in Extrahepatic Scup Tissues
AA metabolism by heart, kidney, and gill was exam-
ined using microsomal preparations of tissues from
control and BP-treated fish. Microsomes from these
tissues when incubated with [1- 14C]AA, NADPH, and
an NADPH-regenerating system formed EETs,
DHETs, midchain HETEs, and -terminal HETEs.
HPLC analysis of EETs and DHETs indicated epoxi-
dation at the 5,6-, 8,9-, 11,12-, and 14,15-olefins by
heart, gill, and kidney microsomes. Individual HETEs
could not be identified because the radioactivity was
too low for further normal-phase separation. The over-
all rates were 10- to 30-fold less than those observed
with liver microsomes (activity in heart ranged from
9.9 to 10.6 pmol/min/mg; in gill, 2.8 to 3.9 pmol/min/
mg; and in kidney, 4.7 to 7.2 pmol/min/mg). Extrahe-
patic microsomal AA metabolism rates were not in-
duced by BP (data not shown). To confirm that AA
metabolism occurs in vivo in scup extrahepatic organs
and to examine the effects of BP, endogenous EETs
were measured in heart and kidney. In the summer
experiment, heart and kidney from untreated fish con-
tained moderate amounts of 8,9-, 11,12-, and 14,15-
EET (Table V). 8,9-EET was the most prominent re-
gioisomer in heart (42% of total EETs), and 14,15-EET
was the most prominent regioisomer in kidney (43% of
total EETs). BP treatment did not significantly alter
the concentration of total EETs present in heart or
250
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FIG. 3. Seasonal and sex differences in scup liver microsomal me-
tabolism of arachidonic acid. Scup liver microsomes (2 mg/ml pro-
tein) were incubated with [1-"'C]AA (50-70 ;pM), NADPH, and an
NADPH-regenerating system at 30*C for 1 h. Products were pro-
cessed, identified, and quantified as described in the legend to Fig. 2.
Spring includes March and May. Data are means ± SE. *Significant-
ly different from spring (P < 0.01, Student's t test). Ordinate, AA
metabolism in pmol product formed/min/mg microsomal protein; ab-
scissa, gender and seasonal group.
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TABLE III
Antibody Inhibition of Scup Liver Microsomal Metabolism of Arachidonic Acid
% Inhibition
Anti-CYPIA Anti-P450B Anti-CYPIA + anti-P450B
4 mg/nmol 8 mg/nmol 4 mg/nmol 8 mg/nmol 4 mg each/nmol 8 mg each/nmol
Metabolites P450 P450 P450 P450 P450 P450
Total 21, 6 44, 21 44, 8 48, 44 34 70
EET/DHET 24, 0 49, 17 49, 3 50, 43 30 67
HETE 16, 5 37, 20 37, 7 44, 34 32 65
Note. Normal rabbit IgG, the polyclonal antibody 118 against scup CYP1A, or the polyclonal antibody 7-94 against scup P450B was added
to microsomal reaction mixtures at protein/total P450 ratios of 4, 8, or 16 mg total IgG/nmol of P450. After 15 min at 30*C, [I- 14CIAA (50-70
pM) was added, and the reaction was initiated with NADPH. Metabolites were extracted, resolved, and quantified as before (2). % Inhibition
was calculated by comparing the metabolism by microsomes in incubations with specific antibodies to that by microsomes incubated under
identical conditions with the same concentration of normal rabbit IgG. Data represent metabolism in a single individual. One individual had
a greater amount of CYPA than the other, but both had similar amounts of P450B. Microsomes from a third individual were incubated with
2.5, 5, and 10 mg anti-CYP1A/nmol P450; increasing inhibition of AA metabolism also was seen.
kidney (Table V). However, the relative concentration
of 14,15-EET tended to increase in heart of BP-treated
fish (Table V).
The stereochemical composition of endogenous EETs
in scup heart and kidney was determined from a pooled
sample of three organs from control animals (Table V).
In kidney, the 8(S),9(R)- and 11(S),12(R)-EETs were
recovered in excess (79 and 69%, respectively). In
heart, the 11(S),12(R)- and 14(S),15(R)-EETs were re-
covered in excess (65 and 77%, respectively). In con-
trast to those EETs and to the liver and kidney, the
8,9-EET showed a strong preference for the 8(R),9(S)-
enantiomers (78% optical purity). The stereochemistry
of EETs formed in extrahepatic organs of BP-treated
fish was not determined.
DISCUSSION
Metabolism of AA by cytochromes P450 results in
products that are physiologically active, affecting a
variety of functions including peptide hormone release
(8), platelet aggregation (3), fluid electrolyte transport
(44), and vascular tone [as reviewed in (5)]. Alteration
in the expression of specific CYP isoforms may affect
these biological processes. A general understanding of
the importance of P450-derived eicosanoids in control-
ling physiological processes may be aided by examining
AA metabolism in early vertebrate species and identi-
fying the CYP isoforms involved: Here we determined
that P450s including CYPlA- and 2B-like proteins in
hepatic microsomes of the marine fish scup (S. chry-
sops) catalyze regioselective metabolism of AA to EETs
and HETEs. Recovery of endogenous AA epoxides from
scup liver, heart, and kidney establishes that fish
P450s metabolize AA in vivo. BP treatment induced
rates of liver microsomal AA metabolism, but that ef-
fect varied with season. Endogenous AA epoxide con-
tent, particularly in liver, was significantly elevated by
BP even when microsomal rates were only slightly
induced. The effects of TCDD on endogenous metabo-
lism were qualitatively similar to those of BP.
Hepatic Metabolism of AA
Untreated scup liver microsomes metabolized AA
predominantly to EETs and also to HETEs. Similarly,
rat, rabbit, and human liver microsomes all favor ep-
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FIG. 4. Effect of BP and TCDD treatment on scup liver microsomal
metabolism of arachidonic acid. Scup liver microsomes (2 mg/ml
protein) were incubated with [1- 14 C]AA (50-70 IpM), NADPH, and
an NADPH-regenerating system at 30*C for 1 h. Products were
processed, identified, and quantified as described in the legend to
Fig. 2. In the March experiment, each dose group consisted of two
females and one male. In the July experiment, each dose group
contained seven to eight fish of mixed sex. Data are means ± SE.
#Significantly different from control (P < 0.1, Student's t test). *Sig-
nificantly different from control (P < 0.05, Tukey-Kramer). Ordi-
nate, AA metabolism in pmol product formed/min/mg microsomal
protein; Abscissa, treatment group.
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oxidation of AA (9, 10, 17, 45). In contrast, chick em-
bryo liver microsomes favor -terminal hydroxylation
of AA (18). Scup liver microsomes had lower rates of
AA metabolism (0.1-0.2 nmol/min/mg microsomal pro-
tein) than did rat, chicken, or human liver microsomes
(0.5, 1.3, and 0.6 nmol/min/mg, respectively) (9, 10, 18,
45). However, the rate obtained with scup was similar
to that measured in liver microsomes of another fish,
F. heteroclitus (0.2 nmol/min/mg).' Similarly, the con-
centration of endogenous EETs in scup liver was six- to
eightfold less than that seen in human or rat liver but
was comparable to that in F. heteroclitus liver (41).5
Both the regio- and stereochemistry of scup liver en-
dogenous EETs differ from that found in F. heterocli-
tus, rat, and human liver (36, 41, 45). 5
Species differences in the amount of endogenous eico-
sanoids recovered may reflect differences in the amount
of AA present endogenously in cell membranes. Marine
fish contain less AA and greater amounts of n-3 fatty
acids (e.g., eicosapentaenoic acid) than do mammals or
freshwater fish (46), presumably due to differences in diet
and in ability to elongate fatty acids (47). However, dif-
ferences in the identity and abundance of specific metab-
olites will depend more on the P450 isoforms involved.
The results here and those of Oleksiak et al.4,s establish
that multiple teleost P450s metabolize AA. Antibody in-
hibition indicated that CYP1A and a CYP2B-like protein
contribute to AA metabolism in scup liver microsomes
and may account for 70% of total AA metabolism. Mem-
bers of two new subfamilies in the CYP2 gene family,
CYP2N and CYP2P, recently identified in the fish F.
heteroclitus, also catalyze AA epoxygenase and hydroxy-
lase reactions.4"5 Homologues of CYP2N and CYP2P have
been identified in scup liver3 and likely contribute to AA
metabolism in this species. CYP4 genes occur in fish (48),
but homologues of CYP2C, prominent AA epoxygenases
and hydroxylases in mammalian liver (45), have not been
identified in fish. Having established that there are mul-
tiple CYP involved in AA metabolism in fish provides a
foundation for determining the regulation of metabolite
formation by P450 pathways in these early vertebrates
and their relationship to P450-mediated AA metabolism
in mammalian systems.
Sex and Seasonal Differences in Hepatic AA Metabolism
Microsomal AA metabolism in scup showed season-
ally dependent sex differences that could result from
hormonal regulation of P450 gene expression. In con-
trol fish in spring (i.e., during gonadal development),
females had lower AA metabolism rates than males. In
'M. F. Oleksiak, S. Wu, C. Parker, J. J. Stegeman, and D. C.
Zeldin, in preparation.
s M. F. Oleksiak, S. Wu, C. Parker, D. C. Zeldin, and J. J. Stege-
man, in preparation.
TABLE IV
Endogenous EET Content in Scup Liver Following
Treatment with CYP1A Inducers
Enantioselectivity
EET Distribution of EET
concentration of EET
Regioisomer (nig/g) (%) (%R, S) (%S, R)
Control
14,15- 19± 1 31 36± 6 64± 6
11,12- 13 1 21 36 ± 2 64 ± 2
8,9- 29± 5 48 20 ± 3 80 ± 3
Total 61 ± 5 100
BP
14,15- 208 ± 62* 64 17 ± 5 83 ± 5
11,12- 39 ± 7* 12 16 ±2 84 : 2
8,9- 77 ± 13* 24 9 ± 0 91 ± 0
Total 324 ± 81* 100
TCDD
14,15- 93 ± 8*** 51 ND ND
11,12- 32 ± 3** 18 ND ND
8,9- 59 ± 7*** 31 ND ND
Total 184 ± 17*** 100
Note. Endogenous scup liver 14,15-, 11,12-, and 8,9-EET were
extracted, purified, and quantified as described under Materials and
Methods. Data are from male fish in the summer experiment. Fe-
males and the spring experiment with BP gave similar results.
Concentration values are means ± SE (n = 3-4). ND, not deter-
mined.
* Significantly different from control (P < 0.01, Tukey-Kramer).
** Significantly different from control (P < 0.05, Tukey-Kramer).
*** Significantly different from control (P < 0.03, Student's t test;
P < 0.1, Tukey-Kramer).
summer (i.e., post-spawning), there was no significant
sex difference in the rates of AA metabolism. CYP1A
and CYP2B- and CYP3A-like proteins are suppressed
by estradiol treatment or during natural maturation of
female fish (43, 49). The lesser amounts of CYP1A and
putative CYP2B in female scup in spring indicate that
at least two CYPs may contribute to the sex differences
in AA metabolism in scup liver. However, expression of
hepatic CYP2P and CYP2N, homologues of which occur
in scup, does not differ between sexes of F. heterocli-
tus.4.s In rats, CYP2A, CYP2C, and CYP4A genes show
sex differences in expression (50, 51); there might be
sex differences in AA metabolism in rats. The physio-
logical significance of sex-linked differences in hepatic
AA metabolism in any species is not known.
Extrahepatic Metabolism of AA
P450-mediated AA metabolism also was demon-
strated in scup heart, gill, and kidney, organs in which
AA metabolites might be expected to be of physiological
importance. Similar to human and rat kidney cortex
(36, 52), the 14,15- and 8,9-EETs predominate in scup
kidney. Interestingly, concentrations of endogenous
EETs were as high in scup kidney as they were in liver,
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TABLE V
Endogenous EET Content of Scup Heart and Kidney
Control BP-treated
EET content Enantioselectivity of EETs EET content
Organ EET regioisomer (ng/g) (%) (%R, S) (%S, R) (ng/g) (%)
Heart 14,15- 11 ± 2 35 23 77 15 ± 2 52
11,12- 7 ± 1 23 35 65 6± 1 22
8,9- 13 ± 3 42 78 22 8± 2 26
Total 34 6 29 6
Kidney 14,15- 35 ± 9 43 ND ND 41± 5 46
11,12- 17 ± 2 21 31 69 17± 1 19
8,9- 29 ± 2 36 21 79 32 ± 2 35
Total 80 ± 20 92 11
Note. Endogenous scup heart and kidney 14,15-, 11,12-, and 8,9-EET were extracted, purified, and quantified as described under Materials
and Methods. Data are from fish in summer experiments. Concentration values for EETs are means : SE from three pools of two to three
individuals. ND, not determined because the "4C/12C ratio was too low for quantification.
suggesting that P450-derived EETs may be important
to kidney function in fish. In mammalian kidney, EETs
and HETEs modulate Na+/K -ATPase, alter Ca 2 +
flux, affect proximal tubule sodium transport, and have
vasoactive effects [see (44)].
The regioisomeric distribution of EETs in scup heart
was similar to that in liver and kidney; however, the
enantiomeric selectivity was different. In contrast to
scup liver and to human and rat heart (12, 15), the
8(R),9(S)-EET predominated in scup heart. Oleksiak et
al.5 determined that CYP2N2 cloned from F. heterocli-
tus heart forms 8(R),9(S)-EET; thus, a CYP2N2 homo-
logue might contribute to the enantioselectivity seen in
scup heart. EETs have been shown to modulate mam-
malian cardiac physiology (15, 53), and their presence
in scup heart may indicate a physiological role for
these AA metabolites in fish heart as well.
CYPIA and AA Metabolism
Following BP treatment of scup, total hepatic micro-
somal AA metabolism increased 2-fold, with compara-
ble increases occurring in hydroxylase and epoxygen-
ase reactions. The regiochemistry of EETs was unaf-
fected by treatment, but hydroxylation shifted in favor
of 17- and 19-HETE. This is similar to results with
some, but not all, other species treated with AhR ago-
nists. In rats, BNF and PeCB decrease total hepatic AA
metabolism, mainly resulting from a suppression of
EET formation, while formation of 16- through 19-
HETE increases (22, 23). In guinea pig and rabbit, AhR
agonists increase total hepatic AA metabolism 2-fold,
with increases mainly in HETE formation (20, 22). In
chick embryo liver, AhR agonists increase total AA
metabolism and formation of EETs 6- to 10-fold (19).
A major question concerns whether effects on AA
metabolism contribute to AhR agonist toxicity (19) and
whether this involves induction of CYP1A. Several re-
sults support a hypothesis that AhR agonists affect AA
metabolism in scup, possibly through CYP1A induc-
tion. (i) Specific antibodies to CYP1A inhibited AA
metabolism in scup liver microsomes. (ii) Treatment of
scup with the CYP1A inducer BP produced an expected
strong induction of CYP1A in liver and increased liver
microsomal AA metabolism, in both epoxygenase and
hydroxylase reactions. (iii) Treatment with BP or
TCDD increased endogenous hepatic EET content. (iv)
Both the regio- and stereochemical profiles of liver
EETs were altered following BP treatment, favoring
the 14,1.5-EET and the S,R-enantiomers of all three
EETs. (v) TCDD also caused a shift favoring the 14,15-
EET in liver. (vi) The regiochemical EET profile in
heart shifted in favor of 14,15-EET following treatment
with BP. On the other hand, BP treatment did not alter
the total endogenous EET content in scup kidney or
heart and did not alter the regiochemical profile of AA
metabolites in the kidney; CYP1A is strongly induced
in those organs by BP (unpublished observations).
Also, treatment of scup with TCDD did not alter rates
of liver microsomal AA metabolism. While the antibody
inhibition results and inducer effects on endogenous
EETs suggest that CYP1A catalyzes AA metabolism in
scup, the TCDD and extrahepatic data are not fully
consistent with this conclusion.
TCDD effects on scup liver AA metabolism were
qualitatively similar to those of BP, but were less
strong, even though both compounds elicited similar
induction of hepatic CYP1A. A difference in AA metab-
olism could occur if BP and TCDD induced different
P450s in scup liver. In chick embryo there are two
CYPlAs which have different efficiencies for AA me-
tabolism (18). Phylogenetic analysis of CYP1A genes
(32) suggests that many fish, including scup, have a
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single CYP1A gene. [Multiple CYP1A genes in trout
represent a very recent divergence (32), distinct from
the divergence in birds and mammals.] Scup CYP1A
expressed in Chinese hamster V-79 cells has catalytic
properties of both mammalian CYP1A1 and CYP1A2,
consistent with the hypothesis that teleost CYPlAs
represent a type ancestral to both of the mammalian
genes (54); however, we cannot rule out that scup have
an inducible CYP not yet identified. Also, BP, but not
TCDD, might induce CYP1A through binding to gly-
cine N-methyltransferase (55) present in scup (56).
Whether different induction processes affect CYPlA
expression in fish is unknown.
To our knowledge, these are the first observations of
effects of TCDD or BP on endogenous AA metabolism.
While CYPA may be involved, alteration of AA metab-
olism in vivo by BP or TCDD might occur through pro-
cesses additional to CYP1A induction, perhaps involving
effects on membrane structure. TCDD causes a loss of
membrane fluidity, possibly by stimulation of lipid per-
oxidation (57), and a decrease in 20:5 and 22:5 polyun-
saturated fatty acids (58). BP causes a transition in mem-
branes from the gel to liquid crystal state (59), although
the effect of this transition on AA availability is not
known. That effects of BP and TCDD cannot be ascribed
solely to their action as AhR agonists is indicated, for
example, by effects of BP but not TCDD on expression of
epidermal growth factor receptors, transforming growth
factor p-1 and c-myc in human placental choriocarcinoma
cells (60), and evidence for an AhR-independent induc-
tion of fos and jun genes by TCDD (61).
Effects of BP treatment on extrahepatic AA metabolism
also are not entirely consistent with CYPlA being a catalyst
ofAA metabolism in scup. CYP1A is strongly induced in the
heart and kidney by AhR agonists (62) and is the dominant
P450 in heart of induced scup (63). However, induction of
CYPA did not affect cardiac microsomal AA metabolism,
although there was a modest increase in endogenous 14,15-
EET of BP-treated fish. CYP2N2 is highly expressed in
heart of some fish,s and a CYP2N homologue might be a
dominant AA metabolizing enzyme in scup heart. It will be
important to determine whether CYPA contributes to AA
metabolism in heart in vivo, given that CYP1A-derived AA
metabolites have been shown to possess potent cardioactive
(15, 53) and vasoactive effects (64). Neither the total endog-
enous EET content nor the regiochemical profile of EETs in
scup kidney was altered by treatment with BP. In contrast,
CYPA inducers have been shown to alter renal microsomal
AA metabolism in the rabbit (20). Proteins in the CYP2C
subfamily may dominate AA metabolism in mammalian
kidney (65). CYP2C homologues have not been identified in
fish, but certainly some isoforms other than CYP1A are
contributing to AA metabolism in teleost kidney.
In summary, the results here demonstrate that the
marine fish scup metabolizes AA in a regio- and ste-
reospecific fashion in vivo and in vitro, producing eico-
sanoids in organs including liver, heart, and kidney.
Physiological roles for cyclooxygenase- and lipooxygen-
ase-derived AA metabolites have been demonstrated in
fish (66, 67). Our results and those of Oleksiak et al.4.s
demonstrate that P450s are members of the AA meta-
bolic cascade in teleosts; P450-derived AA metabolites
may play physiological roles in fish, as they do in mam-
mals. Given the greater content of n-3 fatty acids in some
fish, it will be important to determine whether they also
are metabolized to biologically active metabolites by
teleost P450s. Treatment with AhR agonists produced
variable though generally weak effects on microsomal
metabolism of AA, but they had stronger effects on the
extent of metabolism of endogenous AA and affected the
regio- and stereospecificity of that metabolism. The alter-
ations in AA metabolism following BP or TCDD treat-
ment leave open the possibility that such changes may be
involved in toxicity of AhR agonists in early vertebrates,
although whether such metabolism might act in a pro-
tective way cannot be ruled out.
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CHAPTER 3
Oxidative Inactivation of Cytochrome P450 1A Stimulated by 3,3',4,4'-
Tetrachlorobiphenyl: Production of Reactive Oxygen by Vertebrate
CYP1As
ABSTRACT
Microsomal cytochrome P450 1A (CYP1A) in a vertebrate model (teleost fish scup
(Stenotomus chrysops)) recently was shown to be inactivated by the planar aryl
hydrocarbon receptor agonist 3,3',4,4'-tetrachlorobiphenyl (TCB) (Biochem. Pharmacol.
53, 1029-1040 (1997)). Here, the mechanism of CYPlA inactivation and its relationship
to substrate-dependent generation of reactive oxygen species (ROS) were examined in liver
microsomes.from scup and rat. Initially we confirmed that inactivation of scup CYP1A
activity (7-ethoxyresorufin O-deethylation (EROD)) by TCB was time- and NADPH-
dependent. This loss of EROD activity, equated with CYP1A inactivation, was irreversible
and dependent upon molecular oxygen. Microsomal NADPH oxidation rates increased
upon addition of TCB, and CYP1A inactivation was lessened by addition of cytochrome c.
Loss of EROD activity was accompanied by a loss of spectral P450, by a variable loss of
heme and by a variable appearance of P420. Rates of TCB metabolism were <0.5
pmol/min/mg, indicating that inactivation did not proceed via a TCB metabolite. Addition
of non-heme iron chelators (diethylenetriaminepenta-acetic acid and deferoxamine), anti-
oxidant enzymes (catalase and superoxide dismutase), and ROS scavenging compounds
(ascorbate, mannitol and tocopherol) had no influence on the inactivation. Added H202
enhanced the inactivation, but only the enhanced loss of activity could be eliminated by
addition of catalase. TCB-dependent CYP1A inactivation was accelerated by azide but not
by hydroxylamine or aminotriazole. TCB stimulated the formation of ROS when added to
microsomes with induced levels of CYP1A but not microsomes from untreated animals.
Moreover, as native CYPIA was lost due to TCB-dependent inactivation, there was a
concurrent reduction in ROS formation. TCB-stimulated inactivation of CYP1A also was
identified in rat liver microsomes. Liver microsomes from Aroclor-treated rats also showed
an increased ROS production when incubated with TCB. TCB stimulated ROS formation
by baculovirus expressed human CYP1A1 but not CYP1A2. The results indicate that slow
metabolism of TCB uncouples electron transfer to and monooxygenation by CYP1A,
resulting in inactivation due to the formation and attack of ROS within the CYP1A1 active
site. ROS formed by CYP1A bound with planar halogenated aromatic hydrocarbons may
contribute to the toxic effects of these compounds. Species differences in the metabolism
of and the inactivation by TCB also suggest differences in the topology of the substrate
access channels or the active sites of homologous CYP1As.
INTRODUCTION
Mechanisms by which planar halogenated aromatic hydrocarbons (pHAH)
(2,3,7,8-tetrachlorodibenzo-p-dioxin - TCDD, non-ortho polychlorinated biphenyls -
PCBs) exert toxicity are not understood fully. PHAH, polycyclic aromatic hydrocarbons,
and natural products are agonists of the aryl hydrocarbon receptor (AhR), a basic-helix-
loop-helix/PAS protein that is a ligand activated transcription factor (Hankinson, 1995).
AhR activation leads to altered expression of drug metabolizing enzymes (cytochrome P450
1A, glutathione S-transferase, UDP glucuronosyl transferase) and genes involved in cell
growth control (e.g. transforming growth factors-a and -8, B-Jun, Jun-D) (Hankinson,
1995). Mice rendered AhR deficient by locus-specific homologous recombination are
resistant to TCDD toxicity, indicating that toxicity of pHAH is dependent upon the AhR
(Fernandez-Salguero et al., 1996). The occurrence of oxidative damage in animals or cells
exposed to pHAH (Stohs et al., 1990; Buchmann et al., 1991; Toborek et al., 1995; Park
et al., 1996) suggests that toxicity of some AhR agonists might involve reactive oxygen
species (ROS).
Uncoupling of electron transfer and oxygen reduction from monooxygenation by
cytochromes P450 (CYP) can result in the release of ROS (02 -o and H202). Gillette et al.
(1957) first demonstrated microsomal NADPH-dependent generation of H202 by rabbit
liver microsomes. 02 -*, H202 and/or OH* also are formed by human or rat liver
microsomes in the presence of NADPH (Rashba-Step and Cederbaum, 1994; Reinke et al.,
1994). NADPH-stimulated formation of ROS by liver microsomes can be decreased by the
inhibitor SKF525A (Bondy and Naderi, 1994), implying CYP involvement. CYP forms
including CYP2E1, CYP2B4 and CYP3A have been shown to release ROS, usually upon
substrate binding, which accelerates electron transfer to CYP heme (Kuthan and Ullrich,
1982; Ekstrom et al., 1986; Ahmed et al., 1995). However, for most CYP, the degree to
which uncoupling occurs and the conditions that might favor uncoupling are not known.
This study considers uncoupling of and ROS formation by CYP1As.
Suggestions that CYP1A can produce ROS initially came from studies of
microsomal oxidation of uroporphyrinogen and bilirubin. That oxidation was suggested to
occur as a result of ROS formed during uncoupling of the CYP1A catalytic cycle by non-
ortho PCBs (Sinclair et al., 1986; DeMatteis et al., 1991). Oxidative damage correlated
with CYP1A induction following treatment of cells with pHAH (Toborek et al., 1995; Park
et al., 1996) further suggests uncoupling of CYP1A. To our knowledge, there has been no
direct demonstration that pHAHs stimulate ROS production by CYP1A.
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One effect of ROS generated by CYPIA may be inactivation of the enzyme.
3,3',4,4'-Tetrachlorobiphenyl (TCB) and other planar PCBs not only induce CYP1A but
also can elicit sharp declines in CYP1A activity and content following exposure to high
doses (Gooch et al., 1989; Sinclair et al., 1989; Hahn et al., 1993; Stegeman et al., 1995).
In the fish model, scup (Stenotomus chrysops), the TCB-dependent decrease in CYP1A
was shown to be post-transcriptional, and studies in microsomes showed that TCB can
inactivate as well as inhibit scup CYP1A (White et al., 1997a). TCB is a ligand for scup
CYP1A but is metabolized slowly (Gooch et al., 1989; White et al., 1997b). Therefore, it
was speculated that inactivation may be due to uncoupling of CYP1A and formation of
ROS (White et al., 1997a). A number of enzymes (CYP2B, Cu,Zn-superoxide dismutase
(SOD), Fe-SOD, lactoperoxidase, myeloperoxidase, xanthine oxidase) that use or produce
H202 and that contain a metal ion undergo oxidative auto-inactivation (Loosemore et al.,
1980; Matheson and Travis, 1985; Beyer and Fridovich, 1987; Jenzer et al., 1987;
Karuzina and Archakov, 1994).
In this paper we examine the nature of non-ortho PCB-stimulated inactivation of
CYP1A and its relationship to ROS formation in uncoupled catalytic cycles of CYP1A. We
examine this process using TCB as a model pHAH in liver microsomes from the marine
fish scup, a system in which the phenomenon of CYP1A inactivation was identified and
where it is quite strong. The results indicate that inactivation of CYP1A is a result of
uncoupling and provide the first direct demonstration that CYP1A in the native state bound
with a pHAH is a source of ROS. Similar studies were conducted using rat liver
microsomes and expressed human CYP1As. In the mammals, as in scup, the formation of
ROS was linked to binding of TCB to CYP1A, apparently CYP1A1. However,
inactivation of mammalian CYP1As was less strong than in scup, suggesting differences in
the active sites of the CYP1A homologues in these species.
MATERIALS AND METHODS
Chemicals: Benzo[a]pyrene was purchased from Aldrich (Milwaukee, WI). 2',7'-
Dichloro-dihydrofluorescein diacetate, dihydroethidium, 7-ethoxyresorufin and 7-
methoxyresorufin were purchased from Molecular Probes (Eugene, OR). 3,3',4,4'-
tetrachlorobiphenyl and 3,3',4,4'-tetrachlorobiphenyl-Ring-UL- 14 C (52.1 mCi/mmol)
were purchased from Pathfinder (St. Louis, MO). Analysis of the 14 C-3,3',4,4'-TCB by
GC/ECD and GC/MS revealed no hydrophobic contaminants (>99% pure); small amounts
of polar contaminants were removed by dissolving the TCB in hexane and extracting twice
with NaOH. Hydroxylamine was purchased from Fisher (Pittsburgh, PA). Catalase was
purchased from Sigma, contained less than 0.1% thymol and was determined to have the
manufacturer specified activity. All other reagents were purchased from Sigma (St. Louis,
MO).
Animals: Scup (Stenotomus chrysops ) were caught by angling in Vineyard
Sound, MA in 1992, 1994 and 1996. Fish were held in flow-through seawater tanks at
14°C and maintained on a diet of Purina Trout Chow. Experimental animals ranged in size
from 165 to 358g. Control fish received no treatment. To induce CYP1A, fish were
injected intra-peritoneally with a solution of benzo[a]pyrene (BP) (10 mg/kg) in corn oil.
BP was used because it is a potent inducer, is rapidly metabolized, and does not cause
uncoupling of scup CYP1A (unpublished results). Three days following injection the fish
were killed by severing the spinal cord. The livers were harvested, and microsomes were
made immediately. Eleven microsomal pools were prepared with livers from 3 to 6 fish per
pool.
Microsome preparation: Hepatic microsomal fractions were prepared by differential
centrifugation (Stegeman et al., 1979). Following the initial sedimentation, microsomes
were washed by resuspending in 0.15 M KCI and sedimenting again. Microsomes also
were prepared from post-mitochondrial supernatants from livers of untreated rats and rats
treated with Aroclor 1254 (Molecular Toxicology, Inc., Annapolis, MD). Pellets were
resuspended in buffer (50 mM TRIS, pH 7.4, 1 mM dithiothrietol, 1 mM EDTA, 20%
glycerol) and frozen in liquid N2 until use. Microsomes from baculovirus-infected insect
cells expressing human NADPH cytochrome P450 reductase together with either human
CYP1A1 or CYP1A2 were purchased from Gentest Corp. (Boston, MA). Protein content
was determined by the bicinchoninic acid method (Smith et al., 1985), using bovine serum
albumin (BSA) as a standard.
Western blotting for CYPlA quantification: Immunoblotting procedures were
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal
proteins (10 jgg/lane) were resolved on 12% SDS-PAGE gels and electrophoretically
transferred to 0.1 gtm nitrocellulose membrane. The primary antibodies were the mouse
monoclonal antibody 1-12-3 (Park et al., 1986), raised against scup P450E (CYP1A;
(Morrison et al., 1995)) and the polyclonal antibody Rye, raised against mouse CYP1A2
(Stegeman et al., 1995). MAb 1-12-3 is highly specific for CYPLA in fish and CYP1A1 in
mammals. The secondary antibodies were alkaline phosphatase linked goat anti-mouse
IgG and goat anti-rabbit IgG (Biorad, Hercules, CA). The immunoreactive bands were
visualized using nitro blue tetrazolium and 5-bromo-4-chloro-3-indoyl-phosphate and
quantified by video image analysis (NIH Image 1.60b5) by comparison to scup standards
of known concentration. Where appropriate, the CYP1A1 values for rat are relative,
reported as scup CYP1A equivalents.
Enzyme assays: Microsomal ethoxyresorufin O-deethylation (EROD) and
methoxyresorufin O-demethylation (MROD) were determined fluorometrically (Hahn et al.,
1993), using a Cytofluor 2300 (Millipore) multiwell plate reader. NADPH-dependent
cytochrome c reductase activity was measured at room temperature from the increase in
absorbance at 550 nm using a Shimadzu 210 difference spectrophotometer (Stegeman et
al., 1982). NADPH oxidation was determined at room temperature from the decrease in
absorbance at 340 nm (Imai, 1979). TCB metabolism was assessed using the methods of
White et al. (1997b). Radioactivity was determined by liquid scintillation counting on a
Beckman LS5000TD counter.
In vitro studies of CYPlA inhibition and inactivation: The procedure followed that
of White et al. (1997a). Microsomes were incubated at 0.1 mg/ml in buffer (50 mM TRIS,
0.1 mM EDTA, pH 7.6) at a final volume of 1 ml in glass test tubes at 30 0 C. The
following chemicals were added in various combinations at the final concentrations
indicated: acetone (0.5 %), ascorbate (1 mM), 3-amino-1,2,4-triazole (0.1 mM), azide
(0.01-1 mM), catalase (800 units/ml), cytochrome c (10 gM), deferoxamine (1 mM),
DTPA (1 mM), Fe-EDTA (1 mM), H202 (1 mM), hydroxylamine (0.1 mM), mannitol (1
mM), NADPH (1.8 mM), SOD (400 units/ml), TCB (0.017-17 pM) and tocopherol (1
mM). Aliquots were removed from the reaction mixtures at times zero, 10, 20 and 30
minutes and then were assayed as above for the rate of EROD or MROD over 5 minutes
(White et al., 1997a). Inhibition was calculated by comparing EROD activity at 10 minutes
in control reaction mixtures to that in reaction mixtures containing TCB alone. Inactivation
was calculated by comparing EROD activity at 30 minutes in reaction mixtures containing
TCB alone to that in reaction mixtures containing TCB+NADPH. Curve fitting was
performed using Sigma Plot for Macintosh (SSPS Inc., Chicago, IL). For inhibition, the
IC50 was determined directly from the plot of TCB concentration and activity loss. The
method of (Cha, 1975) was used to convert the IC50 to a Ki, considering TCB as a tight
binding inhibitor. To remove TCB from reaction mixtures, microsomes were sedimented,
resuspended (50 mM TRIS, pH 7.4, 0.15 M KC1, 0.1 mM BSA), incubated 6 minutes at
37"C, sedimented and resuspended.
Some incubations were performed under anaerobic conditions. Hungate techniques
were used to prepare reaction mixtures as these techniques completely purge the
experimental system of oxygen (Hungate, 1969). Reaction mixtures were prepared in
stoppered serum bottles. Oxygen was purged from the bottles by bubbling argon gas
through the bottles for 30 minutes while they were on ice. The argon had been rendered
free of oxygen by passage through a hot, reduced copper column. An NADPH solution
was purged in the same manner. NADPH was added to the appropriate reaction mixtures
using a syringe repeatedly purged of oxygen by filling it with the argon gas and evacuating
it. Aliquots of reaction mixtures also were withdrawn using an argon purged syringe.
Otherwise, sampling and analysis procedures were as described above.
Spectral P450 and heme assays: To determine if there was a loss of P450 or heme,
microsomes (0.4 mg protein/ml) were incubated in buffer (50 mM TRIS, 0.1 mM EDTA,
pH 7.6) at 300 C. The following chemicals were added in various combinations at the final
concentrations indicated: acetone (0.5 %), TCB (17 jiM), and NADPH (0.7 mM).
Following a 30 minute incubation, total P450 concentration was determined by bubbling
reaction mixtures with CO and obtaining the dithionite-difference spectra (Bonkovsky et
al., 1984). Heme was determined in reaction mixtures using the pyridine hemochrome
assay (Omura and Sato, 1964).
Peroxide and superoxide formation: The production of H202 was determined by
measuring the formation of formaldehyde from the oxidation of methanol by the catalase I
complex (Rashba-Step and Cederbaum, 1994). The SOD-sensitive rate of adrenochrome
formation was measured by the absorption change at 485 nm (Misra and Fridovich, 1972).
H202 and 02 -* formation also were determined simultaneously using two
fluorescent dyes. The oxidation of 2',7'-dichlorodihydrofluorescein diacetate (DCDFDA)
and dihydroethidium (HE) to fluorescent products was used to measure H202 and 02 -*
production, respectively. The method is a modification of those by Bondy and Naderi
(1994) and Robinson et al. (1994). In a 48-well plate, 0.1 mg of microsomal protein was
diluted to 160 pl with Hank's buffered salt solution (HBSS)(120 mM NaC1, 2.5 mM,
KCL, 1.2 mM NaH2PO4, 0.1 mM MgCl2, 5.0 mM NaHCO3, 6.0 mM glucose, 1.0 mM
CaCl2 and 10 mM HEPES) containing 5 LM DCDFDA and 7.5 pM HE (final
concentrations). Following a 15 minute pre-incubation at 30"C, either acetone (5 p1) or
TCB (1.7 nmol in acetone) was added. In some cases 200 units of SOD then were added.
Reactions were initiated with NADPH (1.4 mM) and fluorescence was monitored over 10
minutes with 485 nm excitation and 530 nm and 625 nm emission filters for DCDFDA and
HE, respectively. 2',7'-Dichlorofluorescein and ethidium bromide were used as standards.
The capacity for formation of ROS during in vitro inactivation of CYP1A was
determined as follows. Reaction mixtures were prepared as for the inactivation assay.
Aliquots were removed from the reaction mixtures at 10, 20 and 30 minutes. 02's
production was assessed as described above except that 50 pl aliquots were combined with
100 l HBSS and HE (15 jIM). NADPH (1.4 mM) was added to those aliquots taken
from reaction mixtures that did not contain NADPH. Ethidium production rates were
monitored fluorometrically over 5 minutes as described above.
Statistics: Statistics were calculated using SuperAnova for Macintosh (Abacus
Concepts, Inc., Berkeley, CA). Two-factor ANOVAs (microsomal pool and treatment)
were used to analyze the spectral P450, inactivation and ROS time course experiments.
One factor ANOVAs were used to analyze the cytochrome c experiments and ROS
determinations. The Tukey-Kramer and Dunnett's multiple-comparisons tests were used to
determine differences between incubation conditions.
RESULTS
Inactivation of scup liver CYPIA: Initially we sought to confirm that
TCB+NADPH could inactivate microsomal CYP1A, using methods employed previously
(White et al., 1997a). Incubating liver microsomes from BP-treated scup with acetone or
with NADPH over 30 minutes did not alter their capacity to catalyze EROD (Figure 1).
Incubating liver microsomes with TCB alone resulted in an immediate 50% inhibition of
EROD, but the activity did not decline further over time (Figure 1). That inhibition of
EROD was TCB concentration-dependent, and the Ki was 0.16 gLM (Figure 2). In
contrast, when hepatic microsomes were incubated with both TCB and NADPH there were
both an immediate inhibition and a progressive loss of activity (Figure 1). Liver
microsomes incubated with TCB and NADPH for 30 minutes had 63 + 6% less capacity to
catalyze EROD activity than did microsomes incubated with TCB alone. As with
inhibition, the progressive loss of EROD activity also was TCB concentration-dependent
(Figure 2). This inactivation of EROD did not occur when microsomes were incubated
with TCB and NADH instead of NADPH (data not shown).
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Figure 1. TCB-stimulated inactivation of scup liver CYP1A (EROD activity). Microsomes
(0.1 mg protein/ml with 380 ± 150 pmol CYP1A/mg) were incubated in buffer (50 mM
TRIS, 0.1 mM EDTA, pH 7.6) at a final volume of 1 ml in glass test tubes at 300C. The
following chemicals were added in various combinations at the final concentrations
indicated: acetone (5 %), NADPH (1.8 mM), and TCB in acetone (1.7 gM). Aliquots
were removed from the reaction mixtures at times zero, 10, 20 and 30 minutes and then
were assayed fluorometrically for the rate of EROD over 5 minutes. Complete inactivation
of EROD occurred within 1 hour. Data are means ± SD from 11 pools of microsomes.
*Statistically different from all other incubation conditions analyzed at 30 minutes (p<0.01,
Tukey-Kramer).
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Figure 2. TCB concentration dependent inactivation of scup liver CYP1A. Incubation
conditions and assay technique were as described in Figure 1, except that a range of TCB
concentrations was used (0.017-17 gM). Inhibition was calculated by comparing EROD
activity at 10 minutes in control reaction mixtures to that in reaction mixtures containing
TCB alone. Inactivation was calculated by comparing EROD activity at 30 minutes in
reaction mixtures containing TCB alone to that in reaction mixtures containing
TCB+NADPH. Results from 3 pools of microsomes were used to determine the curve fit.
The IC50 was determined by a non-linear regression analysis of the activity loss vs. TCB
concentration plot. The method of (Cha, 1975) was used to convert the IC50 to a Ki (0.16
gM). TCB was considered a tight binding inhibitor because increasing concentrations of 7-
ethoxyresorufin did not effectively displace the TCB (data not shown).
The capacity to catalyze EROD was not restored by removal of TCB from
microsomes incubated with TCB+NADPH. Microsomes incubated for one hour with
TCB+NADPH had only 7 ± 0% of the EROD capacity retained in microsomes incubated
with acetone±NADPH; following repeated washing and resedimenting microsomes to
remove TCB, EROD rates were unchanged. However, at least 50% of EROD activity
could be restored by a similar removal of TCB from microsomes that had been incubated
with TCB alone (37 ± 4% vs. 68 ± 4% of control activity before and after TCB removal,
respectively).
In addition to the loss of EROD, scup liver microsomes incubated with
TCB+NADPH showed a loss of spectral P450. Incubation of microsomes for 30 minutes
with TCB+NADPH resulted in the loss of approximately 50% of the spectral P450 signal
(Table I). There was no loss of spectral P450 when microsomes were incubated with TCB
alone (Table I). A slight, but not significant, loss of spectral P450 occurred when
microsomes were incubated with NADPH alone. The TCB-stimulated loss of P450 was
accompanied by a variable loss of heme and a variable appearance of cytochrome P420
(Table I). Thus, while the amount of P450 decreased consistently in the experiments, the
proportion which was modified to P420 varied.
The above results suggest that TCB could cause the loss of CYP1A activity either
by mechanism-based inactivation, i.e. inactivation by a metabolite of TCB, or by
stimulation of oxidative inactivation. TCB is a substrate for scup CYP1A, but it is
metabolized very slowly (White et al., 1997b). Scup hepatic microsomes used in these
inactivation studies metabolized TCB at a rate of 0.34 ± 0.08 pmol/min/mg. However,
P450 content declined at 12 ± 6 pmol/min/mg, calculated from the difference spectra, and
CYP1A content declined at 8 ± 3 pmol /min/mg, calculated from the loss of EROD
(assuming that loss of EROD is equated with loss of CYP1A). Even though rat liver
microsomes have been shown to activate TCB to a form which can bind to CYP1A1
(Shimada and Sawabe, 1983), the rate of TCB metabolism and hence possible covalent
binding of TCB cannot account for the loss of P450.
In light of the extremely slow metabolism of TCB, we examined the possibility that
catalytic uncoupling may be occurring. Microsomal oxidation of NADPH in the presence
of acetone (carrier) was 13 + 5 nmol/min/mg and increased in the presence of TCB, to 33 ±
9 nmol/min/mg (Table V). When microsomes were incubated under anaerobic conditions,
TCB-dependent inactivation of EROD did not occur. Thus, microsomes incubated
anaerobically with TCB alone for 45 minutes had a capacity for EROD activity of 2544
TABLE I
Loss of scup liver P450 stimulated by TCB and NADPH
P450 P420 Heme
Additions to nmol/mg % Loss nmol/mg nmol/mg % Loss
reaction (Range) (Range) (Range)
mixtures
Acetone 0.89 ± 0.33 ND 1.44 ± 0.52
NADPH 0.73+± 0.35 22 ± 9 0.04 ± 0.07 1.26 ± 0.49 16 ± 12
(17-47) (0.00 -0.19) (0- 37)
TCB 0.91 + 0.46 ND 1.34 ± 0.46
TCB+NADPH 0.48 + 0.22* 49 ± 7 0.07 ± 0.10 1.05 ± 0.40 28 ± 16
(32- 63) (0.00 - 0.29) (1- 48)
To determine if there was a loss of P450
incubated in buffer (50 mM TRIS, 0.1
or heme, microsomes (0.4 mg protein/ml) were
mM EDTA, pH 7.6) at 30 0 C. The following
chemicals were added in various combinations at the final concentrations indicated: acetone
(0.5 %), TCB (17 gM), and NADPH (0.7 mM). Following a 30 minute incubation, total
P450 concentration was determined by bubbling reaction mixtures with CO and obtaining
the dithionite-difference spectrum. Heme was determined in reaction mixtures using the
pyridine hemochrome assay. P450 determinations were made on 9 pools of microsomes
and initial concentrations ranged from 0.53 - 1.40 nmol/mg. Heme determinations were
made on 6. pools of microsomes, and initial concentrations ranged from 0.60 - 2.04
nmol/mg. Heme and P450 determinations were not made in the same experiments. Data
are means ± SD.
* - Significantly different from all other incubation conditions (p<0.01, Tukey-Kramer).
ND - Not detectable.
pmol/min/mg, and aliquots of the same pool of microsomes incubated anaerobically with
TCB plus NADPH had an EROD activity of 2829 pmol/min/mg. Enhanced electron
transfer, oxygen dependence and exceedingly slow rates of substrate turnover are
consistent with uncoupling of electron transport from substrate oxidation.
If inactivation is occurring because of uncoupling, then interruption of the electron
flow to CYP1A should reduce the magnitude of inactivation. Cytochrome c inhibits CYP
by competing for electrons from CYP reductase (Estabrook et al., 1996). Addition of 10
jtM cytochrome c to microsomal incubations with TCB+NADPH lessened the rate of
inactivation (Figure 3). The rate of loss of EROD was 3.5 + 0.6 pmol/min/mg in the
presence of cytochrome c as compared to 7.7 pmol/min/mg in its absence.
A series of antioxidants, prooxidants and enzymes were tested for their influence on
TCB-dependent EROD inactivation. Initially, several catalase inhibitors were tested. Azide
(0.1 mM) caused a 2-fold increase in the rate of inactivation in the presence of
TCB+NADPH by 10 minutes, and inactivation in the presence of TCB+NADPH was
enhanced significantly by azide by 20 minutes (Figure 4A). There was no significant loss
of EROD activity from microsomes incubated with NADPH and 0.1 mM azide and without
TCB. (There was a loss of activity at a higher concentration of azide (1 mM) +NADPH;
Figure 4). Two other catalase inhibitors, aminotriazole (ATA) and hydroxylamine (HA), at
0.1 mM, did not alter the rate of inactivation (Table II). Therefore, the enhanced
inactivation due to azide does not appear to result from inhibition of catalase but rather
occurs through some other mechanism.
As with addition of azide, addition of H202 increased the rate of inactivation by
TCB+NADPH (Figure 4B). At 10 minutes, there was a 3-fold greater loss of EROD
activity from microsomes when H202 was added with the TCB+NADPH, compared to the
loss occurring without added H202. Little loss of activity occurred with H202 alone, or
with H202+NADPH. As expected, when catalase was added together with H202, it
eliminated the increase in inactivation due to the exogenous H202 (Table III). However,
adding catalase did not affect the inactivation caused by TCB+NADPH (Table III).
Attempts to scavenge ROS or to alter the iron concentration external to the active
site had no effect on inactivation. Addition of SOD did not decrease the inactivation due to
TCB+NADPH (Table IV). Similarly, neither the hydrophilic reactive oxygen scavenging
compounds, ascorbate and mannitol, nor the lipophilic reactive oxygen scavenging
compound, tocopherol, altered the inactivation stimulated by TCB (Table IV). Likewise,
manipulation of the iron content in the reaction mixture did not influence inactivation (Table
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Figure 3. Effect of cytochrome c on TCB-stimulated scup liver CYPlA inactivation.
Incubation conditions and assay technique were as described in Figure 1, except for the
addition of cytochrome c (10 gM). Percent control EROD activity was calculated by
comparing reaction mixtures containing TCB+NADPH to control reaction mixtures,
reaction mixtures containing TCB+cytochrome c to those containing cytochrome c and
reaction mixtures containing TCB+cytochrome c+NADPH to those containing
TCB+cytochrome c. Data are the means ± SD from 5 pools of microsomes. *Statistically
different from all other incubation conditions analyzed at 30 minutes (p<0.01, Tukey-
Kramer).
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Figure 4. Effects of azide (A) and H202 (B) on TCB-stimulated scup liver CYPIA
inactivation. Incubation conditions and assay technique were as described in Figure 1,
except for the addition of azide (0.1 mM) or H202 (100 mM). Addition of 1 mM
azide+NADPH resulted in a loss of activity over time; the EROD activity was 3158 ± 1046
pmol/min/mg at 10 minutes and 1599 ± 606 pmol/min/mg at 30 minutes. Addition of 0.1
mM azide or 100 mM H202 to acetone or TCB reaction mixtures did not alter EROD
activity. Data are the means ± SD from 5 pools of microsomes. *Statistically different
from all other incubation conditions analyzed at 20 minutes (p<0.01, Tukey-Kramer).
TABLE II
Effect of catalase inhibitors on TCB-stimulated CYP1A inactivation
Additions to reaction mixtures EROD Activity (pmollmin/mg) % Loss of activitya
in aliquots taken at:
10 minutes 30 minutes 30 minutes
Aminotriazole (ATA)b
TCB 1705 + 831 1626 + 659*
TCB+NADPH 1456 ± 616 785 ± 207 52
0.1 mM ATA+NADPH 3932 ± 1330 3498 ± 841*
0.1 mM ATA+TCB 1653 ± 686 1614 + 547*
0.1 mM ATA+TCB+NADPH 1001 ± 546 709 ± 298 56
Hydroxylamine (HA)c
TCB 3283 ± 257 3118 + 164*
TCB+NADPH 2482 + 483 1072 + 157 66
0.1 mM HA+NADPH 7642 ± 481 6595 ± 1107*
0.1 mM HA+TCB 3283 ± 428 3203 + 379*
0.1 mM HA+TCB+NADPH 2766 + 274 947 ± 85 70
Microsomes (0.1 mg protein/ml) were incubated in buffer (50 mM TRIS, 0.1 mM EDTA,
pH 7.6) at 300 C. The following chemicals were added in various combinations at the final
concentrations indicated: acetone (0.5 %), ATA (0.1 mM), HA (0.1 mM), NADPH (1.8
mM), TCB (1.7 jgM). Aliquots were removed from the reaction mixtures at times 10 and
30 minutes and then were assayed fluorometrically for EROD over 5 minutes. ATA (1
mM) in the presence of NADPH reduced EROD activity; the EROD activity was 2910 +
937 pmol/minlmg at 10 min and 1753 ± 896 pmol/min/mg at 30 minutes.
a - % loss of activity was calculated by comparing EROD activity in reaction mixtures
containing TCB+NADPH to that in reaction mixtures containing TCB.
b - For all of the reaction mixtures described below, data are the means ± SD from 5 pools
of microsomes.
c - For all of the reaction mixtures described below, data are the means ± SD from 3
determinations with one pool of microsomes.
* - Significantly different from TCB+NADPH (p<0.05, Dunnett's).
TABLE III
Effect of H202 on TCB-stimulated CYP1A inactivation
Additions to reaction mixtures EROD Activity (pmol/min/mg) % Loss of activitya
in aliquots taken at:
10 minutes 30 minutes 30 minutes
TCB 2579 + 501 2387 ± 475*
TCB + NADPH 2045 ± 525 879 ± 290 63
TCB + NADPH + Catalase 2072 ± 549 908 ± 204 62
H202 + TCB + NADPH 795 + 400 230 ± 136* 90
H202 + TCB + NADPH + Catalase 1887 + 593 813 ± 195 66
Incubation conditions and assay technique were as described in Figure 2, except for the
additions of catalase (800 units) and H202 (1 mM). Data are the means ± SD from 3 pools
of microsomes.
a - % loss of activity was calculated by comparing the EROD activity in reaction mixtures
containing TCB+NADPH to that in reaction mixtures containing TCB.
* - Significantly different from TCB+NADPH (p<0.05, Dunnett's).
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TABLE IV
Effects of antioxidants and iron concentration on TCB-stimulated inactivation of CYP1A
Additions to reaction mixtures Property EROD Activitya Retained After
Incubation with:
TCB TCB+NADPHb
None 2428 + 512 912 ± 293
Superoxide Dismutase (400 u) Metabolizes superoxide 2563 927
Ascorbate (1 mM) ROS scavenger 2736 1101
Mannitol (1 mM) ROS scavenger 2627 854
Tocopherol (1 mM) ROS scavenger 2509 ± 482 1045 ± 132
Iron (1 mM) 2347 789
DTPA (1 mM) Iron chelator 3352 919
Deferoxamine (1 mM) Iron chelator 2143 554
Incubation conditions and assay technique were as described in Figure 2, except for the
additions listed. Data are either the average of two determinations or the means ± SD of at
least 3 determinations.
a - EROD activity (pmol/min/mg) was measured following a 30 minute incubation.
b - Activity with TCB and NADPH reflects inactivation.
IV). If iron external to the enzyme was catalyzing OH. formation, and if such externally
produced radicals were involved in inactivation, then chelation of external iron may reduce
inactivation. However, addition of the iron chelators, deferoxamine or
diethylenetriaminepenta-acetic acid (DTPA), did not reduce inactivation. Additions of
chelated iron also had no effect on inactivation.
Stimulation of the formation of reactive oxygen species by TCB: The above results
are indicative of oxidative inactivation and suggest that ROS are formed in the active center
of scup CYP1A. This should be accompanied by enhanced release of ROS from
microsomes. The production of H202 and 02-o by liver microsomes was measured by
several methods, but primarily by using the fluorescent probes 2',7'-
dichlorodihydrofluorescein (DCDFDA) and dihydroethidium (HE). DCDFDA is oxidized
to 2',7'-dichlorofluorescein (DCF) by H202, and HE is oxidized by 02-* directly to
ethidium. The stoichiometry of both reactions is 1:1 (Robinson et al., 1994).
Liver microsomes from both control and BP-treated scup oxidized DCDFDA and
HE at very low rates in the presence of the probes alone. These rates were increased by
addition of NADPH (Figure 5). Adding either acetone+NADPH or TCB+NADPH to
control liver microsomes did not alter DCDFDA and HE oxidation rates, compared to rates
obtained with NADPH alone. Addition of acetone+NADPH to liver microsomes from BP-
treated scup also did not alter significantly the DCDFDA and HE oxidation compared to that
with NADPH. However, when TCB + NADPH were added to liver microsomes from
BP-treated scup, there was a significant increase in DCDFDA and HE oxidation over that
seen with NADPH alone (Figure 5). That the HE oxidation stimulated by TCB+NADPH
was due to 02-' was confirmed by addition of SOD to reaction mixtures; SOD abolished
fluorescence produced above the levels occurring with NADPH only.
The Nash and adrenochrome reactions supported conclusions that both H202 and
02'- were being produced by BP-treated scup liver microsomes in the presence of
TCB+NADPH. H202 formation quantified using the Nash reaction was 1 ± 1 nmol
formaldehyde formed/min/mg. 02-' formation determined using the adrenochrome
reaction was 19 + 5 pmol adrenaline oxidized/min/mg.
To evaluate further the possible involvement of CYP1A in production of ROS,
microsomes pre-incubated under various conditions were examined for the capacity to
oxidize HE (Figure 6). When microsomes were pre-incubated with acetone or
acetone+NADPH for periods of 0-30 minutes, and then combined with NADPH and HE,
those microsomes oxidized HE at a very low rate. When microsomes pre-incubated with
Figure 5. ROS production in liver microsomes from control and BP-treated scup. (A)
H202 production as assessed by the oxidation of DCDFDA to DCF. (B) 02-* production
as assessed by the oxidation of HE to ethidium. In a 48-well plate, approximately 0.1 mg
of microsomal protein was diluted with HBSS containing 5 jgM DCDFDA and 7.5 gM HE
(final concentrations). Some reaction mixtures contained 200 units SOD. Following a 15
minute incubation at 30"C, 1.7 nmol TCB in acetone or 5 gl acetone was added. Reactions
were initiated with NADPH (1.7 mM). The rates of DCF and ethidium production were
monitored fluorometrically over 5 minutes. Calculations were made using DCF and
ethidium bromide as standards. Data are the means + SD from at least 3 pools of
microsomes. *Statistically different from acetone+NADPH (p<0.05, Dunnett's).
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Figure 6. Effect of TCB and NADPH on the capacity of scup liver CYPIA to produce
ROS. Microsomes were pre-incubated as described in Figure 1, except that reaction
mixtures contained 0.4 mg of microsomal protein and 17 nmol TCB. Aliquots (50 Rl)
were removed from each reaction mixture at 10, 20 and 30 minutes, and each was
combined with 100 pl HBSS, HE (15 gM), and NADPH (1.4 mM) in a well of a 48-well
plate. The rates of ethidium production were determined as in Figure 6. Data are the
means ± SD from 3 pools of microsomes. *Statistically different from all other incubation
conditions analyzed at 30 minutes (p<0.01, Tukey-Kramer).
TCB alone were combined with HE and NADPH, they oxidized HE at a high rate,
regardless of the duration of the pre-incubation. Aliquots of microsomes pre-incubated
with TCB+NADPH initially had a high capacity for HE oxidation. However, those
microsomes pre-incubated with TCB+NADPH showed a time-dependent loss of the
capacity to produce ROS that paralleled the loss of CYP1A (EROD) activity; by 30
minutes, the capacity to produce ROS decreased to levels seen with microsomes pre-
incubated with acetone or NADPH.
TCB-stimulated CYP inactivation in rat liver microsomes: When microsomes from
Aroclor-treated rats were incubated with TCB+NADPH there was inactivation of CYP1A
(EROD activity) (Table V). However, with rat liver microsomes, the loss of EROD activity
due to inactivation was less than was seen with scup; at 30 minutes there was only a 15%
inactivation of rat CYP1A, compared to the 63% inactivation in scup liver microsomes.
Immunoblot analysis with antibodies to scup CYP1A and to mouse CYP1A2 showed that
both CYP1A1 and CYP1A2 were present in rat liver microsomes (data not shown).
However, methoxyresorufin O-demethylation (MROD), a preferred activity of CYP1A2 in
rat liver microsomes, was not inactivated by TCB+NADPH, while scup liver microsomes
experienced a 77 + 8% loss of MROD activity due to inactivation (Table V). As with scup
liver microsomes, the TCB+NADPH dependent loss of EROD activity from rat liver
microsomes was enhanced by the addition of azide (Table V).
The rate of TCB metabolism by rat liver microsomes was 50 pmol/min/mg.
Although this rate is two orders of magnitude greater than the rate with scup liver
microsomes (Table V), it still may be slow enough to be promote uncoupling. The rat liver
microsomal NADPH oxidation rate in the presence of TCB was similar to that seen with
scup liver microsomes and was greater than the rate of TCB turnover (Table V).
Formation of reactive oxygen species by rat liver microsomes: Patterns of ROS
production similar to those with scup liver microsomes were seen also with rat liver
microsomes. Liver microsomes alone from control or from Aroclor-treated rats oxidized
DCDFDA and HE at low rates, and those rates increased in the presence of NADPH
(Figure 7). With control rat liver microsomes, addition of acetone+NADPH or
TCB+NADPH did not alter DCDFDA and HE oxidation rates, compared to that caused by
NADPH alone. However, when liver microsomes from Aroclor-treated rats were
incubated with TCB+NADPH, there was a significant increase in the rate of both DCDFDA
and HE oxidation compared to that obtained with NADPH alone, or to the rate seen with
control microsomes incubated under any condition (Figure 7). SOD only partly abolished
TABLE V
Comparison of scup and rat liver microsomal enzyme
Assay
Spectral P450
(nmol/mg)
CYPIAa
(nmol/mg)
NADPH Oxidationb
(nmol/min/mg)
Cytochrome c Reductase Activity
(nmol/min/mg)
TCB Metabolism
(pmol/min/mg)
EROD Activity
Scup Liver
Microsomes
(n=-7)
0.75 ± 0.23
0.38 ± 0.15
20 ± 4
125 ± 39
0.3 ± 0.1
4.8 ± 0.9
activities and CYP1A inactivation
Rat Liver
Microsomes
(n=3)
2.38 ± 0.60
0.26 ± 0.28
5 1
263 ± 55
38.5 + 7.8
2.5 + 0.3
(nmol/min/mg)
MROD Activity 2.2 ± 0.8 0.1 + 0.0
(nmollmin/mg)
% EROD Inactivationc 63 + 6 15 ± 3
% MROD Inactivation c  77 + 8 0 + 0
% EROD Inactivation with Azidec 95 + 1 29 + 2
a - The immunoreactive bands were visualized using NBT/BCIP and quantified by video
image analysis by comparison to scup standards of known concentration. Where
appropriate, the CYP1A1 values for rat are relative, reported as scup CYP1A equivalents.
b - Calculated by subtracting the rate of NADPH oxidation with the carrier present from the
rate of oxidation with TCB present.
c - Assayed at 30 minutes.
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Figure 7. ROS production in liver microsomes from control and Aroclor treated rats. (A)
H202 production as assessed by the oxidation of DCDFDA to DCF. (B) 02-* production
as assessed by the oxidation of HE to ethidium. Incubations were as described in Figure 6
using liver microsomes from untreated rats and rats treated with 62.5 to 500 mg/kg Aroclor
1254. Data are the means + SD from 3 pools of microsomes except that values from
control rats were determined from 1 pool of microsomes. *Statistically different from
acetone+NADPH (p<0.05, Dunnett's).
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Figure 8. ROS production in microsomes from insect cells expressing human CYP1Al
and CYP1A2. (A) H202 production as assessed by the oxidation of DCDFDA to DCF.
(B) 02 -* production as assessed by the oxidation of HE to ethidium. Incubations were as
described in Figure 6. The P450 concentration and cytochrome c reductase activity were
the same in both the CYP1A1 and CYP1A2 microsomes, as indicated by the
manufacturer's analyses. Data are the means + SD from three replicates. *Statistically
different from acetone+NADPH (p<0.05, Dunnett's).
E Acetone
e TCB
T
i
HE oxidation, suggesting that radicals additional to 02-* were contributing to the oxidation
by rat liver microsomes (data not shown). Comparing microsomes from rats treated with a
range of doses of Aroclor 1254 (62.5 - 500 mg/kg) showed that ROS production
stimulated by TCB+NADPH was correlated with the CYP1Al catalytic activity (EROD) of
those microsomes (r2 =0.968, p<0.001).
ROS production by human CYPlAs. Microsomes from baculovirus-infected insect
cells expressing NADPH-CYP reductase and either human CYP1A1 or CYP1A2 were
examined for their ability to produce ROS. The rates of DCDFDA and HE oxidation by
microsomes containing either expressed CYP1A1 or CYP1A2, but with no additions, were
low (data not shown). In the presence of NADPH alone, CYP1A2 microsomes oxidized
DCDFDA and HE at substantial rates, 5-fold greater than the rates obtained with CYP1A1
microsomes under the same conditions (Figure 8). Addition of TCB+NADPH stimulated
DCDFDA and HE oxidation by the CYP1A1 microsomes by 2-fold, but decreased probe
oxidation by the CYP1A2 microsomes (Figure 8). Rates of NADPH-CYP reductase
activity were similar in microsomes containing CYP1A1 and CYP1A2, indicating that the
differences in ROS production reflected differences in activity of the CYP1As.
DISCUSSION
3,3',4,4'-Tetrachlorobiphenyl is a competitive inhibitor of CYPlA (Gooch et al.,
1989) and recently was found to inactivate CYP1A (White et al., 1997a). Suppression of
hepatic CYP1A content by high doses of TCB was attributed to that inactivation (White et
al., 1997a). We employed hepatic microsomes from a species (scup) that is highly
susceptible to CYP1A inactivation as a model to investigate the mechanism. We
determined that inactivation occurs through uncoupling, resulting in formation and attack of
ROS within the CYP1A active site. TCB also stimulates release of ROS by liver
microsomes of scup and rats induced for CYP1A. In rat, ROS release and EROD
inactivation appeared to involve CYP1A1, not CYP1A2. The balance between inactivation
and ROS release appears to differ between species, suggesting differences in CYP1A active
site structure. TCB also stimulated ROS production by expressed human CYP1A1 but not
CYP1A2. This is the first demonstration of a pHAH AhR agonist directly stimulating the
release of ROS from CYP1A1.
CYPIA Inactivation: Several observations suggest that inactivation of scup CYP1A
by TCB involves uncoupling. TCB binds tightly in the scup CYP1A active site, indicated
by a low Km for TCB metabolism (0.7 gM (White et al., 1997b)) and low Ki for
competitive inhibition of CYP1A (< 0.3 tM) (Gooch et al., 1989; M. E. Hahn,
unpublished results). Yet, the rate of metabolism is exceedingly slow (<1 pmol TCB
metabolized/min/nmol CYP1A). TCB stimulated microsomal NADPH oxidation, and the
TCB-stimulated inactivation of CYP1A was both NADPH and oxygen dependent. We
speculate that steric hindrance due to lateral chlorines lodges TCB in the substrate access
channel, rendering it inaccessible to attack by the peroxy-ferryl complex of CYP and
favoring release of reduced oxygen from the heme iron. Exogenous antioxidant enzymes,
oxygen scavenging compounds, iron and iron chelators had no effect on CYP1A
inactivation by TCB, indicating that the chemistry involved is initiated and constrained
within the active site.
The identity of the chemical species causing CYPIA inactivation is unclear. Both
H202 and 02-' were released by microsomes incubated with TCB+NADPH. SOD
abolished HE oxidation, indicating that there was release of 02-' following addition of one
electron, as shown for other CYP (Kuthan et al., 1978). H202 could result either from
dismutation of 02 - ' or from direct formation after addition of a second electron. Notably,
the reactivity of H202 or 02 - ' is limited (Davies, 1987), with half-lives three orders of
magnitude longer than that of OH* (Yu, 1994).
It is possible that OH* is responsible for CYP1A inactivation. In the Fenton reaction,
H202 reacts with Fe2 + to form OH*. With unmetabolized TCB lodged in the active site,
heme iron may undergo cycles of oxidation and reduction to Fe2 +. We suggest that penta-
coordinate ferrous heme resulting from that reduction acts as a Fenton catalyst in the
conversion of H202 to OH* in the active site. The ability of heme iron to act as a Fenton
catalyst has been questioned (Gutteridge, 1986). However, observations that Cu,Zn-SOD
and Fe-SOD but not Mn-SOD are oxidatively inactivated suggests that Fenton chemistry
might occur in an enzyme active site; manganese cannot act as a Fenton catalyst (Beyer and
Fridovich, 1987). The auto-inactivation of lactoperoxidase was proposed to involve heme
iron in the ferrous state acting as a Fenton catalyst (Jenzer et al., 1987). It has been
suggested (Hodgson and Fridovich, 1975; Matheson and Travis, 1985) that "free" OHO
(formed external to the active site) is not responsible for inactivation of SOD and
myeloperoxidase, but rather that either a caged OH* or a metal coordinated OH' (in the active
site) causes inactivation of these enzymes. In like fashion, oxidative inactivation of CYP1A
could occur via production and attack of OH* entirely within the active site.
Low concentrations of azide or H202 enhanced the TCB-dependent inactivation of
CYP1A. Other catalase inhibitors, ATA or HA, did not affect the inactivation, indicating that
the azide effect did not result from catalase inhibition. This implies that both azide and H202
can enter the active site even with TCB bound in the access channel, while slightly larger
molecules (ATA or HA) can not. The release of 02-* suggests latitude for passage of small
molecules. As with H202, azide can interact with reduced iron to form highly reactive azidyl
radical (Ortiz de Montellano et al., 1988); microsomes incubated with azide and NADPH can
produce azidyl radicals (Reinke et al., 1994). Azide is thought to inactivate horseradish
peroxidase via formation and addition of an azidyl radical to the heme (Ortiz de Montellano et
al., 1988). CYP1A heme iron transiently reduced in the presence of TCB could catalyze
conversion of both azide and H202 to radical species. The results with azide and H202
support the possibility that heme iron may be acting as a Fenton catalyst.
Microsomes incubated with TCB+NADPH consistently lost spectral P450 content,
corresponding to the loss of CYP1A activity (EROD). However, the fate of that P450
appeared to vary. Cytochrome P420 was formed in some instances, indicating modification
of the environment of an intact heme (Stern et al., 1973). 'However, the amount of P420
formed was always less than the amount of P450 lost. In most incubations heme was lost,
but the extent of that loss also was highly variable. Lack of correspondence between P450
loss, heme loss and P420 formation implies that there may be multiple sites of attack during
inactivation of CYP1A. Oxidative auto-inactivation in other enzymes can involve amino acid
modification (Blech and Borders, 1983) and/or heme modification (Matheson and Travis,
1985; Beyer and Fridovich, 1987).
As far as we are aware, this is the first study to show that substrate-mediated
inactivation of CYP1A can result from attack of ROS formed in situ. This differs from the
inactivation of rat CYP1A1 by the alkylating agent 2-bromo-4'-nitroacetophenone (Parkinson
et al., 1986). Alkylation destabilizes the oxy-cytochrome complex so that it decomposes
before mono-oxygenation of a substrate can occur. Decomposition of the oxy-cytochrome
complex results in ROS release, but unlike TCB-stimulated inactivation of CYP1A,
alkylation does not result in oxidative modification of the protein or in a loss of spectrally-
detectable P450.
Previously, inactivation of CYP2B was proposed to result from the production of
H202 (Guengerich and Strickland, 1977; Karuzina and Archakov, 1994), but that
inactivation, and hence the mechanism, differs from the inactivation of scup CYP1A. First,
CYP2B inactivation occurred with excess NADPH alone and decreased when substrate was
added (Guengerich and Strickland, 1977; Loosemore et al., 1980; Karuzina and Archakov,
1994). Inactivation of CYP1A required the presence of both NADPH and TCB. Second,
CYP2B inactivation was attributed to H202 released from the enzyme. With CYP1A,
oxygen is released as 02 -* and possibly as H202. Third, inactivation of CYP2B was
exacerbated by catalase inhibitors, both azide and HA, and was relieved by catalase and the
radical scavengers ionol and mannitol (Guengerich and Strickland, 1977; Karuzina and
Archakov, 1994). Similar attempts to modify ROS concentrations external to the active site
had no influence on CYP1A inactivation. Fourth, inactivation of CYP2B was primarily due
to effects on heme; spectral P450 content declined in parallel with heme, there was no P420
formation, and heme was covalently bound to the protein (Guengerich, 1978; Karuzina and
Archakov, 1994). In contrast, heme loss and P420 formation both occurred, and were
variable, during CYP1A inactivation by TCB.
CYPlAs and Reactive Oxygen Production: The evidence here indicates that CYP1A
is a source of ROS when microsomes are incubated with the AhR agonist TCB. Control
scup liver microsomes formed ROS when incubated with NADPH, similar to results with
control rat and human liver microsomes (Rashba-Step and Cederbaum, 1994; Reinke et al.,
1994). The stimulation of ROS formation by TCB occurred only with liver microsomes
from animals induced for CYP1A. Induced rat liver microsomes also formed ROS; these
microsomes metabolized TCB at 100 times the rate seen in scup liver microsomes, yet that
rate was only 50 pmol/min/mg, slow enough to suggest that TCB could uncouple rat
CYP1A. As activity of scup CYP1A declined due to inactivation, ROS production declined
in parallel, further supporting the role of CYP1A in the production of ROS.
A single CYP1A form has been identified in scup, and while it has properties of both
CYP1A1 and CYP1A2, scup CYP1A is more like CYP1A1 (Morrison et al., 1995;
Stegeman et al., 1996). Given the role of mammalian CYP1A1 in TCB metabolism (Ishida
et al., 1991), we hypothesized that CYP1A1 might form ROS when bound with TCB. TCB
stimulated ROS production only by rat liver microsomes having high levels of CYP1A. Both
CYP1A1 and CYP1A2 were detectable by Western blot in the rat microsomes. However,
rates of EROD (a preferred CYP1A1 activity) in native microsomes were correlated closely
with the degree to which TCB stimulated ROS production by those microsomes. Moreover,
EROD in rat liver microsomes was inactivated while MROD, a preferred CYP1A2 activity
(Tsyrlov et al., 1993), was not inactivated by incubation with TCB+NADPH. The results
with baculovirus-expressed human CYP1A1 and CYP1A2 also support the hypothesis that
TCB-bound CYP1A1 is a source of ROS. TCB stimulated an increase in ROS production by
expressed human CYP1A1, while it decreased ROS production by expressed human
CYP1A2. Notably, when incubated with NADPH alone, CYP1A2 released much more ROS
than did CYP1A1.
Others have suggested that rat CYP1A1 can form ROS when bound with pHAH.
The pHAH-stimulated oxidation of bilirubin was proposed to result from its reaction with
ROS produced during uncoupling of CYP1A1, although ROS were not directly measured
(DeMatteis et al., 1991). Our findings that pHAH stimulate release of ROS by CYP1A1 may
also help to explain observations of oxidative damage associated with induction of CYP1A1.
Porcine endothelial cells treated with TCB showed increased CYP1A1, ROS production and
lipid peroxidation (Toborek et al., 1995). In Hepalclc7 cells, TCDD treatment resulted in
increased CYP1A1 activity and oxidative DNA damage (Park et al., 1996). Thus, CYP1A1
induced by pHAH may be a source of ROS, thereby contributing to oxidative damage in
vivo.
In conclusion, the results here demonstrate that rat, human and scup CYP1As
produce ROS in the presence of a slowly metabolized pHAH, apparently due to uncoupling.
One result of ROS production is the inactivation of CYP1A via attack of ROS within the
active site. We suggest that the attacking species is OH*, formed via Fenton chemistry
between H202 and the heme iron. The oxidation of CYPIA could target it for degradation
(Davies, 1987), which could explain the decrease in CYP1A content seen in animals and cells
in culture exposed to higher concentrations of pHAH (Sinclair et al., 1989; Stegeman et al.,
1995; White et al., 1997a). Such an in vivo effect has not been described for oxidative
inactivation of other CYP. The difference in susceptibility of scup and rat CYP1A to
inactivation suggests that the active sites are conformationally different. Such differences
may favor metabolism of TCB by rat CYP1A1 and retention of ROS by scup CYP1A.
Modeling studies are underway to determine if TCB "fits" differently into CYP1A active sites
from various species. ROS from CYP1A may modify proteins, lipids and nucleotides (Yu,
1994) as well as alter gene expression (Sen and Packer, 1996). The pHAH-stimulated
formation and release of ROS from CYP1A may be a mechanism contributing to the toxicity
of planar halogenated AhR agonists.
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CHAPTER 4
Structure-Activity Relationships in the Stimulation of Reactive Oxygen
Production and Cytochrome P450 1A Inactivation by Halogenated Aromatic
Hydrocarbons
ABSTRACT
The relationship of chemical structure to the substrate-dependent inactivation of
cytochrome P4501A (CYP1A) was investigated in the marine teleost scup (Stenotomus
chrysops). Previously, we demonstrated that the binding of 3,3'4,4'-tetrachlorobiphenyl
(IUPAC# 77) to scup CYP1A elicited oxidative inactivation of the enzyme and also resulted
in release of reactive oxygen species (ROS) (Chapter 3). Here, benzo[a]pyrene (BP), two
ortho substituted chlorobiphenyls (CB), 2,2',5,5'-tetrachlorobiphenyl (IUPAC# 52) and
2,3,3',4,4'-pentachlorobiphenyl (IUPAC# 105) and two non-ortho substituted CBs,
3,3',4,4',5' pentachlorobiphenyl (IUPAC# 126) and 3,3',4,4',5,5'-hexachlorobiphenyl
(IUPAC# 169) were examined for the ability to stimulate ROS generation and to inactivate
CYP1A in scup liver microsomes containing high levels of CYP1A. Both CB 126 and 169
stimulated release of ROS from liver microsomes in the presence of NADPH, while BP
and the ortho-substituted CBs, 52 and 105, did not. Microsomal NADPH oxidation rates
increased upon addition of BP, or CBs 105, 126 and 169. Microsomal ethoxyresorufin 0-
deethylation (EROD) was inhibited by BP and CBs 105, 126 or 169. Ki values for CBs
126 and 169 were similar (0.16 and 0.20 gM, respectively); however, that for CB 105 was
greater (0.60 gM). In addition to inhibition, there was a progressive loss of EROD in the
presence of NADPH and CBs 105, 126 or 169, attributed to inactivation of CYP1A.
Following a 30 minute incubation, the KmInactivation values were similar for CBs 77, 126
and 169, and that for CB 105 was greater (0.05, 0.14, 0.08, and 0.37 gM, respectively).
Similarly, the rate of inactivation stimulated by CB 105+NADPH was 70% less than the
rates seen with CBs 77, 126 or 169. CB 52 neither inhibited nor inactivated EROD.
Inactivation of CYP1A stimulated by CBs 126 and 169 was accompanied by loss of
spectral P450, enhanced by the addition of azide or H202 and decreased by addition of
cytochrome c. Thus, CB 126 and 169 appear to oxidatively inactivate CYP1A, as has been
shown for CB 77. The inactivation of CYP1A and the release of ROS were stimulated
only by planar CBs that are aryl hydrocarbon receptor (AhR) agonists and possibly CYP1A
substrates. The release of ROS resulting from planar CB binding to CYPlA represents a
possible mechanism by which these AhR agonists exert their toxicity.
INTRODUCTION
Polychlorinated biphenyls are ubiquitous in the global environment, and exposure
can result in hepatocellular carcinoma, immunotoxicity, wasting syndrome and
reproductive, endocrine and developmental toxicity (as reviewed in (Safe, 1994)).
Congeners that lack substitution at ortho sites (e.g. 3,3',4,4'-tetrachlorobiphenyl, IUPAC#
77) can achieve a planar conformation similar to that of 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) (Safe et al., 1985). By comparing the TCDD equivalency factors (TEF) of
chlorobiphenyl (CB) congeners, the coplanar congeners, including CB 77, 3,3',4,4',5,-
pentachlorobiphenyl (IUPAC# 126) and 3,3',4,4',5,5'-hexachlorobiphenyl (IUPAC#
169), are most potent in eliciting toxic effects in fish (Janz and Metcalfe, 1991; Walker and
Peterson, 1991; Newsted et al., 1995) and mammals (Safe, 1990; Tillitt et al., 1991).
Even though other congeners are found more frequently or at greater concentrations in
environmental samples, the coplanar CB congeners 77, 126 and 169 are most likely to
contribute to adverse biological effects attributable to pHAH in environmental samples
(McFarland and Clark, 1989).
Despite intensive study confirming the aryl hydrocarbon receptor-dependence of
pHAH toxicity (Poland and Glover, 1980; Fernandez-Salguero et al., 1996), the
mechanism(s) of toxicity remains unclear. Bioactivation has not been found to be a
significant avenue to toxicity of pHAH. Metabolism of pHAH is slow, and the metabolites
are not considered reactive (Yoshimura et al., 1987; Koga et al., 1990; Safe, 1992).
Potential mechanisms of pHAH-mediated toxicity may include altered regulation of genes
involved in growth and differentiation (Choi et al., 1991; Gaido et al., 1992; Hoffer et al.,
1996; Wang et al., 1997), altered arachidonic acid metabolism (Rifkind et al., 1990;
Schlezinger et al., 1998) and altered Ca2 + homeostasis (McConkey et al., 1988). In
addition, stimulation of oxygen activation may contribute significantly to pHAH toxicity,
considering that reactive oxygen species (ROS) can attack any member of the cellular
machinery, including proteins (Davies, 1987; Stadtman and Berlett, 1991), lipids (Girotti,
1985) and nucleotides (Breen and Murphy, 1995).
A growing number of studies support the conclusion that TCDD and CB congeners
induce oxidative stress and that this is dependent upon the aryl hydrocarbon receptor (AhR)
(Faux et al., 1992; Alsharif et al., 1994; Park et al., 1996). Although the mechanism of
ROS generation by AhR agonists also is not clear, evidence supports the hypothesis that
induction of cytochrome P4501A (CYP1A) might be involved in ROS generation. CYPIA
induction has been correlated with oxidative damage following pHAH exposure (Toborek
et al., 1995; Park et al., 1996). Hepatic microsomal and mitochondrial fractions but not
cytosolic fractions from TCDD-treated rats can stimulate oxidative DNA damage (Wahba et
al., 1989). CB 77 stimulates the production of ROS by teleost and mammalian CYP1As
(Chapter 3), and this supports the earlier suggestion that bilirubin oxidation is catalyzed by
ROS produced during uncoupling of rat CYP1A1 by CB 77 (DeMatteis et al., 1991).
Under the same conditions, CB 126 stimulates bilirubin oxidation as well (DeMatteis et al.,
1991). Considering also that CB 126 is even more refractory to metabolism than CB 77
(Yoshimura et al., 1987; Koga et al., 1990), ROS production via uncoupling of CYP1A
may be a common effect of pHAH.
Determining the structure-activity relationships for uncoupling should indicate
whether CYP1A-generated ROS might be involved in AhR agonist toxicity. Our approach
to determine uncoupling was to examine oxidative inactivation of CYP1A. We have
demonstrated that CYP1A is oxidatively inactivated when CB 77 is present in the active site
in the marine fish model scup (Stenotomus chrysops) and have hypothesized that
inactivation occurs by the attack of OH., leading to denaturation of the protein (Chapter 3).
Evidence from earlier studies suggesis that like uncoupling, oxidative inactivation of
CYP1A by planar CB congeners including CBs 126 and 169 may be a general
phenomenon (Rodman et al., 1989; Newsted et al., 1995; Lorenzen et al., 1997).
In this paper we examined the hypothesis that, like CB 77, planar CB congeners in
general stimulate the production of ROS through uncoupling of the CYP1A catalytic cycle
and oxidative inactivation of the enzyme. We used scup CYP1A as our model because it
has been shown to be extremely sensitive to inactivation by CB 77 in vitro and to
suppression in-vivo (White et al., 1997a; Chapter 3). We investigated the effects of a
rapidly metabolized substrate, benzo[a]pyrene (BP), and both ortho and non-ortho
substituted CB congeners on scup liver CYP1A. ROS release and inactivation of CYP1A
appear to be dependent upon chemical structure; only substrates of CYP1A that are slowly
metabolized stimulated inactivation. While the physiological consequences of a loss of
CYP1A are unknown, release of ROS may represent a mechanism of pHAH toxicity.
MATERIALS AND METHODS
Chemicals: Benzo[a]pyrene was purchased from Aldrich (Milwaukee, WI). 2',7'-
Dichlorodihydrofluorescein diacetate, 7-ethoxyresorufin, and dihydroethidium were
purchased from Molecular Probes (Eugene, OR). 2,2',5,5'-Tetrachlorobiphenyl (IUPAC#
52) was purchased from Pathfinder (St. Louis, MO). 3,3',4,4'-Tetrachlorobiphenyl
(IUPAC# 77), 2,3,3',4,4'-pentachlorobiphenyl (IUPAC# 105), 3,3',4,4',5-
pentachlorobiphenyl (IUPAC# 126) and 3,3',4,4',5,5'-hexachlorobiphenyl (IUPAC# 169)
were purchased from Ultra Scientific (North Kingstown, RI). All other reagents were
purchased from Sigma (St. Louis, MO).
Animals: Scup (Stenotomus chrysops ) were caught by trapping in Vineyard
Sound, MA in August of 1996. Fish were held in flow-through seawater tanks at 14"C
and maintained on a diet of Purina Trout Chow. Experimental animals ranged in size from
182 to 305g. Control fish received no treatment. To induce CYP1A, fish were injected
intra-peritoneally with a solution of benzo[a]pyrene (10 mg/kg) in corn oil. Three days
following injection the fish were killed by severing the spinal cord. The livers were
harvested, and microsomes were made immediately. Four microsome pools were prepared
with livers from 3 fish per pool.
Microsome preparation: Microsomes were prepared from livers by differential
centrifugation (Stegeman et al., 1979). Following the initial sedimentation, microsomes
were washed by resuspending in 0.15 M KCl and sedimenting again. Pellets were
resuspended in buffer (50 mM TRIS, pH 7.4, 1 mM dithiothrietol, 1 mM EDTA, 20%
glycerol) and frozen in liquid N2 until use. Protein content was determined using the
bicinchoninic acid method (Smith et al., 1985), with bovine serum albumin standards.
Western blotting for CYPIA quantification: Immunoblotting procedures were
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal
proteins (10 pg/lane) were resolved on 8-16% SDS-PAGE gels and electrophoretically
transferred to 0.05 gm nitrocellulose membrane. The primary antibody was the mouse
monoclonal antibody 1-12-3 (Park et al., 1986), raised against scup P450E (CYP1A;
(Morrison et al., 1995)). The secondary antibody was alkaline phosphatase linked goat
anti-mouse IgG (Biorad, Hercules, CA). The immunoreactive bands were visualized using
nitro blue tetrazolium and 5-bromo-4-chloro-3-indoyl-phosphate and quantified by video
image analysis (NIH Image 1.60b5) by comparison to scup standards of known
concentration.
In vitro studies of CYPIA inactivation: The procedure was as described in Chapter
3 except for the following additions: BP (1.5 M), CB 52 (1.7 pgM), CB 105 (0.015-31
jtM), CB 126 (0.015-15 jiM), and CB 169 (0.014-14 jiM). EROD loss resulting from
inhibition was calculated by comparing EROD at 10 minutes in control and CB reaction
mixtures. EROD loss resulting from inactivation was calculated by comparing EROD at 30
minutes in CB and CB+NADPH reaction mixtures. Curve fitting was performed using
Sigma Plot for Macintosh (SSPS Inc., Chicago, IL). For inhibition, the IC50 values were
determined directly from the plot of CB concentration and activity loss. The methods of
(Cha, 1975) and (Cheng and Prusoff, 1973) were used to convert the IC50 to a Ki with
0.22 gM as the Km for 7-ethoxyresorufin metabolism (M. E. Hahn, unpublished results).
NADPH oxidation: NADPH oxidation was determined by monitoring the decrease
in absorbance at 340 nm in reaction mixtures prepared as in the inactivation assay using 0.4
mg protein/ml and 15 jtM CB (Imai, 1979).
Spectral P450 assay: Loss of spectral P450 was determined as described in
Chapter 3 except for the following additions: CB 126 or 169 (13-15 jtM)
Peroxide and superoxide formation: H202 and 02 -* formation were determined as
described in Chapter 3 except for the following additions: BP and CBs 52, 105, 126, or
169 (1.5 nmol in acetone).
Statistics Statistics were calculated using Microsoft Excel (Microsoft, Inc.,
Redmond, WA) and SuperAnova for Macintosh (Abacus Concepts, Inc., Berkeley, CA).
A two-tailed Student's t-test was used to analyze EROD and total P450 inactivation data
(CB vs. CB+NADPH). A one-factor ANOVA was used to analyze the inactivation
experiments including additions and the ROS experiments. The Tukey-Kramer multiple-
comparisons test was used in analyses of inactivation experiments. The Dunnett's test was
used for the ROS experiments with the acetone+NADPH reaction mixture as the control.
RESULTS
ROS production stimulated by CYPIA substrates: BP and the CB congeners were
tested for the ability to stimulate ROS production in scup liver microsomes. Production of
ROS during incubation of liver microsomes from untreated scup with NADPH was
unaffected by the addition of any CB congener (data not shown). As with CB 77,
incubation of liver microsomes from BP-treated scup with NADPH and the non-ortho CBs
126 and 169 significantly increased DCDFDA and HE oxidation (Figure 1). DCDFDA is
oxidized to DCF by H202, and HE is oxidized to ethidium by 02 -*. BP and the ortho CBs
52 and 105, did not alter ROS production significantly from that obtained with
acetone+NADPH.
Inactivation of scup liver CYPIA: CB- and NADPH- dependent inactivation of
CYP1A was studied in liver microsomes from BP-treated scup using the in vitro assay
employed previously (White et al., 1997a). In control reaction mixtures containing
acetone±NADPH, EROD remained constant over 30 minutes (data not shown). When
microsomes were incubated with CB alone, EROD was decreased 20 ± 10% with CB 105,
70 ± 6% with CB 126 and 62 ± 10% with CB 169 as compared to control reaction
mixtures (Figure 2), but this decrease remained constant through time (data not shown). At
30 minutes, reaction mixtures containing CB 105+NADPH showed a 32 ± 7% loss of
EROD, containing CB 126+NADPH showed a 70 ± 7% loss of EROD and containing CB
169+NADPH showed a 67 ± 11% loss of EROD compared to those reaction mixtures
containing CB alone (Figure 2). Confirming earlier results, reaction mixtures containing
CB 77 showed a 50 ± 6% decrease in EROD due to inhibition and 62 ± 6% decrease in
EROD due to inactivation when NADPH was added (Figure 2). The capacity to catalyze
EROD was not altered by incubation of microsomes with either CB 52 alone or CB
52+NADPH (Figure 2). When microsomes were incubated with BP alone, EROD
decreased 93 ± 6%. due to inhibition. However, in contrast to results with the CB
congeners, EROD in reaction mixtures containing BP+NADPH increased 7-fold above that
in reaction mixtures with BP alone, by 30 minutes (Figure 2).
To determine if loss of P450 protein co-occurred with loss of CYP1A catalytic
activity, spectral P450 content was assessed in the reaction mixtures. Similar to EROD, no
significant loss of total P450 occurred with either CB 126, CB 169 or NADPH alone
(Figure 3a). Incubation of hepatic microsomes for 30 minutes with CB 126 or 169
+NADPH resulted in 52 ± 8% and 47 ± 9% losses of P450, respectively (Figure 3b). The
loss of P450 was accompanied by a variable appearance of cytochrome P420, with
amounts of P420 formed ranging from 0.14-0.20 nmol/mg for CB 126, and 0.11-0.19
nmol/mg for CB 169. In comparison, incubation of microsomes for 30 minutes with CB
77 and NADPH resulted in a 38 ± 9% loss of P450 and formation of 0.15-0.26 nmol
P420/mg (Figure 3b).
Both inhibition and inactivation were CB concentration dependent (Figure 4).
Variation of the 7-ethoxyresorufin concentration had little affect on the inhibition of EROD
by the non-ortho CB congeners (data not shown), therefore the Cha calculation for the
conversion of the IC50 to a Ki may provide the closest approximation of the true Ki. CB
126 and CB 169 had Ki values similar to that for CB 77 while that for CB 105 was 3-fold
greater (Table I). The KmInactivation values for CBs 126 and 169 were 2 to 3-fold less
than that for CB 105 (Table I). CBs 126 and 169 had greater efficacy in stimulating
inactivation than did CB 105 (Table I). Using EROD and spectral P450 data
Figure 1. Effect of CB congeners and BP on ROS production in scup liver microsomes.
A) 02 -* production as assessed by oxidation of HE to ethidium. B) H202 production as
assessed by oxidation of DCDFDA to DCF. In a 48-well plate, approximately 0.1 mg of
microsomal protein (398 ± 42 pmol CYP1A/mg) was diluted to 160 pl with HBSS
containing 5 M DCDFDA and 7.5 pM HE (final concentrations). Following a 15 minute
incubation at 30"C, 1.3-1.5 nmol BP or CBs 52, 105, 126 or 169 in acetone or 5 ll
acetone was added. Reactions were initiated with NADPH (1.7 mM). The rates of DCF
and ethidium production were monitored fluorometrically over 5 minutes. Calculations
were made using DCF and ethidium bromide as standards. Incubation of microsomes
without NADPH resulted in very low levels of DCF or ethidium production. Data for CB
77 are from Chapter 3. Data are means ± SD from at least 3 pools of .microsomes.
*Statistically different from acetone+NADPH (p<0.01, Dunnett's).
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Figure 2. Inhibition and inactivation of scup liver CYP1A stimulated by BP and CBs 52,
77, 105, 126 and 169. Microsomes (0.1 mg protein/ml with 398 ± 42 pmol CYP1A/mg)
were incubated in buffer (50 mM TRIS, 0.1 mM EDTA, pH 7.6) at a final volume of 1 ml
in glass test tubes at 300C. The following chemicals were added in various combinations at
the final concentrations indicated: acetone (5 jl), NADPH (1.8 mM), CB 52, 77, 105, 126
or 169 (1.3-1.7 gM). Aliquots were removed from reaction mixtures at times zero, 10, 20
and 30 minutes and assayed fluorometrically for EROD over 5 minutes. Data shown here
are from the 30 minute time point. EROD was constant in microsomes incubated with
acetone or NADPH. Following an initial loss of EROD upon addition of CBs 77, 105,
126 or 169, EROD remained constant. The rate of loss of EROD during incubation with
NADPH and CBs 77, 105, 126 or 169 was constant over time for each congener. Data are
means ± SD from 3-4 pools of microsomes. *-Significantly different from CB (p<0.005,
Student's t-test).
independently, rates of inactivation were calculated (Table I). Rates of inactivation were
determined from the decline in EROD by assuming that loss of EROD is equated with loss
of CYP1A. Both methods rendered similar rates of inactivation. CBs 77, 126 and 169
stimulated loss of P450 at a similar rate. In comparison, the rate of inactivation with CB
105+NADPH was at least 70% less than that seen with the coplanar congeners.
Previously, azide and H202 were shown to enhance CB 77 stimulated inactivation
of CYP1A (Chapter 3). Azide caused a 2-fold increase in the rate of inactivation in the
presence of CB 126+NADPH or CB 169+NADPH at 10 minutes (Figure 5). Incubation
of azide with CB 126+NADPH resulted in statistically significant enhancement of
inactivation at both 10 and 30 minutes. Similarly, H202 increased the loss activity due to
inactivation stimulated by CBs 126 and 169 by 3-fold at 10 minutes (Figure 6). Incubation
of H202 with CB 126+NADPH resulted in statistically significant enhancement of
inactivation at 10 and 30 minutes and with CB 169+NADPH resulted in statistically
significant enhancement of inactivation at 10 minutes.
Electron transfer was found to be an essential component in the inactivation of
CYP1A mediated by CB 77, therefore BP and the CB congeners were tested for the ability
to stimulate NADPH oxidation. BP stimulated NADPH oxidation to the greatest extent,
with CBs 105, 126 and 169 also causing significant increases (Table II). CB 52 did not
significantly stimulate NADPH oxidation (Table II ).
Cytochrome c inhibits CYP1A by competing for electrons from cytochrome P450
reductase (Estabrook et al., 1996), thereby reducing inactivation by preventing the
reduction of molecular oxygen bound to the heme. When cytochrome c (10 jRM) was
added to reaction mixtures containing CBs 126 or 169 and NADPH, the rate of inactivation
decreased (Figure 7). The rate of loss of EROD was 7 + 4 pmol/minlmg in the presence of
CB 126+NADPH+cytochrome c as compared to 12 pmol/min/mg the absence of
cytochrome c. The rate of loss of EROD was 4 ± 2 pmol/min/mg in the presence of CB
169+NADPH+cytochrome c as compared to 16 pmol/min/mg the absence of cytochrome c.
Electron transfer appears to be an essential component in the inactivation of CYP1A by
CBs 126 and 169.
DISCUSSION
Microsomal CYP1A in the fish Stenotomus chrysops has been shown to be
extremely susceptible to oxidative inactivation when CB 77 binds and uncouples the
catalytic cycle of the enzyme (White et al., 1997a; Chapter 3). In addition, ROS are
Figure 3. Loss of spectral P450 in the presence of CBs and NADPH. A) P450 spectra of
scup liver microsomes following incubation with acetone, NADPH, CB 126 or CB
126+NADPH. B) Total spectral P450 content (nmol/mg) of scup liver microsomes. To
determine if there was a loss of P450, microsomes (0.4 mg protein/ml) were incubated in
buffer (50 mM TRIS, 0.1 mM EDTA, pH 7.6) at 300C. The following chemicals were
added in various combinations at the final concentrations indicated: acetone (0.5 %), CB
126 or 169 (13-15 gM), and NADPH (0.7 mM). Following a 30 minute incubation, total
P450 concentration was determined by bubbling reaction mixtures with CO and obtaining
the dithionite-difference spectra (Bonkovsky et al., 1984). Data are means ± SD from 3
pools of microsomes. *-Significantly different from CB (p<0.05, Student's t-test). **-
Significantly different from CB (p<0.001, Student's t-test).
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Figure 4. Concentration dependent inhibition and inactivation of CYP1A stimulated by
CBs 105 (A), 126 (B) and 169 (C). Incubation conditions and assay technique were as
described in Figure 2, except that a range of CB concentrations was used (0.013-30 gM).
Open circles - EROD loss due to inhibition was calculated by comparing EROD at 10
minutes in control and CB reaction mixtures. Closed squares - EROD loss due to
inactivation was calculated by comparing EROD at 30 minutes in CB and CB+NADPH
reaction mixtures. Results from 2-3 pools of microsomes were used in the non-linear
regression analysis.
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TABLE I
In vitro inhibition and inactivation of EROD by CB congeners in scup liver microsomes.
Inhibition Inactivation
CB IC50 Kia Kib Max. % Km Max. % Ratec Ratec
(pM) (pM) (1pM) Activity (piM) Activity Calculated Calculated
Lost Lost from EROD from P450
77 0.18 d  0.02 0.16 60 0.05 55 8 + 3 e 12 + 3
105 6.00 0.59 80 0.37 50 3 +2 ND
126 0.18 0.02 0.16 81 0.14 74 12 ± 5 11 1
169 0.22 0.02 0.20 72 0.08 68 16 ± 5 6 + 1
Inhibition and inactivation constants and maxima were calculated from data presented in
Figure 4. The IC50, KmInactivation and maximum values were determined by a non-
linear regression analysis of the plot of CB concentration and activity loss (Figure 3).
a - The method of (Cheng and Prusoff, 1973) was used to convert the IC50 to a Ki with
0.22 p~M as the Km for 7-ethoxyresorufin metabolism (M. E. Hahn, unpublished results).
b - For CBs 77, 126 and 169, the method of (Cha, 1975) was used to convert the IC50 to a
Ki, considering the planar CB congeners as tight binding inhibitors.
c - Rates were calculated from the data in Figures 2 and 4 and are presented as pmol
P450/min/mg. The rate of inactivation was determined by equating the loss of EROD
activity in a given set of microsomes over a 30 minute time period with the specific CYP1A
content of those microsomes.
d - Data from Chapter 3.
e - Mean ± SD from 3-4 pools of microsomes.
ND - Not determined.
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Figure 5. Effect of azide on CB-stimulated CYPlA inactivation in scup liver microsomes.
A) CB 126. B) CB 169. Incubation conditions and assay technique were as described in
Figure 2, except for the addition of azide (0.1 mM). The azide concentration used was
previously determined not to cause a loss of activity without the presence of both NADPH
and CB (Chapter 3). Data are means ± SD from 4 pools of microsomes. *Statistically
different from CB (p<0.05, Tukey-Kramer). **Statistically different from CB and
CB+NADPH (p<0.05, Tukey-Kramer).
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Figure 6. Effect of H202 on CB-stimulated CYP1A inactivation in scup liver microsomes.
A) CB 126. B) CB 169. Incubation conditions and assay technique were as described in
Figure 2, except for the addition H202 (100 mM). The H202 concentration used was
previously determined not to cause a loss of activity without the presence of both NADPH
and CB (Chapter 3). Data are means ± SD from 4 pools of microsomes. *Statistically
different from CB (p<0.05, Tukey-Kramer). **Statistically different from CB and
CB+NADPH (p<0.05, Tukey-Kramer).
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TABLE II
NADPH oxidation in scup liver microsomes.
Additions NADPH Oxidation
(nmol/min/mg)
NADPH 13 ± l a
NADPH+
Acetone 11 + 3
BP 33 7*
CB 52 14 + 4
CB 105 24 + 5*
CB 126 28 + 2*
CB 169 28 ± 8*
The rate of NADPH oxidation was determined by monitoring the decrease in absorbance at
340 nm (Imai, 1979) in incubations prepared as in the inactivation assay using 0.4 mg
protein/ml and acetone (0.5 %) or 15 plM CB in acetone.
a - Mean ± SD from at least 3 microsome pools.
* - Significantly different from acetone+NADPH (p<0.01, Dunnett's).
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Figure 7. Effect of cytochrome c on CB-stimulated CYP1A inactivation in scup liver
microsomes. Incubation conditions and assay technique were as described in Figure 2,
except for the addition of cytochrome c (10 RM). Data shown are from the 30 minute time
point. Data are means ± SD from 3-4 pools of microsomes. *Statistically different from
CB (p<0.01, Tukey-Kramer). **Statistically different from CB and CB+NADPH
(p<0.01, Tukey-Kramer).
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released during the interaction of CB 77 and CYP1A. Here we addressed the hypothesis
that any pHAH that is an AhR agonist would bind to CYP1A with effects similar to CB 77.
As occurs with CB 77, the coplanar CBs 126 and 169 stimulated ROS formation by and
inactivation of scup CYP1A. The mono-ortho CB 105 also stimulated CYP1A inactivation
although to a lesser extent than the non-ortho CBs and did not stimulate ROS release. The
di-ortho CB 52 and the rapidly metabolized CYP1A substrate, BP, stimulated neither ROS
release nor CYP1A inactivation. This study lends support to the hypothesis that catalytic
uncoupling by slowly metabolized substrates may also create an environment in the active
site which is favorable to the formation and attack of ROS. Moreover, release of ROS
promoted by pHAH could be a mechanism by which some AhR agonists/CYP1A
substrates exert toxicity.
Inactivation of CYPlA Stimulated by CBs: We previously hypothesized that the
inactivation of CYP1A mediated by CB 77 occurs through an oxidative mechanism
(Chapter 3). We speculated that steric hindrance due to the chlorines may lodge the CB in
the substrate access channel, rendering the molecule largely inaccessible to attack by the
peroxy-ferryl complex of P450. As a result, reduced oxygen is released from the heme
iron. The exact identity of the ROS causing CYP1A inactivation is unknown. Some
studies have suggested that 02 -' can cause release of iron from heme (Gutteridge, 1986;
Das et al., 1992); however, the data in our study suggested that OHO is responsible.
Fenton chemistry requires the presence of both H202 and a reduced iron. H202 is
produced by scup CYP1A as a result of uncoupling during CB metabolism. If the CB
remains in the active site stimulating electron flow and oxygen binding, activation and
release, then presumably, the heme iron continues to cycle between Fe3 + and Fe2 +. We
suggested that penta-coordinate ferrous heme in the active site is able to act as a Fenton
catalyst in the conversion of H202 to OH-. Oxidative inactivation in other enzymes can
involve OH* attack on an amino acid or the heme (Matheson and Travis, 1985; Beyer and
Fridovich, 1987; Jenzer et al., 1987).
Results from this study suggest that this oxidative inactivation can be stimulated by
any CB that is a slowly metabolized substrate for CYP1A. 1) Stimulation of NADPH
oxidation and inhibition of EROD .by CBs 126 and 169 suggest that they interact with the
CYP1A active site. 2) ROS production was stimulated by both CBs 126 and 169, but
only in microsomes with induced levels of CYP1A. Thus the presence of CYP1A is
required for the production of ROS. 3) Both CBs 126 and 169 stimulated loss of CYP1A
catalytic activity and total P450. The rate of loss was greater with CBs 126 and 169 than
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had been seen previously with CB 77 (Chapter 3). Both CBs 126 and 169 are more
refractory to metabolism than CB 77 (Safe, 1994), potentially increasing uncoupling. 4)
The inactivation stimulated by CBs 126 and 169 was dependent upon electron flow. 5) As
has been seen with CB 77, the inactivation of CYP1A could be accelerated by the addition
of azide and H202, both of which undergo Fenton chemistry to form highly reactive
radicals (Ortiz de Montellano et al., 1988; Partridge et al., 1994). 6) CB 52, a di-ortho CB
which is not a substrate for CYP1A, did not stimulate NADPH oxidation, inhibit EROD,
inactivate CYP1A or stimulate ROS release. 7) BP, a rapidly metabolized substrate,
stimulated NADPH oxidation and inhibited EROD but did not stimulate CYP1A
inactivation or ROS release. These results are consistent with attack of internally produced
activated oxygen being a generalized mechanism of inactivation stimulated by slowly
metabolized CYP1A substrates.
On the other hand, the mono-ortho CB 105 inactivated CYP1A but did not stimulate
ROS release. Mono-ortho CBs, including CB 105, can assume an almost co-planar
configuration and thus are able to interact with the AhR and induce EROD activity in
mammals (Safe et al., 1985; McFarland and Clark, 1989). Even though CB 105 is
ineffective at inducing CYP1A in several fish species (Gooch et al., 1989; Bernhoft et al.,
1994; Newsted et al., 1995), it apparently can interact with scup CYP1A as was indicated
by its ability to stimulate NADPH oxidation and to inhibit EROD activity. Another mono-
ortho CB, 2,3,3',4,4',5-hexachlorobiphenyl (IUPAC #156), also inhibits EROD activity
in scup liver microsomes (Gooch et al., 1989). However, CB 105 inhibited and
inactivated CYP1A to a lesser extent than the coplanar CBs. Activation of oxygen may not
be as rapid, as suggested by the lesser rate of CYP1A inactivation in the presence of CB
105, and thus no increase in ROS release was seen. Other studies have demonstrated that
treatment with the mono-ortho CB 2,3,4,4'5-pentachlorobiphenyl (IUPAC #118) increases
oxidase activity in rat liver microsomes (Buchmann et al., 1991) and in porcine pulmonary
endothelial cells (Toborek et al., 1995). Just as CB 105 is less effective at inhibiting and
inactivating CYP1A than the coplanar congeners, it also is a less potent AhR agonist and
has a lower TEF than the coplanar CB congeners (Safe et al., 1985; Safe, 1994).
CYPIA and Oxidative Stress: Exposure to pHAH can result in oxidative stress.
Kestrels show increased lipid peroxidation following treatment with CB 126 (Hoffman et
al., 1996), and rats respond to TCDD treatment with increased lipid peroxidation and
oxidative DNA damage (Stohs, 1990; Stohs et al., 1990). Furthermore, pHAH-induced
oxidative stress has been correlated with activation of the AhR (Faux et al., 1992; Alsharif
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et al., 1994; Park et al., 1996)., as well as induction of CYPlA (Otto and Moon, 1995;
Toborek et al., 1995; Palace et al., 1996). In vitro experiments performed here with CBs
126 and 169 and earlier studies with CB 77 (Chapter 3) showed that coplanar CB
congeners stimulate ROS production in liver microsomes from scup induced for CYP1A
but not from liver microsomes from control fish. In addition, hepatic microsomal and
mitochondrial fractions but not cytosolic fractions from TCDD-treated rats can increase the
incidence of DNA single strand breaks (Wahba et al., 1989). Together, these results
indicate that interaction of pHAH with CYPlA induced through the AhR could be the
immediate source of ROS in vivo.
Whether CB congeners can stimulate ROS release from CYP other than CYP1A is
not known. Several psuedosubstrates, including perfluoro-n-hexane and 1,1,1-
trichloroethane, and partial uncouplers, including hexobarbital, 5-alkyl-5-ethylbarbituates,
and benzphetamine, stimulate the release of ROS by CYP2B (Estabrook et al., 1979;
Jeffery and Mannering, 1982; Kuthan and Ullrich, 1982; Ekstrom and Ingelman-
Sundberg, 1986; Takamo et al., 1988). CB congeners with di-ortho substitutions can
induce the CYP2B subfamily (Safe et al., 1985), and 2,2',4,4',6,6'-hexachlorobiphenyl
(IUPAC #155) may uncouple microsomal CYP2B as it stimulates NADPH oxidation and
oxygen consumption but is not metabolized (Hesse and Wolff, 1977). However, studies
of porphyrinogen and bilirubin oxidation, attributed to ROS produced during catalytic
uncoupling, show that 2,2',4,4'-tetrachlorobiphenyl (IUPAC #47) only weakly induces
this oxidation in vivo and in vitro (DeMatteis et al., 1988; DeMatteis et al., 1989). Whether
non-coplanar CB congeners stimulate ROS production by CYP2B remains to be
determined.
Considering that bioactivation of pHAH does not contribute significantly to their
toxicity, the uncoupling of CYPIA and resultant release of ROS may be an important
contributor to the toxicity of pHAH. We have demonstrated that the coplanar CB
congeners stimulate release of ROS from scup liver microsomes with induced levels of
CYP1A. Further investigation with CBs 126 and 169 indicated that the mechanism of
CYP1A protein and activity loss associated with incubation with these CB congeners was
oxidative inactivation, as has been shown for CB 77 (Chapter 3). Data here, together with
results with CB 77, show that the interaction of pHAH with scup liver CYPlA stimulates
the production of ROS in vitro. Planar HAH stimulate oxidative stress (Faux et al., 1992;
Alsharif et al., 1994; Smith et al., 1995; Park et al., 1996), suggesting that ROS may play
a role in AhR agonist toxicity in vivo. CBs occur in the environment as complex mixtures;
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thus while single congeners may exist at very low concentrations, particularly coplanar
CBs, a combination of CBs may additively or synergistically induce CYP1A catalytic
activity and toxicity (Bol et al., 1989; Janz and Metcalfe, 1991; Newsted et al., 1995; Zabel
et al., 1995). Potentially, combinations of congeners could stimulate physiologically
significant amounts of ROS during environmental exposure. We suggest that release of
ROS may be a mechanism by which pHAHs promote toxicity.
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CHAPTER 5
Inactivation of Cytochrome P450 1A In Vivo by 3,3',4,4',5-
Pentachlorobiphenyl and its Potential Relationship to Oxidative Stress
107
ABSTRACT
In vertebrates, the planar halogenated aromatic hydrocarbon (pHAH) 3,3',4,4'-
tetrachlorobiphenyl both induces and inhibits cytochrome P450 1A (CYP1A). Moreover,
multiple pHAHs, including 3,3',4,4'-tetrachlorobiphenyl (IUPAC #77), 3,3',4,4',5-
pentachlorobiphenyl (PeCB) (IUPAC #126) and 3,3',4,4',5,5'-hexachlorobiphenyl
(IUPAC #169), inactivate CYP1A and stimulate the production of reactive oxygen (ROS)
in vitro. The ability of PeCB to stimulate CYP1A inactivation, ROS production and
oxidative stress in vivo was examined in the marine teleost scup (Stenotomus chrysops).
In liver, a low dose of PeCB (0.01 mg/kg) induced total P450, CYP1A protein and
CYP1A catalytic activities (ethoxyresorufin O-deethylation and methoxyresorufin 0-
demethylation) over an 18 day period. A high dose of PeCB (1 mg/kg) only minimally
induced hepatic total P450 and CYP1A protein, and CYP1A catalytic activities remained at
control levels. In contrast, CYP1A mRNA expression was induced strongly by both doses
(15- to 35-fold). That the inactivating effect was largely specific for CYP1A was
suggested by the minimal effects on P450A (a CYP3A-like protein), P450B (a CYP2B-like
protein) and cytochrome b5 content. Less inactivation of CYP1A occurred in heart, gill or
kidney. ROS production (measured by the oxidation of dihydroethidium) was stimulated
by PeCB in liver microsomes from the low dose fish, and the rate of PeCB-stimulated ROS
production was correlated with EROD activity (r2 =0.641, p<0.0005). Oxidative stress, as
indicated by increases in catalase, glutathione peroxidase, glutathione reductase and
superoxide dismutase activities, was simulated transiently by the low dose. PeCB appears
to oxidatively inactivate scup liver CYP1A both in vitro and in vivo.
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INTRODUCTION
Interaction of planar halogenated aromatic hydrocarbons (pHAH), as well as
polynuclear aromatic hydrocarbons and natural products, with the aryl hydrocarbon
receptor results in the increased expression of drug metabolizing enzymes (Hankinson,
1995). In particular, cytochrome P450 1A (CYPlA) is induced potently by such
compounds in mammals (Parkinson et al., 1980; Parkinson et al., 1983) and fish
(Melancon and Lech, 1983; Gooch et al., 1989; Miranda et al., 1990; Monosson and
Stegeman, 1991). However, pHAH may regulate CYPlA at multiple levels. 3,3',4,4-
tetrachlorobiphenyl (TCB) is a substrate of CYP1A in fish (White et al., 1997b) and
CYP1A1 in mammals (Ishida et al., 1991) and therefore can competitively inhibit CYP1A
catalytic activity in vitro (Gooch et al., 1989). Loss of catalytic activity following treatment
with high doses of coplanar chlorobiphenyl (CB) congeners occurs without the loss of
protein in vivo (Melancon and Lech, 1983; Voorman and Aust, 1988; Miranda et al.,
1990; Monosson and Stegeman, 1991; Lindstrom-Seppa et al., 1994) and in cultured cells
(Sawyer and Safe, 1982; Rodman et al., 1989; Hahn et al., 1993; Kennedy et al., 1993;
Lorenzen et al., 1997), suggesting that coplanar CB congeners could inhibit CYP1A in
vivo. Last, TCB, at high doses, suppresses CYP1A protein induction in several species
(Lambrecht et al., 1988; Sinclair et al., 1989; Newsted et al., 1995; Stegeman et al., 1995;
White et al., 1997a).
Suppression of CYPlA protein induction at high doses of planar CB congeners has
been hypothesized to result from oxidative inactivation. In vivo, suppression occurs post-
transcriptionally. A low dose of TCB (0.1 mg/kg) induces hepatic CYPIA mRNA
expression, protein and catalytic activity to nearly maximal levels in the marine fish model
scup (Stenotomus chrysops); a high dose of TCB (5 mg/kg) strongly induces CYP1A
mRNA expression but minimally induces CYP1A protein and activity (White et al.,
1997a). Loss of CYPIA occurs during the incubation of scup liver microsomes with
TCB+NADPH, as well (White et al., 1997a; Chapter 3). Attack of a metabolically
activated product cannot account for the loss of CYP1A because metabolism of TCB by
scup proceeds exceedingly slowly (White et al., 1997a; White et al., 1997b). Enhanced
electron transfer, oxygen dependence and exceedingly slow rates of TCB turnover are
consistent with uncoupling of electron transport from substrate oxidation (Chapter 3). As a
result, reactive oxygen species (ROS) may be released from the active site of CYP1A or
may attack and inactivate the protein (Chapter 3). ROS attack may be involved in the
decline in CYP1A seen in vivo.
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In vitro oxidative inactivation and ROS release are stimulated by several slowly
metabolized pHAH that are CYP1A substrates, including 2,3,3',4,4'-pentachlorobiphenyl,
3,3',4,4',5-pentachlorobiphenyl (PeCB) and 3,3',4,4',5,5'-hexachlorobiphenyl (Chapter
4). Loss of protein induction but not CYP1A mRNA expression following treatment with
high doses of multiple planar CB congeners suggests that inactivation may occur with
pHAH generally in vivo, as well (Rodman et al., 1989; Newsted et al., 1995; Lorenzen et
al., 1997). Recently, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) also has been shown to
cause suppression of CYP1A1, but not CYP1A2, in mice, in combination with an increase
in 8-hydroxydeoxyguanosine content (Shertzer et al., 1998).
We hypothesized from the in vitro data that the coplanar PeCB would suppress
CYP1A induction in scup liver and induce oxidative stress in vivo. Of the coplanar CB
congeners, PeCB is the most potent in eliciting toxic effects in fish (Janz and Metcalfe,
1991; Walker and Peterson, 1991; Newsted et al., 1995) and mammals (Safe, 1990; Tillitt
et al., 1991). If uncoupling and ROS production are involved in PeCB toxicity, that
toxicity may be enhanced by the lack of PeCB metabolism (Yoshimura et al., 1987; Koga
et al., 1990). Although low doses of PeCB (0.01-0.1 mg/kg) potently induced CYP1A
mRNA, protein and activity in scup liver, a high dose (1 mg/kg) induced only CYP1A
mRNA and suppressed induction of CYP1A protein and activity. As with TCB, this effect
appeared to be largely specific to CYP1A. Interestingly, suppression of CYP1A induction
was organ-dependent, with hepatic CYP1A being most susceptible to inactivation. PeCB
transiently stimulated anti-oxidant enzyme activity in scup liver in vivo. Furthermore, the
capacity for hepatic microsomes to produce ROS was correlated with CYP1A activity. The
results are consistent with the hypothesis that ROS are involved in the in vivo suppression
of scup liver CYP1A by coplanar CB congeners.
MATERIALS AND METHODS
Chemicals: 7-Ethoxyresorufin and dihydroethidium were purchased from
Molecular Probes (Eugene, OR). 3,3',4,4',5-Pentachlorobiphenyl (IUPAC# 126) was
purchased from Ultra Scientific (North Kingstown, RI). All other reagents were purchased
from Sigma (St. Louis, MO).
Animals: Scup (Stenotomus chrysops ) were caught by trapping in Vineyard
Sound, MA in August, 1996, and experiments were conducted in August, 1997. Fish
were held in flow-through seawater tanks at 14°C and maintained on a diet of Purina Trout
Chow. Experimental animals (mixed sex) were gonadally undeveloped and ranged in size
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from 136 to 327g. Fish were injected intra-peritoneally with corn oil or solutions of
3,3',4,4',5-pentachlorobiphenyl (0.01, 0.1 or 1 mg/ml, 1 ml/kg body weight) in corn oil.
For each dose group, three tanks contained six fish, and at each time point two fish from
each tank were sampled. Fish were fed once weekly. Untreated fish were killed by
severing the spinal cord on Day 0. Injected fish were killed 3, 7, and 16 or 18 days
following dosing. Body and liver weights were recorded and used to calculate the
Hepatosomatic Index (HSI=the percent of total body weight represented by the liver).
Sections of liver for RNA preparation were removed and frozen in liquid N2. Immediately
following dissection of heart, gill, kidney and liver, microsomes and cytosols were
prepared from sections of each (Stegeman et al., 1979). Microsomal pellets were
resuspended in buffer (50 mM TRIS, pH 7.4, 1 mM dithiothrietol, 1 mM EDTA, 20%
glycerol) and frozen in liquid N2 until use. Protein content was determined using the
bicinchoninic acid method (Smith et al., 1985), using bovine serum albumin as a standard.
Quantification of CYPIA mRNA: RNA was prepared using RNA-Stat (Tel-Test
Inc., Friendswoods, TX) by following the manufacturer's instructions. RNA pellets were
washed once in 4 M LiCI to remove glycogen, followed by two washes in 95% ethanol.
Total RNA was quantified by its absorbance at 260 nm on a Shimadzu UV-2401PC
spectrophotometer.
Total RNA samples (10 pgg each) were denatured in formamide/formaldehyde and
separated on a 1% agarose/2.2 M formaldehyde gel, in 20 mM MOPS running buffer.
RNA was transferred to a positively charged membrane (Chomczynski, 1992). Equal
loading was assessed from visualization of ethidium bromide staining of ribosomal RNA.
The dried membrane was pre-hybridized for 2 hr at 42"C, in a buffer composed of 5x
SSPE, 0.1% SDS, 2x Denhardt's solution, 50% formamide and 100 lgg/ml calf thymus
DNA. 3 2P-Labeled probe (see below) was added to the pre-hybridization buffer, and the
membrane was hybridized at 42"C for approximately 12 hrs. The membrane was washed
two times at 42"C for 30 minutes with 2x SSC, 0.1% SDS and exposed to Kodak X-
OMAT AR film. The relative amount of CYP1A mRNA was determined using
densitometric analysis of a video image (NIH Image 1.60b5).
A cDNA probe containing 75% of the scup CYP1A coding region (Morrison et al.,
1995) was used for quantification of CYP1A mRNA. The probe was radiolabeled with [a-
3 2 P]dCTP (Amersham, Arlington Heights, IL) using a Prime-a-Gene labeling kit
(Promega, Madison, WI).
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Western blotting for CYPIA quantification: Immunoblotting procedures were
modified from those previously described (Kloepper-Sams et al., 1987). For CYP1A
determinations, liver microsomal protein was applied to nylon membrane using a slot
manifold (Kloepper-Sams and Stegeman, 1994). For all other analyses microsomal
proteins (30-40 gg) were resolved on 6-18% SDS-PAGE gels and electrophoretically
transferred to nylon membrane. The primary antibodies were the mouse monoclonal
antibody 1-12-3 (Park et al., 1986), against scup P450E (CYP1A; (Morrison et al.,
1995)), the rabbit polyclonal antibody against scup P450B (a CYP2B-like protein) (Gray,
1988; Stegeman et al., 1990)) and the rabbit polyclonal antibody against scup P450A (a
CYP3A-like protein) (Celander et al., 1996). The secondary antibodies were alkaline
phosphatase linked goat anti-mouse IgG and goat anti-rabbit IgG (Schleicher and Schuell,
Keene, NH). Bands were developed using enhanced chemiluminescence (Tropix,
Bedford, MA) and quantified by video image analysis (NIH Image 1.60b5) by comparison
to scup standards of known concentration..
Cytochromes b5 and P450 The content of hepatic microsomal P450 was
determined from the dithionite-difference spectra of CO-treated microsomes (Bonkovsky et
al., 1984), and cytochrome b5 content was determined from NADH difference spectra
(Stegeman et al., 1979), as previously described.
Enzyme assays: Microsomal ethoxyresorufin (EROD) and methoxyresorufin
(MROD) O-dealkylation activities were determined fluorometrically by the method of Hahn
et al. (1993), using a Cytofluor 2300 (Millipore) multiwell plate reader. Microsomal
NADPH-cytochrome P450 reductase activity was determined as previously described
(Stegeman et al., 1982). The activities of catalase (Beutler, 1975), glutathione peroxidase
(Sies et al., 1979), glutathione reductase (Sies et al., 1979), and superoxide dismutase
(McCord and Fridovich, 1969) were determined in the cytosols.
Superoxide formation: 02 -* formation was determined using the fluorescent dye,
dihydroethidium (HE), as described in Chapter 3. Additions included acetone (5 gl),
PeCB (1.7 nmol in acetone) and NADPH (1.4 mM). ROS production stimulated by PCB
126 was calculated by subtracting the fluorescence in the well containing acetone to that in
the well containing PeCB.
Statistics Statistics were calculated using SuperAnova for Macintosh (Abacus
Concepts, Inc., Berkeley, CA). Nested, one-factor ANOVAs were used to analyze
differences between treatment groups within sampling days. Tank was not found to be a
significant factor. Because RNA and extrahepatic tissue samples were pooled per tank,
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Figure 1. Effect of PeCB on hepatic microsomal cytochrome P450 (A) and cytochrome b5
(B) content. Cytochrome contents were determined spectrally. Data represent the means ±
SD of measurements on 6 fish per treatment group except for the 0.01 mg/kg dose on Day
18 (n=4) and the 1 mg/kg dose on Day 16 (n=3). +-Statistically different from control and
1 mg/kg dose (p<0.05). #-Statistically different from control (p<0.05). The 0.1 mg/kg
dose was significantly different from control and 1 mg/kg dose (p<0.05).
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Figure 2. Effect of PeCB on CYP1A mRNA expression in scup liver. A) Northern blot of
CYP1A mRNA. Lanes 1-2. Control, Day 3. Lanes 3-4. 0.01 mg PeCB/kg, Day 3.
Lanes 5-6. 1 mg PeCB/kg, Day 3. Lanes 7-8. 0.01 mg PeCB/kg, Day 7. Lanes 9-10.
0.1 mg PeCB/kg, Day 7. Lanes 11-12. 1 mg PeCB/kg, Day 7. Lanes 13-14. 0.01 mg
PeCB/kg, Day 18. Lanes 15-16. 1 mg PeCB/kg, Day 16. B) Comparison of CYP1A
mRNA in liver of scup treated with various doses of PeCB. For each time point, livers
from fish in the same tank were pooled before RNA preparation. Total RNA (10 jtg/lane)
was separate on agarose gel, transferred to nylon membrane, probed with a 32P-labeled
cDNA containing 75% of the scup CYP1A coding region, and densitometrically quantified.
Data represent the means ± SD of measurements on 3 pools per treatment group except for
the 0.01 mg/kg dose on Day 18 (n=4) and the 1 mg/kg dose on Day 16 (n=3). ++-
Statisically different from control and 1 mg/kg dose (p<0.01). #-Statistically different from
control (p<0.05). ##-Statistically different from control (p<0.01). The 0.1 mg/kg dose
was significantly different from control and 1 mg/kg dose (p<0.01).
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one-factor ANOVAs were to analyze assays using these samples. The Tukey-Kramer
multiple-comparisons test was used to determine which doses were different. Due to
deaths in the 1 mg/kg dose group, fish in this group were killed on Day 16 while those in
the control and 0.01 mg/kg dose groups were killed on Day 18. Fish killed on days 16 and
18 were analyzed together.
RESULTS
Gross effects: No change in the Hepatosomatic Index occurred in any dose group
over the experimental period (data not shown). However, while no deaths due to toxicity
occurred in the first seven days post-injection, one of the five remaining fish in the 0.01 mg
PeCB/kg dose group died between Days 7 and 18, and three of the six remaining fish in the
1 mg PeCB/kg dose group died between Days 7 and 16.
Hepatic mono-oxygenase components: The content of total spectral P450 in hepatic
microsomes from control fish decreased over time; however, the change was not
statistically significant. Although the content of total P450 in hepatic microsomes from
fished dosed with 0.01 mg PeCB/kg peaked on Day 3, it was not significantly induced
above controls until Day 7 and remained elevated on Day 18 (Figure 1A). The 0.1 mg
PeCB/kg dose significantly induced total P450 by Day 7, and the level of total P450 was
similar to that induced by the 0.01 mg PeCB/kg dose. The 1 mg PeCB/kg dose did not
significantly induce total P450 until Day 16. The maximal induction of total P450 by the
0.01 mg PeCB/kg dose was 3-fold, while that by the 1 mg PeCB/kg dose was 2-fold. The
specific content of b5 was not affected by any of the treatments (Figure 1B).
CYPIA expression, protein content and activity: Hepatic CYP1A mRNA
expression was assessed using a cDNA probe containing 75% of the scup CYP1A coding
region (Figure 2A). Ethidium bromide staining of ribosomal RNA was visualized on the
membrane to confirm equivalent loading of samples (data not shown). CYP1A mRNA
expression was significantly elevated by Day 3 in both the 0.01 and 1 mg PeCB/kg dose
groups and remained elevated through Days 16-18 (Figure 2B). Maximal induction (15-
fold) by the 0.01 mg PeCB/kg dose occurred 18 days post-injection, and maximal
induction (35-fold) by the 1 mg PeCB/kg dose occurred 7 days post-injection. The 0.1 mg
PeCB/kg dose significantly induced CYP1A mRNA expression at Day 7 (Figure 2B).
Induction of CYP1A protein followed a similar pattern to that seen with total P450
content. Despite being in captivity for one year, the presence of measurable CYP1A in
controls suggests that these fish were not depurated fully. A peak in CYPlA content
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occurred on Day 3 following the 0.01 mg PeCB/kg dose; however, CYP1A protein was
significantly induced only on Days 7 and 18 (Figure 3A). The 0.1 mg PeCB/kg dose
significantly induced CYP1A protein at Day 7, and the content was similar to that induced
by the 0.01 mg PeCB/kg dose. The 1 mg PeCB/kg dose did not significantly induce
CYP1A protein over that seen in controls until Day 16; however, the content of CYP1A
was still significantly less than that seen in the 0.01 mg PeCB/kg dose group (3-fold vs. 5-
fold, respectively).
EROD and MROD activity have been attributed to CYP1A1 and CYP1A2 in
mammals (16). As of yet, a single CYP1A form has been identified in scup, and it is
hypothesized to be a type ancestral to both mammalian CYP1A1 and CYP1A2 (4,17).
Scup CYP1A is thought to catalyze both EROD and MROD. EROD activity increased by
Day 3 in the 0.01 mg PeCB/kg dose group but was not induced significantly above EROD
in controls until Day 7 (Figure 3B). EROD activity reached maximal induction (4-fold) on
Day 18 in the 0.01 mg PeCB/kg dosed fish. The 0.1 mg PeCB/kg dose significantly
induced EROD activity (3-fold) at Day 7. EROD activity was not induced by the 1 mg
PeCB/kg dose over the course of the experiment. Unlike EROD activity, MROD activity
peaked at 6-fold induction in the 0.01 mg PeCB/kg dosed fish on Day 3 and declined
through Day 18 (Figure 3C). MROD activity was induced significantly at Day 7 by the
0.01 and 0.1 mg PeCB/kg doses. MROD activity was not induced by the 1 mg PeCB/kg
dose over the course of the experiment.
Total P450 was correlated strongly with CYP1A throughout the experiment (Figure
4A). EROD activity also was correlated strongly with CYP1A content; however, on Day 3
the slope of the correlation decreased, i. e. the turnover number for EROD activity
decreased (Figure 4B).
Other CYP proteins : Hepatic microsomes were immunoblotted with antibodies to
two other major P450 forms expressed in scup liver: P450A, a possible CYP3A
homologue (Celander et al., 1996) and P450B, a probable CYP2B homologue (Gray,
1988; Stegeman et al., 1990). The content of P450A was not affected by any of the
treatments (Figure 5A). Little change in P450B content occurred with any treatment
(Figure 5B). However, on Day 7 the 0.01 mg PeCB/kg dose slightly induced P450B, and
the 1 mg PeCB/kg dose slightly suppressed P450B content. P450B content in the 0.01 mg
PeCB/kg dose group was only significantly different from the 1 mg PeCB/kg dose group
on Day 7.
Oxidative stress: Several studies have suggested that CYP1A produces reactive
117
Figure 3. Effect of PeCB on hepatic microsomal CYP1A content (A) and catalytic activity
(EROD - B; MROD - C). Liver microsomal fractions (0.2-4 g/slot) were applied to nylon
membrane with a slot blot manifold, and immunoblotted with MAb 1-12-3 against scup
CYP1A. CYP1A reactive bands were visualized using enhanced chemiluminescence and
quantified by densitometric analysis. Enzyme activities were determined fluorometrically
by the method of Hahn et al. (1993). Data represent the means ± SD of measurements on 6
fish per treatment group except for the 0.01 mg/kg dose on Day 18 (n=4) and the 1 mg/kg
dose on Day 16 (n=3). +-Statisically different from control and 1 mg/kg dose (p<0.05).
++-Statisically different from control and 1 mg/kg dose (p<0.01). ##-Statistically different
from control (p<0.01). The 0.1 mg/kg dose was significantly different from control
(p<0.05).
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enhanced chemiluminescence and quantified by densitometric analysis. Data represent the
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oxygen species during its interaction with pHAHs (DeMatteis et al., 1991; Park et al.,
1996; Chapters 3 and 4). The potential for hepatic microsomes to produce ROS was
determined by incubating microsomes with PCB 126, NADPH and HE. HE is oxidized to
the fluorescent product ethidium by superoxide (Robinson et al., 1994). HE oxidation was
greatest in microsomes from fish treated with the 0.01 mg PeCB/kg dose (Figure 6A). The
potential to produce ROS was significantly elevated by Day 7 in the 0.01 and 0.1 mg
PeCB/kg dose groups, and it remained elevated in the 0.01 mg PeCB/kg dose group
through Day 18. The 1 mg PeCB/kg dose did not significantly affect the potential to
produce ROS. The potential to produce ROS was highly correlated with EROD activity
(Figure 6B).
In vivo oxidative stress was assessed by measuring the activities of several anti-
oxidant enzymes. Similar patterns of induction were seen with all of the anti-oxidant
enzymes measured, including catalase, glutathione peroxidase, glutathione reductase and
superoxide dismutase (Figure 7). The activities of all of the enzymes were significantly
induced by the 0.01 mg PeCB/kg dose at Day 3 and then decreased through Day 18.
Glutathione peroxidase activity remained significantly elevated on Day 7. The 0.1 and 1
mg PeCB/kg doses did not significantly alter the activity of any of the anti-oxidant enzymes
over the course of the experiment.
Extrahepatic organs: The patterns of CYP1A induction in microsomes from extra-
hepatic tissues differed from that seen liver microsomes. In heart, CYP1A content was
significantly induced by the 0.01 mg PeCB/kg dose by Day 7 and continued to increase
over time (Figure 8A). The 1 mg PeCB/kg dose strongly induced CYP1A content in the
heart by Day 16. In gill, only the 0.01 and 0.1 mg PeCB/kg dose significantly induced
CYP1A content over that in controls, despite an increase in CYP1A content in the 1 mg
PeCB/kg dose group on Day 16 (Figure 8B). In the kidney, a significant increase in
CYPIA content was seen in the 1 mg PeCB/kg dose group by Day 3 (Figure 8C). By Day
7, all three dose groups had similar induction of renal CYP1A. The CYP1A content
remained elevated in both the 0.01 and 1 mg PeCB/kg dose groups through Days 16-18.
EROD induction had a slightly different pattern than that seen with CYP1A content
in extra-hepatic organs. In heart, EROD activity was significantly induced by 0.01 mg
PeCB/kg, reaching a maximal level by Day 7 (9-fold induction) which was sustained to the
end of the experiment (Figure 9A). The 0.1 mg PeCB/kg dose did not induce EROD
activity significantly in heart. EROD activity was strongly induced by the 1 mg PeCB/kg
dose at Day 16 (10-fold induction). In gill, the 0.01 mg PeCB/kg dose significantly
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Figure 6. Effect of PeCB on the potential of hepatic microsomes to produce ROS (A) and
correlation of ROS production with EROD activity (B). Microsomal protein (0.1 mg) was
diluted in HBSS containing 7.5 pCM HE (final concentration). Following a 15 minute pre-
incubation at 30"C, either acetone (5 .1) or PeCB (1.7 nmol in acetone) was added.
Reactions were initiated with NADPH (1.4 mM), and fluorescence was monitored over 10
minutes. ROS production stimulated by PCB 126 was calculated by subtracting the
fluorescence in the well containing acetone to that in the well containing PeCB. Data
represent the means ± SD of measurements on 6 fish per treatment group except for the
0.01 mg/kg dose on Day 18 (n=4) and the 1 mg/kg dose on Day 16 (n=3). ++-Statisically
different from control and 1 mg/kg dose (p<0.01). The 0.1 mg/kg dose was significantly
different from control and 1 mg/kg dose (p<0.05).
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of measurements on 6 fish per treatment group except for the 0.01 mg/kg dose on Day 18
(n=4) and the 1 mg/kg dose on Day 16 (n=3). +-Statisically different from control and 1
mg/kg dose (p<0.05). ++-Statisically different from control and 1 mg/kg dose (p<0.01).
#-Statistically different from control (p<0.05).
124
40
30
20
10
4-
CO°0
.>
xcz
a)
Cl)Vcz
0
:3
"0O
r °
a)
o
.24-0,(.;
-o
.o-'
0.a5e
(5
0.5 I ,,,0.5-
0
0 5 10 15
C
30
1 - --25-2051510-
5 -
0
0 5 10 15
------ Control
--- 0.01 mg/kg
* 0.1 mg/kg
1 mg/kg
20
20
20
300
200
100
0 5 10 15
Time (Days)
125
0 5 10 15
B
20
Figure 8. Effect of PeCB on extra-hepatic microsomal CYP1A content. A) Heart. B)
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induced EROD activity by Day 7, and the activity continued to increase through Day 18
(14-fold maximal induction)(Figure 9B). At Day 7, EROD activity was greatest in the 0.1
mg PeCB/kg dose group (9-fold induction). The 1 mg PeCB/kg dose significantly
increased EROD activity in gill by Day 3 with a slight increase in activity through Day 16.
Unlike the other extrahepatic organs, while the 0.01 mg PeCB/kg dose strongly induced
renal EROD activity from Days 7-18, the EROD activity in the 1 mg PeCB/kg dose group
was suppressed throughout the entire experiment (Figure 9C). The 0.1 mg PeCB/kg dose
significantly induced renal EROD activity on Day 7.
DISCUSSION
Planar HAH can regulate CYP1A via induction, inhibition and inactivation.
Coplanar CB congeners, including TCB, PeCB and 3,3',4,4',5,5-hexachlorobiphenyl are
potent inducers of CYP1A (Parkinson et al., 1980; Melancon and Lech, 1983; Parkinson et
al., 1983; Gooch et al., 1989; Miranda et al., 1990; Monosson and Stegeman, 1991; Palace
et al., 1996). Presumably all coplanar CBs are competitive inhibitors of CYP1A, as has
been shown for TCB (Gooch et al., 1989). In vitro studies also have shown that coplanar
CB congeners oxidatively inactive CYP1A (White et al., 1997a; Chapters 3 and 4). PeCB
potently induced CYP1A mRNA, protein and catalytic activity at low doses (0.01-0.1
mg/kg) and induced CYP1A mRNA at a high dose (1 mg/kg) but suppressed induction of
CYP1A protein and catalytic activity at that high dose. Suppression of hepatic CYP1A
content by high doses of TCB (White et al., 1997a) and PeCB may be attributed to the
same oxidative inactivation seen in vitro. The organ specificity of CYP1A-suppression
could result simply from a lesser concentration of PeCB or from a reduction in reductase
activity in extra-hepatic organs (Stegeman et al., 1982). This study and others have
demonstrated oxidative stress resulting from pHAH exposure, supporting the conclusion
that CYP1A produces ROS in vivo and that ROS are the in vivo mechanism of CYP1A
inactivation.
Comparison of Induction and Suppression of CYPIA by PeCB and TCB: PeCB
was a more potent inducer of CYP1A than TCB, with maximal induction being reached at a
dose of 0.01 mg PeCB/kg, as compared to a dose of 0.1 mg TCB/kg (White et al., 1997a).
The same relationship has been seen in rainbow trout (Newsted et al., 1995) and mammals
(Safe et al., 1985). At a dose of 0.1 mg/kg PeCB, CYP1A induction was similar to that
with 0.01 mg PeCB/kg, although there may have been slight inactivation at this dose. In
absolute values, the low dose of PeCB induced CYPlA protein and activity with similar
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efficacy as TCB (White et al., 1997a). The fold induction of CYPIA protein and activity
by PeCB was lower than that seen with TCB; however, this is only a result of the fact that
the fish used in the current experiment were not depurated as long as those in the TCB
experiment.
In vitro studies have suggested that oxidative inactivation of scup CYP1A occurs
not only with TCB, but also with PeCB, 2,3,3',4,4'-pentachlorobiphenyl, and
3,3',4,4',5,5'-hexachlorobiphenyl (Chapter 4). In this study, we have demonstrated that
inactivation of CYP1A by PeCB apparently occurs in vivo. Comparison of nominal doses
of TCB and PeCB suggests that a similar dose (= 1 mg/kg) is required for PeCB and TCB
to inactivate CYP1A in vivo. Ki and KmInactivation values for TCB and PeCB are similar;
however the rate of inactivation of EROD activity was greater with PeCB than with TCB
(Chapter 4). The loss of suppression by TCB at Day 16 probably resulted from the
significant decrease in the hepatic TCB concentration (White et al., 1997a). Suppression of
CYP1A was maintained by the high dose of PeCB despite the dose being 5-fold lower than
that used previously with TCB; this may result from PeCB being eliminated more slowly
than TCB (Yoshimura et al., 1987; Koga et al., 1990). Residue analysis of the livers of
these fish are required to confirm this hypothesis.
High doses of both TCB and PeCB caused complete suppression of EROD but
induced CYP1A protein moderately. Loss of catalytic activity following treatment with
high doses of coplanar CB congeners without the loss of protein occurs in vivo (Melancon
and Lech, 1983; Voorman and Aust, 1988; Miranda et al., 1990; Monosson and Stegeman,
1991; Lindstrom-Seppa et al., 1994) and in cultured cells (Sawyer and Safe, 1982;
Rodman et al., 1989; Hahn et al., 1993; Kennedy et al., 1993; Hahn and Chandran, 1996;
Lorenzen et al., 1997). This suggests that inhibition may contribute partially to the loss of
EROD activity (Gooch et al., 1989). However, in in vitro assays, despite the total loss of
EROD activity and substantial loss of spectral P450 during incubation with TCB and
NADPH, there is no loss of immunodetectable CYP1A (White et al., 1997a). Thus, the
inactivated protein may retain the epitope recognized by the antibody, and degradation of
the protein may occur more slowly than inactivation. A similar lag between loss of catalytic
activity and loss of protein is seen during the mechanism-based inactivation of CYP1A1 by
analogues of 3,5-diethoxycarbonyl-1.4-dihydro-2,4,6-trimethylpyridine (Riddick et al.,
1990).
As with the regulation of CYP1A by TCB, the effects of PeCB appear to be largely
specific for CYP1A. Heme production was not suppressed generally, as the cytochrome
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b5 content remained constant for all treatments over the course of the experiment.
Significant, sustained protein induction following the low dose PeCB treatment and
significant suppression of protein induction following the high dose of PeCB only occurred
with CYP1A and not with P450A or P450B.
The data also may suggest that another CYP was induced transiently. While the
relationship between total P450 and CYP1A remained constant throughout the experiment,
the turnover number for EROD activity decreased on Day 3. Peaks in total P450, CYP1A
content and MROD activity, but not EROD activity occurred on Day 3. PeCB induces both
CYP1A1 and CYP1A2 in mammals (Safe et al., 1985). Therefore, one explanation for this
anomaly may be that a P450 that is recognized by MAb 1-12-3 and catalyzes MROD
activity was induced on Day 3. However, to date, MAb 1-12-3 has been thought to
recognize only one protein (Park et al., 1986), and scup have been thought to have only
one CYP1A (Morrison et al., 1995). Multiple CYP1A genes have been isolated from trout
treated with 3-methylcholanthrene (Berndtson and Chen, 1994), and potentially a second
CYP1A exists in scup. Further, experiments are required to address this issue.
CYPIA and Oxidative Stress In Vivo: Induction of specific P450 isoforms has
been correlated with increased oxidase activity in microsomes. Ethanol treatment in rats
results in induction of CYP2E1, oxidase activity and lipid peroxidation (Ekstrom and
Ingelman-Sundberg, 1989). Some studies indicate that there is an increase in microsomal
oxidase activity following treatment with CYP2B inducers; however, results have been
variable (Auclair et al., 1978; Urquhart and Elder, 1987; Buchmann et al., 1991; Sakai et
al., 1992). Liver microsomes from mice treated with hexachlorobenzene or 3-
methylcholanthrene (MC) and rats treated with TCB or MC produce elevated amounts of
ROS (Urquhart and Elder, 1987; Buchmann et al., 1991). However, the results with rats
also have been contradicted (Sakai et al., 1992). In the experiments performed here, there
was no increase in oxidase activity without the presence of additional PeCB. Very low
doses of PeCB were originally administered, therefore much of it may have been removed
during microsome preparation. Thus, the variable results seen previously with CYP1A
may be related to the original dose and the removal of the compound during microsome
preparation.
A growing body of studies support the conclusion that the pHAH, TCDD, induces
oxidative stress in vivo. Treatment of female rats with TCDD results in a 600% increase in
single strand breaks in DNA and a 500% increase in lipid peroxidation in the liver (Stohs et
al., 1990). Peritoneal lavage cells (PLC) from TCDD treated rats exhibit increased 02-*
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production and single strand DNA breaks (Alsharif et al., 1994). TCDD-stimulated
toxicity (Poland and Glover, 1980) and oxidative stress both appear to be AhR dependent
In PLC from AhR-responsive mice a 25-fold lower dose of TCDD is required to stimulate
02-' production than that required in non-responder mice (Alsharif et al., 1994). TCDD
exposure induces both CYP1A activity and oxidative DNA damage in Hepalc1c7 cells, but
induces neither in AhR defective c4 cells (Park et al., 1996). Potentially, H202, 02 -' and
OH* all are involved in TCDD-induced oxidative damage (Stohs et al., 1986).
Treatment with CB mixtures, as well as specific congeners, also promotes oxidative
stress. Aroclor 1254 treatment stimulates hepatic lipid peroxidation in chickens, rats and
guinea pigs (Combs and Scott, 1975; Kato et al., 1981; Dogra et al., 1988). Kestrels show
increased lipid peroxidation following treatment with PeCB (Hoffman et al., 1996). This
study and others have demonstrated increases in both CYP1A content and antioxidant
enzyme activity following exposure to TCB and PeCB in fish (Otto and Moon, 1995; Palace
et al., 1996). Further, iron potentiates 8-hydroxydeoxyguanosine formation, hepato-
carcinogenesis and uroporphyria in AhR responsive mice (C57BL but not DBA/2) exposed
to Aroclor 1254 (Faux et al., 1992; Smith et al., 1995). Considering that iron can act as a
Fenton catalyst converting ROS produced in cells to OH' which can attack cellular
components, this data suggests that ROS are associated with that toxicity.
Despite that facts that pHAH-stimulated oxidative stress is apparently AhR
dependent (Faux et al., 1992; Smith et al., 1995) and that only microsomes with induced
levels of CYP1A produce ROS (Chapter 3), there may be in vivo sources of ROS other
than CYP1A. Potential sources of ROS can be narrowed by the fact that hepatic
microsomal and mitochondrial fractions but not cytosolic fractions from TCDD-treated rats
can increase the incidence of DNA single strand breaks (Wahba et al., 1989). First, pHAH
may stimulate xanthine oxidase, peroxisome proliferation or mitochondrial multiplication
(Stohs, 1990). Polychlorinated biphenyls with 3 or fewer chlorine substitutions can be
metabolized to redox-cycling quinones (Oakley et al., 1996). Neutrophils can be activated
by PCBs, but only by ortho-substituted PCBs (Ganey et al., 1993). Finally, NADPH-
cytochrome P450 reductase can be induced by pHAH (Manjunath and Dufresne, 1988) and
is a known source of ROS (Morehouse et al., 1984). While CYP1A is implicated as the
source of ROS in in vitro studies, alterations in mitochondrial activities or reductase activity
may contribute to the oxidative stress stimulated by more highly chlorinated pHAHs in
vivo.
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The toxicity of coplanar PCBs is correlated with the AhR and CYPIA induction;
however, metabolic activation of these congeners is not significant. The production of
ROS during the interaction of coplanar congeners with CYPIA may explain in part the role
of CYP1A in the toxicity of pHAHs. One consequence of that ROS production may be
self-inactivation of CYP1A, as has been shown with several coplanar congeners in vitro
and with TCB and PeCB in vivo in the fish model scup. The consequences of a loss of
CYP1A are unknown, but studies have shown a regulatory relationship between CYP1A
and the AhR which may be perturbed by the loss of CYP1A (Chang and Puga, 1998). The
multiplying studies which demonstrate oxidative stress following exposure to pHAHs
supports the in vitro evidence of ROS production by CYP1A.
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CHAPTER 6
Characterization of the Reactive Oxygen Sensitive Transcription Factor,
Nuclear Factor-KB in the Marine Fish Scup (Stenotomus chrysops) and
Examination of its Activation by Aryl Hydrocarbon Receptor Agonists
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ABSTRACT
Members of the Rel family of proteins have been identified in Drosophila,
Xenopus, birds and mammals, and evidence suggests that xenobiotic compounds may alter
the activation of nuclear factor-xB (NF-KB). Here we demonstrate that apparent members
of the Rel protein family also exist in liver, kidney and heart of the marine fish scup
(Stenotomus chrysops). Using the electrophoretic mobility shift assay, binding of an NF-
KB consensus sequence was evident, but highly variable, in vehicle-treated fish. The
activation of NF-rB in vehicle-treated fish appeared to decrease over time. Two xenobiotic
compounds, benzo[a]pyrene (BP) and 3,3',4,4',5-pentachlorobiphenyl (PeCB), were
tested for the ability to activate NF-KB-DNA binding in scup liver. A 10 mg BP/kg dose
had no effect on NF-KB-DNA binding either at 3 or 6 days following treatment. Two
experiments with PeCB gave conflicting results. The first experiment showed a 6-8-fold
increase in activation 16-18 days following treatment with PeCB (0.01-1 mg/kg); however,
the second experiment showed no significant activation 14 days following treatment. The
results appeared to be confounded both by the apparent injection effect and by high
variability. Nuclear proteins from scup kidney and heart also specifically bound the NF-
KrB consensus sequence, but with no dose specific pattern. The specificity and identity of
the shifted band was confirmed. Scup liver nuclear extracts did not bind to the consensus
binding sequences of another redox sensitive transcription factor AP-1 or a ubiquitous
mammalian transcription factor Octl. The binding was specifically competed by
oligonucleotides containing various sequences of NF-B binding regions; however, an
oligonucleotide containing the aryl hydrocarbon receptor dioxin response element did not
inhibit the band-shift. A DNA-protein crosslinking technique demonstrated that 3 proteins
bound the NF-KB consensus sequence in scup liver, kidney and heart, 2 of which
potentially correspond to the mouse p50 and RelA (p65) proteins as well as a smaller
protein of approximately 30 kD. Antibodies to mammalian p50 primarily
immunoprecipitated the apparent 50 kD protein in scup liver, kidney and heart. The data
indicate that the Rel family of proteins is present in fish and represented by at least a p50
homologue. Activation of NF-KB by aryl hydrocarbon receptor agonists remains a
question, however.
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INTRODUCTION
NF-rKB is a multisubunit transcription factor that can rapidly activate genes
encoding cytokines, cell surface receptors, cell adhesion molecules and acute phase
proteins (Baeuerle, 1991). NF-KB subunits are members of the Rel homology family of
proteins. The Rel homology domain is a 300-amino acid region which contains a DNA-
binding region, a dimerization domain, a nuclear translocation signal and a region of
interaction with proteins of the IKB family (Miyamoto and Verma, 1995; Verma et al.,
1995). In mammals, the Rel family is represented by RelA, RelB, cRel, NF-B 1
(p52/p100) and NF-KB2 (p50/p105) (see (Huguet et al., 1997)). The Rel family is
represented by dorsal, dif and relish in Drosophila (Steward, 1987; Ip et al., 1993; Dushay
et al., 1996). Homologs of NF-KB 1, RelA, RelB and cRel have been sequenced from
Xenopus (Kao and Hopwood, 1991; Suzuki et al., 1995; Tannahill and Wardle, 1995;
Suzuki et al., 1998), and homologs of NF-KB1, NF-KB2, RelA and cRel have been
sequenced from birds (Wilhelmsen et al., 1984; Capobianco et al., 1990; Capobianco et
al., 1992; Ikeda et al., 1993; Sif and Gilmore, 1993). RelA, RelB and cRel are
synthesized "ready-to-use" and contain a transactivating domain, while p50 and p52 are
proteolytically matured and do not contain a transactivating domain. Multiple homo- and
heterodimers may by formed, the classic NF-KB dimer being p50/RelA. Different KB
binding sites in gene promoters have different affinities for dimers, and thus the identity of
the subunits in the dimer confer specificity to gene activation (Miyamoto and Verma, 1995;
Muller et al., 1996).
Usually, NF-KB dimers are sequestered in the cytoplasm by an inhibitor, IKB.
Upon stimulation by cytokines, mitogens, viral infection, UV irradiation or reactive oxygen
species (ROS), the inhibitor is phosphorylated, ubiquinated and digested by a proteosome,
allowing NF-KB to translocate to the nucleus and bind DNA (Baldwin, 1996). In many
cases, ROS are used as second messengers to initiate degradation of IKB, as antioxidants
block NF-KB activation by potent activators such as tumor necrosis factor-a, interlukin-1,
phorbol 12-myristate 13-acetate, lipopolysaccharide and okadaic acid (Schreck et al.,
1991).
Recent studies have shown that xenobiotic compounds also may activate NF-KB
binding. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) transiently stimulates NF-KB
binding in rat thymocytes (Olnes et al., 1994), and TCDD-mediated activation of
expression of a chloramphenicol acetyltransferase (cat) reporter gene linked to the promoter
sequence of the human immunodeficiency virus type 1 (HIV-1) requires NF-KB activation
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(Yao et al., 1995). Two polynuclear aromatic hydrocarbons, 7,12-dimethylbenz[a]-
anthracene (DMBA) and benzo[a]pyrene (BP), transiently stimulate NF-rB binding in
murine hepatoma cells (Shneider et al., submitted) and murine stromal cells (K. K. Mann,
unpublished results). A more sustained activation of NF-KB binding is seen following
treatment of HepG2 cells with quinones, including menadione and tert-butylhydroquinone
(Pinkus et al., 1996; Chen and Cederbaum, 1997). In vivo, phenobarbital, ciprofibrate
and carbon tetrachloride all have been shown to activate NF-KB binding in rat liver
(Gruebele et al., 1996; Li et al., 1996; Li et al., 1996). ROS have been suggested to be a
second messenger in the activation of NF-KB by xenobiotic compounds.
Aryl hydrocarbon receptor (AhR) mediated pathways may be contributing to the
activation of NF-B. DMBA- and BP-mediated NF-KrB activation have been shown to be
AhR dependent (Shneider et al., submitted). The AhR regulates the expression of drug
metabolizing enzymes, including cytochromes P450 1As (CYP1A), and genes involved in
cell growth control (Hankinson, 1995). Studies have produced conflicting results as to
whether AhR-mediated NF-rB activation is dependent upon CYP1A (Yao et al., 1995;
Shneider et al., submitted). AhR agonists may activate NF-KB through CYP1A by
stimulating its production of ROS. CYPlA might contribute to the production of ROS by
forming redox cycling metabolites or by abortive reduction. In this study we investigated
the effects of two AhR agonists on NF-KB activation in the marine fish scup (Stenotomus
chrysops). BP is metabolized to 3 redox cycling quinones in mammals and fish (Lorentzen
and Ts'o, 1977; Stegeman, 1981; Klotz et al., 1983), and the coplanar polychlorinated
biphenyl 3,3',4,4',5-pentachlorobiphenyl (PeCB) stimulates ROS production by
uncoupling the CYP1A catalytic cycle (Chapter 4).
Here we demonstrate for the first time that members of the Rel family of proteins
are present in a teleost. An NF-KB consensus sequence bound at least 3 proteins in scup
liver, kidney and heart, two of which potentially correspond with mammalian p50 and
RelA. An antibody to mammalian p50 immunoprecipitated the =50 kD binding protein in
all 3 organs. An NF-KB consensus sequence was bound by nuclear proteins from
untreated scup. BP did not increase the activation of NF-KB, and PeCB activated NF-KB
in only 1 of 2 experiments. While, we have confirmed the presence of the Rel family of
proteins in a teleost, their regulation by AhR agonists is still a question.
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MATERIALS AND METHODS
Chemicals: 3,3',4,4',5-Pentachlorobiphenyl (IUPAC# 126) was purchased from
Ultra Scientific (North Kingstown, RI). Poly [dI-dC], pNd6 and 5-bromo-2'deoxyuridine
were purchased from Boehringer Mannheim (Indianapolis, IN). [y- 3 2 P]ATP and [a-
3 2 p]CTP were purchased from Amersham (Arlington Heights, IL). All other chemical
reagents were purchased from Sigma (St. Louis, MO).
Animals: Scup (Stenotomus chrysops ) were caught by trapping in Vineyard
Sound, MA in August, 1996 and the experiment conducted in August, 1997 or were caught
in August, 1995 and the experiment conducted in June, 1998. Fish were held in flow-
through seawater tanks at 14°C and maintained on a diet of Purina Trout Chow. Treatment
of fish in the August, 1997 experiment was described in Chapter 5. For the June, 1998
experiments, fish (mixed sex) were gonadally undeveloped. For the BP experiment, fish
ranged in size from 90 to 252 g. Fish were injected intra-peritoneally (lml/kg body
weight) with corn oil or a solution of BP (10 mg/ml) in corn oil. For each dose group, 3
tanks contained 3 fish each. At day 3 following injection one fish from each tank was
sampled, at a day 6 the remaining fish were sampled. For the PeCB experiment, fish
ranged in size from 39 to 107 g. Fish were injected intra-peritoneally (lml/kg body
weight) with corn oil or solutions of PeCB (0.01 or 1 mg/ml) in corn oil. For each dose
group, fish were split between 3 tanks. The control tanks contained 2 fish/tank. The low
dose tanks contained 3 fish/tank. The high dose tanks contained 4 fish/tank. Fish were fed
Purina Trout Chow once weekly and were sampled 14 days following treatment. Two of
the high dose fish died prior to the completion of the experiment. Immediately following
dissection, sections of liver, heart and kidney were frozen in liquid N2. Microsomes were
prepared from portions of liver immediately following dissection.
Microsome preparation and analysis of CYPIA: Microsomes were prepared by
differential centrifugation (Stegeman et al., 1979). Pellets were resuspended in buffer (50
mM TRIS, pH 7.4, 1 mM dithiothrietol, 1 mM EDTA, 20% glycerol) and frozen in liquid
N2 until use. Protein content was determined using the bicinchoninic acid method (Smith
et al., 1985), with bovine serum albumin standards. Microsomal ethoxyresorufin 0-
deethylation (EROD) was determined fluorometrically (Hahn et al., 1993), using a
Cytofluor 2300 (Millipore) multiwell plate reader. Immunoblotting procedures were
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal
proteins (0.5-15 tg/lane) were resolved on 6-18% SDS-PAGE gels and electrophoretically
transferred to 0.05 gtm nitrocellulose membrane. The primary antibody was the mouse
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monoclonal antibody 1-12-3 (Park et al., 1986). The secondary antibody was a
horseradish peroxidase-linked sheep anti-mouse IgG (Amersham). The immunoreactive
bands were visualized using enhanced chemiluminescence (Amersham) and quantified by
video image analysis (NIH Image 1.60b5) by comparison to scup standards of known
concentration.
Nuclear extract preparation: Crude nuclear extracts were prepared from tissues by
the method of Deryckere and Gannon (1994). All manipulations were carried out at 40 C.
Tissues (100-300 mg) were ground in liquid N2 and added to a 15 ml centrifuge tube with
5 ml of isolation buffer (10 mM HEPES pH 7.9, 10 mM KC1, 0.1 mM EDTA, 0.1 mM
EGTA, 1 mM dithiothrietol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF)) that
contained 0.6% IGEPAL. The ground tissues were homogenized with five strokes of
pestle B in a Dounce homogenizer. Homogenates were spun at 500 g in a Sorval
centrifuge for 30 seconds to remove unbroken tissue. The supernatant was transferred to
another 15 ml centrifuge tube, incubated for 5 minutes on ice and centrifuged for 5 minutes
at 3000 g. The supernatant was removed and the nuclear pellet transferred to a micro
centrifuge tube. The pellet was resuspended in 50-100 pl of extraction buffer (20 mM
HEPES pH 7.9, 400 mM NaC1, 1.2 mM MgC12, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM
PMSF and 5 gg/ml of each protease inhibitor (leupeptin, aprotinin, and pepstatin)) and
incubated for 20 minutes. The supernatant was cleared by centrifuging at maximum speed
in a microcentrifuge for 5 minutes. Protein content was determined using the bicinchoninic
acid method (Smith et al., 1985), using bovine serum albumin as a standard. Supernatants
were collected and stored at -80 0 C.
Gel-shift analysis of NF-B activation: For analysis of NF-KB activation, the
double-stranded oligonucleotide 5'-AGTTGAGGGGACTTTCCCAGGC-3' (Promega,
Madison, WI)) was used. The DNA probe was end-labeled using T4 polynucleotide
kinase (Promega) and [y- 3 2 P]ATP and was purified using a Centrispin-20 column
(Princeton Separations, Adelphia, NJ). The electrophoretic mobility shift assay (EMSA)
was performed as follows: the 3 2 P-labeled DNA (-0.5 ng, 50,000 cpm) and 2 jgg of
nuclear extract were combined with buffer (Final concentrations: 10 mM TRIS-HC1 pH
7.5, 1 mM EDTA, 40 mM KC1, 0.5 mM MgCl2, 1 mM DTT, 10% glycerol) and poly dI-
dC (1 Gjg) in a final volume of 20 il. The mixture was incubated at room temperature for
30 minutes. Polyacrylamide gels (6%) were pre-run at 80V for 1 hour. Mixtures were
electrophoresed at 80V for 1.5 hours in 0.25x TBE (Final concentrations: 22 mM TRIS-
base pH 8, 22 mM boric acid, 0.4 mM EDTA). The gels were dried and exposed to film
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(Kodak X-OMAT AR). Shifted bands were quantified by video image analysis. EMSAs
also were performed with 3 2 P-labeled probes containing the AP-1 (Santa Cruz
Biotechnology, Santa Cruz, CA) or Octl (Promega) consensus binding sequences.
Specificity of shifted bands was determined by including 50-100x cold specific (NF-B
consensus sequences) and non-specific (AhR DRE 5'-GATCCGGC-
TCCGGCTCTTCTCACGCAACTCCGAGCTCAAAAA-3') oligonucleotides.
Identification of specific subunits: To identify specific NF-rB/Rel subunits, DNA-
protein crosslinking studies were used (Ballard et al., 1989; Ballard et al., 1990). The
photoreactive 32P-labeled oligonucleotide was prepared as follows. The oligonucleotide
(5'-CAACGGCAGGGGAATTCCCCTCTCCTT-3') was annealed with the primer (5'-
AAGGAGAGGG-3') and filled in using the large fragment of DNA polymerase
(Promega). The labeling mixture contained annealed oligonucleotide probe (5 pmol), [a-
3 2p]CTP (50 pCi), Klenow (2 units), BSA (2 mg) and buffer (Final concentrations: 20
mM HEPES 6.6, 2 mM MgCl2, 0.2 mM DTT, 100 jM each dATP, dGTP, dTTP, 100
gLM 5'bromo-2'deoxyuridine). The labeling reaction was performed at 160 C for 4 hours,
chased with 0.4 mM cold dCTP at room temperature for 30 minutes and purified using a
Centrispin-20 column. The binding reaction was performed as follows: 5-20 glg of
nuclear extract were combined with buffer (Final concentrations: 20 mM HEPES pH 7.9, 1
mM DTT, 1 mM EDTA, 5% glycerol), poly dI-dC (1 gg), BSA (5 ig), pdN6 (1 gLg) in a
final volume of 20 pl. The mixture was incubated at room temperature for 5 minutes. The
3 2 P-labeled DNA (-2.5-5 ng, 200,000-500,000 cpm) was added, and the mixture was
incubated for 15 minutes at room temperature. The mixture was then incubated for 15
minutes under UV. At this point, some samples were boiled with sample treatment buffer
and frozen at -200 C. Or, reaction mixtures were immunoprecipitated with antibodies to
specific NF-KB/Rel subunits (Santa Cruz Biotechnology). To immunoprecipitate, a
reaction mixture was combined with 180 jl of RIPA buffer (10 mM TRIS pH 7.5, 150
mM NaCl, 1 mM EDTA, 1% Triton x-100, 0.1% SDS) to which 0.5 mM PMSF and 5
gg/ml of each protease inhibitor (leupeptin, pepstatin, and sodium orthovanadate) were
added). An antibody was added and the mixture incubated on ice for 1 hour. Protein A-
sepharose (25 jl of a 50% slurry) was added and the mixture rotated for 1 hour at 4*C.
The mixture was quickly spun to remove the supernatant. The pellet was washed twice in
RIPA containing 0.5 mM PMSF. Sample treatment buffer was added to the mixture, and it
was boiled for 5 minutes. All samples then were loaded on a 10% SDS polyacrylamide gel
and electrophoresed at 10-14 mAmps. The portion of the gel containing free probe was
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removed. The gel was fixed in MeOH (5%)/acetic acid (5%) for 30 minutes, dried and
exposed to film.
Statistics: Statistics were calculated using Microsoft Excel (Microsoft, Inc.,
Redmond, WA) and SuperAnova for Macintosh (Abacus Concepts, Inc., Berkeley, CA).
The Student's t-test was used to determine differences from control values in the BP
experiment. Nested, one-factor ANOVAs with the Tukey-Kramer multiple comparisons
test were used to analyze differences between treatment groups within sampling days for
the PeCB experiments.
RESULTS
Fish treated with two AhR agonists, BP and PeCB, were examined for activation of
the AhR and of NF-KB-DNA binding. BP strongly induced CYP1A protein and catalytic
activity 3 and 6 days post-treatment (Figure 1). Binding of an NF-B consensus sequence
was determined with an EMSA. Hepatic nuclear proteins from both control and BP-treated
scup bound an NF-rB consensus sequence (Figure 2). NF-rB activation decreased in the
controls over time: however, no change in NF-KB activation occurred following BP
treatment. CYP1A protein and catalytic activity were strongly induced by a low dose (0.01
mg/kg) of PeCB; while they were suppressed by treatment with a high dose of PeCB
(Chapter 5, Figure 3). Like was seen in the BP experiment, hepatic nuclear proteins from
both control and PeCB-treated scup bound an NF-KB consensus sequence (Figure 4). NF-
KB activation decreased over time in the controls. In the initial experiment, there was no
significant increase in activation of NF-rB until days 16-18 at which time there was a 6-
fold increase in activation with the low dose and an 8-fold increase with the high dose. In
the second experiment, a slight increase in activation occurred with the low dose at day 14;
however, the variability was very large (Figure 4).
In order to confirm further that a Rel family protein was responsible for the band-
shift of the NF-KB binding oligonucleotide, competition, crosslinking and
immunoprecipitation studies were performed. First, liver nuclear extracts from control or
treated fish did not bind to the consensus binding sequences of AP-1, another redox
sensitive transcription factor (Meyer et al., 1994), or Octl, a ubiquitous mammalian
transcription factor (Pfisterer et al., 1994) (Figure 5). When a 50-100 fold excess of
unlabeled oligonucleotides containing various sequences of NF-KB binding regions, the
band-shift was eliminated (Figure 6). However, a 50-100 fold excess of unlabeled
oligonucleotide containing the aryl hydrocarbon receptor dioxin response element (DRE)
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Figure 1. Effect of BP on scup hepatic microsomal CYP1A content (A) and catalytic
activity (EROD - B). Scup were injected IP with corn oil or 10 mg BP/kg and killed 3 or 6
days post-injection. Liver microsomal fractions (0.5-15 gg/lane) were electrophoresed,
transferred to nitrocellulose, immunoblotted with MAb 1-12-3 against scup CYP1A,
visualized using enhanced chemiluminescence and quantified by densitometric analysis.
EROD was determined fluorometrically. Data represent the means ± SD of measurements
on 3 to 6 fish per treatment group. #-Statisically different from control (p<0.05, Student's
t-test). ##-Statistically different from control (p<0.01, Student's t-test).
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Figure 2. Binding of an NF-KB consensus sequence to liver nuclear proteins from control
and BP-treated scup. Scup were injected IP with corn oil or 10 mg BP/kg and killed 3 or 6
days post-injection. Nuclear extracts were prepared from livers from fish killed on Day 3
(A) and Day 6 (B) and analyzed by electrophoretic mobility shift assay for 3 2 P-labeled NF-
rB oligonucleotide binding. C) Band intensity was quantified using video image analysis.
*-Significantly different from day 3 (p<0.03, Student's t-test).
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Figure 3. Effect of PeCB on hepatic microsomal CYP1A content (A) and catalytic activity
(EROD - B). Scup were injected IP with corn oil, 0.01 mg PeCB/kg or 1 mg PeCB/kg and
killed 14 days post-injection. CYP1A content and activity in liver microsomes were
determined as described in Figure 1. Data represent the means ± SD of measurements on
6-10 fish per treatment group. +- Significantly different from control and 1 mg/kg dose
groups (p<0.01, Tukey-Kramer).
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Figure 4. Quantification of NF-cB activation in liver of control and PeCB-treated scup.
Nuclear extracts were prepared from livers and analyzed by electrophoretic mobility shift
assay for 3 2 P-labeled NF-B oligonucleotide binding. Band intensity was quantified
using video image analysis. A - Experiment 1. Scup were injected IP with corn oil, 0.01
mg PeCB/kg, 0.1 mg PeCB/kg or 1 mg PeCB/kg and killed 3,7,16,or 18 days post-
injection. Data represent the means ± SD of measurements on 6 fish per treatment group
except for the 0.01 mg/kg dose on Day 18 (n=4) and the 1 mg/kg dose on Day 16 (n=3).
#-Statisically different from control (p<0.01). B - Experiment 2. Scup were injected IP
with corn oil, 0.01 mg PeCB/kg or 1 mg PeCB/kg and killed 14 days post-injection. Data
represent the means + SD of measurements on 6-10 fish per treatment group.
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Figure 5. Nuclear proteins from scup liver bound an NF-B consensus sequence but not
AP-1 or Octl consensus sequences. Nuclear extracts were prepared from fish 3 days
post-injection of 10 mg BP/kg and analyzed by electrophoretic mobility shift assay for 32 p-
labeled NF-cB, AP-1 or Octl oligonucleotide binding.
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did not inhibit the band-shift (Figure 6). The NF-B consensus binding sequence was
bound by hepatic nuclear proteins corresponding to mouse p50 and RelA (p65) and a
smaller protein of approximately 30 kD (Figure 7). The middle band could be
immunoprecipitated with an antibody to mammalian p50 (Figure 7), but none of the bands
was recognized by antibodies to mammalian p52, RelA, cRel or RelB (data not shown).
Nuclear proteins from scup kidney and heart also specifically bound the NF-KB
consensus sequence, but with no dose specific pattern (Figure 8). Similar to liver, 3
nuclear proteins from scup heart and kidney bound the NF-B consensus sequence (Figure
9). One of these proteins (=50 kD) was recognized by an antibody to mammalian p50
(Figure 9).
DISCUSSION
The Rel family of proteins has been identified and characterized in Drosophila,
Xenopus, birds and mammals. ROS are responsible for the activation of nuclear
translocation and DNA binding of NF-KB, a transcription factor comprised of dimers of
members of the Rel protein family. Previous work has shown that a number of xenobiotic
compounds activate NF-rB and that this activation may occur through the stimulation of
ROS production (Olnes et al., 1994; Gruebele et al., 1996; Li et al., 1996; Li et al., 1996;
Pinkus et al., 1996; Chen and Cederbaum, 1997; Shneider et al., submitted). Here we
have demonstrated the presence of the Rel protein family in a teleost, scup. Attempts to
activate NF-KB DNA binding by treatment with AhR agonists gave conflicting results,
however. While, we have confirmed the presence of the Rel family of proteins in a teleost,
the regulation of NF-B activation by AhR agonists is still a question.
A large gap exists in the knowledge of the evolution of Rel family proteins. While
these proteins have been characterized in Drosophila (Steward, 1987; Ip et al., 1993;
Dushay et al., 1996), the next higher animal in which they have been identified is an
amphibian (Kao and Hopwood, 1991; Suzuki et al., 1995; Tannahill and Wardle, 1995;
Suzuki et al., 1998). Considering the important function of Rel family proteins during
development and in the immune system (Steward, 1987; Ip et al., 1993; Baeuerle and
Henkel, 1994; Tannahill and Wardle, 1995), these proteins presumably should occur in
teleosts, as well. Here we provide biochemical evidence for the presence of multiple Rel
family proteins in the teleost scup. 1) An oligonucleotide containing an NF-KB consensus
binding sequence forms a band shift in EMSAs with nuclear proteins from multiple scup
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Figure 6. Specific competition of binding of an NF-cB consensus sequence to scup liver
nuclear proteins. Nuclear extracts were prepared from fish 3 days post-injection of 10 mg
BP/kg and analyzed by electrophoretic mobility shift assay for 3 2 P-labeled NF-KB
oligonucleotide binding. The specificity of NF-KB binding activity was tested by the
addition of 50-100-fold molar excess of unlabeled NF-xB binding oligonucleotide or the
aryl hydrocarbon receptor dioxin response element (DRE). Lanes 4,6,8,10- 50-fold
excess. Lanes 2,3,5,7,9- 100-fold excess.
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Lane 2.
Lanes 3-4.
Lanes 5-6.
Lanes 7-8.
Lanes 9-10.
5'-AGT TGA GGG GAC TTT CCC AGG C-3'
5'-CGG CAG GGG AAT TCC CCT CTC C-3'
5'-CGG CAG GGC AAT TCC CCT CTC C-3'
5'-CCG CTG GGG ACT TTC CAG GC-3'
5'-GAT CCG CTC CGG CTC TTC TCA CGC
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Figure 7. Binding of an NF-KB consensus sequence to at least 3 scup liver nuclear
proteins. Nuclear extracts were prepared from fish 3 days post-injection of 10 mg BP/kg
or nuclear extracts from preB lymphocyte (BU- 11) cells were incubated with a 5-bromo-2'-
deoxyuridine-substituted 3 2 P-labeled NF-rcB oligonucleotide probe and crosslinked by UV
irradiation. The resultant labeled DNA-protein complexes also were immunoprecipitated
with antibodies to specific NF-rcB subunits. All were resolved on a 10% polyacrylamide
gel. Results shown are different exposures of the same gel. Lanes 1&5. No
immunoprecipitation. Lane 2&6. Immunoprecipitation with p50 antibody. Lane 3.
Immunoprecipitation with RelA antibody. Lane 4. Molecular weight standards
corresponding to 250, 98, 64, 50, 36, 30 and 16 kD.
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Figure 8. Specific binding of an NF-KB consensus sequence to scup kidney (A) and heart
(B) nuclear proteins. Nuclear extracts were prepared from kidney or heart from scup 3
days post-injection of 10 mg BP/kg and analyzed by electrophoretic mobility shift assay for
3 2 P-labeled NF-B oligonucleotide binding. The specificity of NF-KB binding activity
was tested by the addition of 100-fold molar excess of unlabeled NF-KB binding
oligonucleotide or the aryl hydrocarbon receptor DRE. Lanes 1-3. No competitor. Lane
4. 100-fold excess specific competitor. Lane 5. 100-fold excess of non-specific
competitor.
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Figure 9. Binding of an NF-KB consensus sequence to at least 3 scup kidney (A) and heart
(B) nuclear proteins. Nuclear extracts from kidney and heart from scup 3 days post-
injection of 10 mg BP/kg were incubated with a 5-bromo-2'-deoxyuridine-substituted 3 2p-
labeled NF-B oligonucleotide probe and crosslinked by UV irradiation. The resultant
labeled DNA-protein complexes also were immunoprecipitated with antibodies to specific
NF-rB subunits. All were resolved on a 10% polyacrylamide gel. Results shown are
different exposures of the same gel. Lane 1. Molecular weight standards corresponding to
250, 98, 64, 50, 36, 30 and 16 kD. Lanes 2-3. No immunoprecipitation. Lane 4.
Immunoprecipitation with p50 antibody.
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organs. 2) The oligonucleotide binding could be specifically competed. 3). Protein/DNA
crosslinking studies demonstrated 2 proteins which appeared to correspond with murine
p50 and RelA. 4). The =50 kD binding protein in multiple organs was recognized by an
antibody to mammalian p50. The NF-KB 1 and NF-KB2 genes have been found to evolve
at the slowest rate of the Rel proteins (Huguet et al., 1997), thus the p50 antibody was
most likely to recognize the teleost protein. Alignment analyses suggest that all Rel/NF-KB
and IrB proteins truly belong to a superfamily of genes whose precursor contained both a
Rel homology domain and an ankyrin repeat area (Huguet et al., 1997). Therefore, it is not
surprising that these proteins would be present in fish as they are present in insects.
Furthermore, an NF-KB binding site has been identified in the promoter of mitogen-
activated protein kinase kinase 1 of carp (Leu et al., 1996).
A number of xenobiotic compounds have been shown to activate NF-KB-DNA
binding. Redox cycling quinones activate NF-KB in HepG2 cells, apparently as a
protective mechanism (Pinkus et al., 1996; Chen and Cederbaum, 1997). Phenobarbital
and ciprofibrate have been shown to activate NF-KB-DNA binding in rat liver (Li et al.,
1996; Li et al., 1996). Phenobarbital induces CYP2B1/2B2, which was suggested to
produce ROS as a metabolic by-product. Ciprofibrate, a peroxisome proliferator, induces
enzymes in the peroxisomal 13-oxidation pathway which also produce ROS as a by-
product. However, phenobarbital and ciprofibrate apparently activate different Rel
proteins, suggesting that they activate NF-KB through different pathways (Li et al., 1996;
Li et al., 1996).
AhR agonists also have been shown to activate NF-KB. DMBA- and BP-mediated
NF-KB activation have been shown to be AhR dependent, but CYP1Al independent
(Shneider et al., submitted). Activation of NF-KB by BP and DMBA occurs within an
hour of treatment, a time too short for CYP1A induction, and activation occurs in Hepa
cells with a functional AhR but deficient in CYP1A (Shneider et al., submitted). The effect
of an antioxidant was not examined. In contrast, TCDD-mediated activation of expression
of a cat reporter containing an NF-KB binding sequence occurred 24 hours post-treatment,
could be blocked by anti-oxidants and required a functional CYP1A1 (Yao et al., 1995). It
was hypothesized that the IgK light chain enhancer and the HIV-1 long terminal repeat are
regulated differentially by NF-KB, though the NF-KB subunits involved in each case have
not been identified (Yao et al., 1995; Shneider et al., submitted). It also is possible that
there is a direct interaction between the AhR and RelA. RelA can be coimmunoprecipitated
with AhR in cytosol or nuclear fractions of TCDD-treated COS cells that are cotransfected
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with AhR and RelA, and TCDD down-regulates NF-KB mediated gene expression in these
cells (Tian et al., 1998).
Both BP and PeCB are AhR agonists and are capable of stimulating ROS
production. BP is metabolized to 3 redox cycling quinones in scup (Klotz et al., 1983),
and the coplanar polychlorinated biphenyl PeCB stimulates ROS production by uncoupling
the CYP1A catalytic cycle (Chapter 4). Liver should be an appropriate site to analyze NF-
KB activation, as NF-KB is an important mediator of hepatocyte proliferation. NF-KB is
rapidly activated following partial hepatectomy (Cressman et al., 1994), and livers of RelA
knockout mice undergo massive apoptosis early in gestation (Beg et al., 1995). However,
treatment of scup with BP and TCDD did not cause a consistent effect on hepatic NF-KB
activation. Undeniably, the results were confounded by the fact that injection alone
appeared to activate NF-KB. Why this occurred is unknown. One can only speculate that
the stress of injection stimulated one of the many activators of NF-KB. It does not appear
that AhR agonists activate NF-KB simply by activating the AhR. If this were the case then
both BP and PeCB would have activated NF-KB. Although, activation was not analyzed at
very early time points, as the results in cell culture suggest is necessary to observe this
phenomenon. The suppression of injection-induced NF-KB activation by BP at Day 3, is
reminiscent of the results seen with COS cells (Tian et al., 1998), although this
suppression was not seen with PeCB treatment. In at least one of the experiments with
PeCB there appeared to be activation of NF-KB at late time points. This is unlike results
with other xenobiotics which cause activation within 3-6 days of treatment (Li and Furness,
1991; Li et al., 1996; Li et al., 1996). The delay might have been caused by the type of
ROS that were being produced. During CYP1A uncoupling in vitro, CBs appear to
stimulate 02 -* production to a greater extent than H202 production (Chapter 3). Studies
have suggested that O2 -* is only indirectly involved in a NF-KB activation, as a source of
H202 (Schmidt et al., 1995). In the end, these experiments have raised more questions
than they have answered.
NF-KB could play an important role in the defense against the effects of
xenobiotics. First, the AhR regulates genes involved in the antioxidant response. AhR
agonists can induce glutathione S-transferase Ya and NADPH:quinone oxidoreductase via
the AhR as well as via an antioxidant response element (Rushmore et al., 1991;
Hankinson, 1995). Proteins that are involved in the antioxidant response are also induced
following NF-KB activation, suggesting that NF-KB may regulate their expression. These
proteins include Mn-SOD (Pang et al., 1992), NADPH-oxidoreductase (Yao and
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O'Dwyer, 1995), inducible nitric oxide (Xie et al., 1994), and ferritin H (Kwak et al.,
1995). NF-B activation was suggested to be the mechanism by which HepG2 cells are
protected from oxidative stress-induced cytotoxicity (Chen and Cederbaum, 1997).
Second, an NF-kB consensus binding sequences has been identified in the promoter of the
P-glycoprotein gene (Zhou and Kuo, 1997). P-glycoprotein can be induced by TCDD
(Schuetz et al., 1995), and xenobiotics may be removed from cells via the P-glycoprotein
transporter (Yeh et al., 1992). Therefore, it is important to continue to investigate the
apparently complicated relationship between the AhR and NF-KB and the contribution of
NF-~B to the defense against xenobiotic induced effects.
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CHAPTER 7
Tissue Distribution of and Induction of Cytochrome P4501A by Model Aryl
Hydrocarbon Receptor (AhR) Agonists in the American Eel and
Investigation of the Effect of Endothelial CYP1A on AhR Agonist
Pharmacokinetics
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ABSTRACT
We investigated both the dose-dependent response of hepatic cytochrome P4501A
(CYP1A) in relation to inducer distribution and the in vivo dose-dependent response of
endothelial CYP1A in a fish model, American eel (Anguilla rostrata). First, injection
studies were used to determine the distribution of different doses of two radiolabeled model
aryl hydrocarbon receptor (AhR) agonists, benzo[a]pyrene (BP), a polynuclear aromatic
hydrocarbon, and 3,3',4,4'-tetrachlorobiphenyl (TCB), a planar halogenated aromatic
hydrocarbon. Concentrations of BP and TCB were greatest in bile, liver, gut and kidney
and were dose-dependent in bile, gill, gut, liver, muscle and rete mirabile. Second,
increasing doses of B-naphthoflavone (BNF) (0.1, 1, 5, 10, and 100 mg/kg), BP (0.1, 1
and 10 mg/kg), and TCB (0.1, 1, 10 and 20 mg/kg) all produced dose-dependent induction
of CYP1A content and catalytic activity. Using the liver microsomal EROD data, BP, BNF
and TCB all had ED50s of approximately 5 mg/kg. However, BNF and BP had greater
efficacy than TCB in eliciting hepatic CYP1A induction. Hepatic inducer concentration and
CYP1A levels were correlated significantly. Third, previous studies have shown that
endothelium is a major site of induction of CYP1A in vertebrates and have suggested that
CYP1A induction in peripheral vasculature may be related to inducer dose (Drug Metab.
Dispo. 19, 113-123 (1991)). Biochemical analysis of microsomes from heart and rete
mirabile, organs in which CYP1A induction occurs predominantly in endothelial cells,
showed an increase in CYP1A content and EROD activity following treatment with BP,
BNF or TCB. CYP1A content and activity also were elevated in heart and rete mirabile in
eels from a notably polluted site. Immunohistochemical (IHC) analysis with MAb 1-12-3
revealed increasing induction of CYP1A in the endothelium of the heart, gill, kidney and
rete mirabile with increasing dose of BNF, BP and TCB. In the rete mirabile, greater
doses of inducers were associated with increasing penetration of induction. In addition, a
transition from endothelial to epithelial staining occurred in the gill, heart and kidney at high
doses of BNF. We conclude not only that the penetration of endothelial cell CYP1A
expression in the vessels of the rete mirabile reflects greater concentrations of inducer
reaching the distal circulation, but also that endothelial CYP1A induction may limit the local
distribution of inducers. The results are consistent with the hypothesis that endothelial
CYP1A may participate in removal of AhR agonist/CYPlA substrates from the circulation.
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INTRODUCTION
Endothelial cells make up the lining of all blood and lymphatic vessels. The
functions of endothelium are diverse, including providing a physical lining, maintaining
blood vessel tone, controlling microvascular permeability, regulating platelet clumping,
clotting and lymphocyte traffic, repairing damaged blood vessels and initiating
angiogenesis (Pearson, 1991). Thus endothelium may be a site that is particularly sensitive
to xenobiotic toxicity. For instance, activation of promutagens in endothelium may play a
role in atherosclerosis (Juchau et al., 1976). Edema is a symptom of a syndrome common
among developing fish, birds and mammals exposed to planar halogenated aromatic
hydrocarbons (pHAH) (Peterson et al., 1993). Finally, both polynuclear aromatic
hydrocarbons (PAH) and pHAH have been shown to alter endogenous arachidonic acid
(AA) metabolism (Schlezinger et al., 1998); these metabolites can affect a number of
endothelial cell functions (Schwartzman et al., 1987; Ohnishi et al., 1992; Harder et al.,
1995; Campbell et al., 1996).
PAH and pHAH induce the expression of a number of genes, including cytochrome
P4501A (CYP1A), through their interaction with the aryl hydrocarbon receptor (AhR)
(Hankinson, 1995). The toxicity of PAH and pHAH may be mediated in part by their
interaction with CYP1A. Liver is the major site of CYP1A induction (Goldstein and
Linko, 1984); however, CYPlA can be induced in a variety of organs and cells types
(Goldstein and Linko, 1984; Smolowitz et al., 1991). Human umbilical vein endothelial
cells express CYP1A1 mRNA at a low constitutive level and at an increased level following
polychlorinated biphenyl (PCB) or 1-naphthoflavone (BNF) exposure (Farin et al., 1994).
3-Methylcholanthrene (MC) induces CYP1A protein in rat and rabbit aorta (Thirman et al.,
1994; Stegeman et al., 1995), and TCDD induces an endothelial CYP, presumably
CYP1A, in rabbit kidney and lung (Dees et al., 1982).
Strong induction of CYP1A has been seen in the endothelium of fish exposed to
AhR agonists. Initially observed in the heart of scup (Stegeman et al., 1989), induction of
CYP1A has been seen in endothelium in the liver, heart, gill, kidney, gut, gonad, spleen,
red muscle and brain of fish exposed to BNF, 3,3',4,4'-tetrachlorobiphenyl (TCB), and
2,3,7,8-tetrachlorodibenzofuran (TCDF) (Miller et al., 1989; Stegeman et al., 1989;
Smolowitz et al., 1991). By calculation, CYP1A could account for as much as 25% of the
endothelial microsomal protein in the heart of BNF-treated fish (Stegeman et al., 1982;
Stegeman et al., 1989). In scup dosed with the potent CYP1A agonist TCDF given at 3
tg/kg and TCB, as less potent inducer, given at 1 mg/kg, similar CYP1A induction occurs
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in liver and sites proximal to large vessels. However, in scup dosed with TCB, CYP1A
induction also was seen in distal regions of the fish (Smolowitz et al., 1991). It was
hypothesized that induction of endothelial CYP1A could influence the local concentration of
inducer, both limiting the amount that could penetrate to the underlying tissue and the
spread of the inducer to distal areas of the organism (Stegeman et al., 1995).
The extent to which endothelial CYP1A is catalytically active is not clear. In rabbit
lung, CYP1A was ultrastructurally localized to endothelial cells, but cytochrome P450
reductase (CPR) was not detected (Overby et al., 1992). However, studies of porcine
aorta endothelial cells (PAEC) confirm the presence of CPR in both catalytic and
immunoblot assays (Stegeman et al., 1995). Bovine aorta endothelial cells and cardiac
microsomes from scup produce metabolites of BP indicative of CYP1A metabolism (Baird
et al., 1980; Stegeman et al., 1982). Mouse heart and kidney also have a BNF-inducible,
metabolically active P450 in the endothelium (Brittebo, 1994). However, the catalytic
activity of endothelial CYP1A is lower than that of equivalent amounts of hepatic CYP1A
(e.g. (Stegeman et al., 1982)). The full significance of endothelial CYP1A remains a
question because despite its low catalytic activity, its induction correlates with the toxicity
of TCDD to embryos (Guiney et al., 1997).
In this study we investigated both induction of CYP1A in liver in relation to inducer
distribution and induction of endothelial CYP1A in relation to its effect on AhR agonist
pharmacokinetics. American eels (Anguilla rostrata) were exposed to model AhR
agonists/CYP1A substrates. We demonstrated that liver CYP1A responds to BP, BNF and
TCB in a dose-dependent fashion and that this induction correlates with hepatic inducer
concentration. Eels may be particularly useful for the study of in vivo induction of
endothelial CYP1A because they have a rete mirabile, a counter-current vascular structure,
composed entirely of capillaries, which increases the partial pressure of oxygen to aid its
secretion into the swim bladder (Krogh, 1959). We show that endothelial CYP1A is
inducible in a number of organs and is metabolically active, albeit at low levels. We
addressed the hypothesis that substrates might remain "bound" to endothelial CYP1A,
limiting their distribution; CYP1A2 already is recognized as a binding protein in
mammalian liver (Diliberto, 1997). In the rete mirabile, penetration of endothelial CYP1A
induction increased with increasing dose of AhR agonists, corresponding with an increase
in inducer concentration. In addition, a transition from endothelial to epithelial staining
occurred in the gill, heart and kidney at high doses of BNF. Endothelial CYP1A may both
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enhance and ameliorate the toxicity of AhR agonists by holding them in a sensitive cell type
but also by slowing their spread to underlying tissues and distal areas.
MATERIALS AND METHODS
Chemicals: Benzo[a]pyrene and (-naphthoflavone were purchased from Aldrich
(Milwaukee, WI). Benzo[a]pyrene (3H, 55 Ci/mmol) was purchased from Amersham
(Arlington Heights, IL). Soluble was purchased from Dupont/NEN (Boston, MA). 7-
Ethoxyresorufin was purchased from Molecular Probes (Eugene, OR). 3,3',4,4'-
Tetrachlorobiphenyl (IUPAC# 77), and 3,3',4,4'-tetrachlorobiphenyl-Ring-UL- 14 C (52.1
mCi/mmol) were purchased from Pathfinder (St. Louis, MO). MS 222 was the generous
gift of Dr. Adria Elskus, but can be purchased from Sigma (St. Louis, MO). All other
reagents were purchased from Sigma.
Animals used in experimental exposures: One hundred and twelve American eels,
Anguilla rostrata, were purchased from Marine Resources at the Marine Biological
Laboratory, Woods Hole, MA. All of the eels were females. For the first experiment the
eels were kept at 20"C. For all other experiments, the eels were kept for at least 3 days at
10*C in flow-through tanks until treated.
Animals from environmental collections: Eels were collected from three sites near
Woods Hole, MA. Traps baited with horseshoe crab meat were used to collect the eels.
Eighteen eels were collected from New Bedford Harbor, MA at the Aerovox site. Eight
eels were collected from Marion Harbor, MA. Eleven eels were collected from Vineyard
Sound, MA. Eels were killed and dissected immediately upon return to the lab as described
below.
Treatment for chemical distribution: The eels were anesthetized in a solution of MS
222 (6g/4L sea water) and injected intra-peritoneally (IP) with corn oil or varying
concentrations of 3H-BP (1 and 10 mg/kg) and 14 C-TCB (1 and 10 mg/kg) in corn oil.
Eight days following injection, each eels was anesthetized in a solution of MS 222, and the
spinal cord severed. Portions of freshly dissected organs (0.1-0.25 g each of liver, heart,
gill, spleen, gut, kidney and muscle or 0.03-0.13 g of rete mirabile) were removed,
weighed, rinsed with water, blotted and placed in 20 ml scintillation vials. Bile was
collected via syringe, and blood was collected from the caudal vein via syringe. Both were
placed in 20 ml scintillation vials.
Chemical distribution analysis: Soluble (1 ml) was added to organs in the
scintillation vials. The organs were minced with scissors and placed in a 500C oven until
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dissolved (12-48 hours). A mixture of ethanol:Soluble (1:2) was added to the blood, and
the vials were warmed to 50"C for 1 hour. H202 (30%, 0.75 ml) was added to all vials
except those containing gut and muscle. All samples containing Soluble were acidified
with 200 pl of 6N HCL. Scintiverse (15 ml) was added to the vials and the samples were
allowed to quench overnight before counting them on a Beckman LS5000TD scintillation
counter. To calculate the concentration of BP and TCB in each organ, the radioactivity in
control organs was subtracted from that in organs from treated eels. The remaining
radioactivity was converted into gg.
Treatment for dose response The eels were anesthetized in a solution of MS 222
and injected IP with corn oil or varying amounts of B-naphthoflavone (BNF) (0.1, 1, 5,
10, and 100 mg/kg), benzo[a]pyrene (BP) (0.1, 1 and 10 mg/kg), or 3,3',4,4'-
tetrachlorobiphenyl (TCB) (0.1, 1, and 10 mg/kg) in corn oil. Each dose group consisted
of at least 3 eels. Eels were kept in flow-through tanks at 20"C for experiment 1 and at
10*C for experiments 2-7. They were not fed. Eels were killed on day 5 (Expt. 1) or day
8 (Expts. 2-7). Eels were killed as described above. Portions of heart, gill, kidney, rete
mirabile and liver were preserved in 10% neutral buffered formalin. Liver, heart and rete
mirabile also were collected for microsome preparation.
Microsome preparation and assays: Freshly dissected livers were immediately
homogenized in cold homogenization buffer (0.15M KC1, 0.05M TRIS, pH 7.2). Hearts
and rete mirabile were frozen in liquid N2 before homogenization. Microsomes were
prepared as previously described (Stegeman et al., 1979). Protein content was determined
using the bicinchoninic acid method (Smith et al., 1985), using bovine serum albumin
standards. Microsomal ethoxyresorufin O-deethylase (EROD) activity was determined
fluorometrically by the method of Hahn et al. (1993) using a Cytofluor 2300 (Millipore)
multiwell plate reader. NADPH-cytochrome P450 reductase activity in rete microsomes
was determined as previously described (Stegeman et al., 1982), using a Shimadzu 210
difference spectrophotometer. Microsomal P-450 content was determined using dithionite-
difference spectra of CO-treated samples (Bonkovsky et al., 1984). Cytochrome b5 was
determined using NADH difference spectra as previously described (Stegeman et al.,
1979).
Western blotting for CYPIA quantification Immunoblotting procedures were
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal
proteins (10-80 pg/lane) were resolved on 12% SDS-PAGE gels and electrophoretically
transferred to nylon or nitrocellulose (1 pm) membrane. The primary antibody was the
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mouse monoclonal antibody 1-12-3 (Park et al., 1986), raised against scup P450E
(CYP1A; (Morrison et al., 1995)). The secondary antibody was alkaline phosphatase
linked goat anti-mouse IgG (Biorad, Hercules, CA). The immunoreactive proteins on
nitrocellulose membrane were visualized using nitro blue tetrazolium and 5-bromo-4-
chloro-3-indoyl-phosphate (NBT/BCIP). The immunoreactive proteins on nylon
membranes were visualized using enhanced chemiluminescence (Tropix, Bedford, MA).
CYPlA content was quantified by densitometric analysis of video images (NIH Image,
1.60b5). The CYP1A values are relative, reported as scup CYP1A equivalents.
Immunohistochemical analysis: Preserved organs (liver, heart, kidney, gill and rete
mirabile) were embedded in paraffin by Pathology Services, Inc., Cambridge, MA or by
the Laboratory of Aquatic Animal Medicine and Pathology at the Marine Biological
Laboratory, Woods Hole, MA. Tissue sections were cut to a thickness of 5 pLm and
mounted on Fisher Superfrost Plus slides. Prior to staining, the sections were
deparaffinated and hydrated in 1% PBS/BSA. While being hydrated the sections were
incubated in 3% H202 in water to block the activity of endogenous peroxidases. The
hydrated sections were stained using an indirect peroxidase stain (Universal
Immunoperoxidase Staining Kit (Murine), Signet Lab, Dedham, MA). The antibodies
used were the monoclonal antibody MAb 1-12-3 and a peroxidase labeled goat anti-mouse
secondary antibody. The staining procedure used was as described by Smolowitz et al.
(1991). Staining of CYP1A was scored for intensity of staining (0-no stain, 1=mild stain,
2=moderate stain, 3=strong stain, 4=very strong stain) and for occurrence of staining
(O=no cells, 1=rare cells , 2=some cells, 3=many cells, 4=all cells staining). The stain
index was computed by multiplying the intensity and occurrence scores for a scale from 0-
16.
Statistics: Statistics were calculated using Microsoft Excel (Microsoft, Inc.,
Redmond, WA) and SuperAnova for Macintosh (Abacus Concepts, Inc., Berkeley, CA).
A Student's t-test was used to test differences between the dose groups in the chemical
distribution experiments. A one-factor ANOVA in combination with the Tukey-Kramer or
Dunnett's multiple-comparisons tests was used to analyze all other data.
RESULTS
Chemical distribution analysis: First, the patterns of distribution of BP and TCB
following IP injection into eels were examined (Figure 1) so that the distribution of the
inducers might be compared with induction of CYPIA. Two doses (1 and 10 mg/kg) of
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Figure 1. Distributions of 3H-BP and 14C-TCB in eels injected IP. A) lmg/kg dose B)
10 mg/kg dose C) Bile. Eels were injected IP with BP or TCB at the doses indicated and
killed 8 days post-injection. Portions of freshly dissected organs were removed, weighed,
rinsed with water, blotted and digested with Soluble. The organs were minced with
scissors and placed in a 50"C oven until dissolved. Bile was collected via syringe. Blood
was collected from the caudal vein via syringe and then added to ethanol:Soluble (1:2).
H202 was added to all vials except those containing gut and muscle. All samples
containing Soluble were acidified with HCL. Scintiverse was added to the vials, and the
samples were allowed to quench overnight before counting. Data are means ± SD of 3-6
individuals. a- Significantly greater than 1 mg/kg dose (p<0.05, Student's t-test) b-
Significantly greater than blood (p<0.05, Dunnett's).
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BP and TCB were tested, and tissues were sampled eight days after treatment.
Concentrations of BP and TCB were found to be dose-dependent in gill, gut, liver, muscle
and rete mirabile. In all cases bile contained the highest concentration of BP and TCB, and
the concentrations of both chemicals were similar. Of the organs, liver contained the
greatest concentration of BP and TCB. The other excretory organs, gut and kidney, also
had comparatively high concentrations of BP and TCB. The chemical concentrations in the
gill, heart, and rete mirabile were higher than that seen in blood, though variability in the
results prevented the differences from being significant.
Liver
Experimental exposure: We assessed CYP1A induction in liver to determine the
responsiveness of CYP1A in eels to induction by model AhR agonists. MAb 1-12-3
reacted with one band in eel liver microsomes (Figure 2). Control eels had low basal levels
of total P450 content, CYP1A content and ethoxyresorufin O-deethylase (EROD) activity
(Table I, Figure 3).
Treatment with BNF, BP and TCB resulted in minimal effects on total P450 and b5
content (Table I). Significant increases in total P450 occurred only at the 10 mg/kg dose of
BNF and BP.
Induction of CYP1A protein and activity in liver microsomes varied with inducer
(BNF, BP or TCB) and dose (Figure 3). CYP1A content was induced significantly by
doses greater than 1 mg BNF/kg, and CYP1A content in the 10 and 100 mg BNF/kg
groups was significantly greater than in all other groups. Doses greater than 5 mg BNF/kg
resulted in EROD activities significantly greater than in control eels. EROD activity in the
100 mg BNF/kg group was significantly different from that in all other groups. Both the 1
and 10 mg BP/kg doses elicited significant CYP1A protein induction The 10 mg BP/kg
group had significantly greater CYP1A protein and activity than all other doses. Doses
greater than 5 mg TCB/kg resulted in significant increases in CYP1A content and EROD
activity compared to the control group. However, the 20 mg TCB/kg dose did not
significantly induce CYP1A content or EROD activity above that in eels receiving 10 mg
TCB/kg. Treatment with TCB resulted in a lesser induction of CYP1A protein and activity
than was seen with BNF and BP (Table II), at comparable doses.
The results as described above refer to nominal or administered dose. Induction of
CYP1A content and catalytic activity was assessed in livers of eels used in the chemical
distribution studies to relate responses to tissue dose. For both BP and TCB, CYP1A
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Figure 2. CYP1A protein expression in liver microsomes from eels treated with BNF, BP
and TCB. Eels were injected IP with BNF, BP or TCB at the doses indicated and killed 8
days post-injection. Liver microsomal fractions were electrophoresed, transferred to
nitrocellulose, immunoblotted with MAb 1-12-3 against scup CYP1A and visualized using
NBT-BCIP. Lane 1: Scup CYP1A. Lanes 2-3: Control (80 gig). Lanes 4-5: BNF-
treated (5 & 10 gig) Lanes 6-7: TCB-treated (5 & 10 gig). Lanes 8-9: BP-treated (10 ig).
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TABLE I
Total spectral P450 and cytochrome b5 content in eels treated with BNF, BP and TCB
Treatment Dose n b5 Total P450
(mg/kg) (nmol/mg) (nmol/mg)
Corn Oil Control 24 0.07 ± 0.03 0.28 ± 0.08
TCB 0.1 6 0.09 ± 0.03 0.34 ± 0.10
1 8 0.05 ± 0.01 0.32 ± 0.03
5 3 0.12 ± 0.03 0.43 ± 0.11
10 18 0.08 ± 0.03 0.34 ± 0.15
20 3 0.11 + 0.02 0.38 ± 0.101
BNF 0.1 3 0.08 ± 0.05 0.31 + 0.06
1 3 0.10 ± 0.02 0.30 ± 0.03
5 3 0.10 ± 0.03 0.24 ± 0.04
10 9 0.13 + 0.04 0.42 + 0.15*
100 3 0.18 ± 0.03 0.42 + 0.09
BP 0.1 4 0.07 ± 0.02 0.22 ± 0.04
1 13 0.08 ± 0.02 0.31 ± 0.07
10 12 0.11 ± 0.03 0.38 + 0.08*
Eel liver microsomal cytochrome P450 and b5 contents were determined spectrally as
described in Methods. Values are means ± SD.
* - Significantly different from control (p<0.05, Tukey-Kramer).
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Figure 3. Quantification of liver CYP1A protein and activity in eels treated with BNF, BP
and TCB. A) EROD activity. B) CYP1A content. Eels were injected IP with BNF, BP
or TCB at the doses indicated and killed 8 days post-injection. Microsomal EROD activity
was determined fluorometrically Immunoblot analysis was performed as described in
Figure 2, and quantified by densitometric analysis. a- Significantly different from control
(p<0.05, Tukey-Kramer). b-Significantly different from all doses (p<0.05, Tukey-
Kramer).
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TABLE II
Comparison of the efficacy of BNF, BP and TCB in inducing
Treatment Dose CYP1A
(mg/kg) (pmol/mg)
Corn Oil Control
BNF 1
BP
TCB
BNF 10
BP
TCB
Eel liver microsomal CYP1A content and EROD
Methods. Values are means ± SD.
* - Significantly different from TCB (p<0.05).
** - Significantly different from TCB (p<0.01).
2+3
58 ± 12*
43 + 32*
12 ± 4
156 ± 37**
122 ± 34**
65 ± 27
activity were
CYPlA in eel liver
EROD Activity
(pmol/min/mg)
81 ± 47
661 + 194**
422 ± 234*
193 ± 70
1115 + 901*
1312 + 600**
502 + 191
determined as described in
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content and activity were correlated strongly with the inducer concentrations in the liver
(Figure 4).
Environmental exposure: Three sites were chosen for sampling of eels exposed to
AhR agonists in the environment. PCB, dioxin and PAH concentrations in sediment were
2100, 8, 170 ug/g dry weight in New Bedford Harbor, MA (Pruell et al., 1990). This led
to concentrations of PCBs as high as 1400 gg/g dry weight in F. heteroclitus and 700 gg/g
dry weight (i.e. approximately 70 mg/kg wet weight) in A. rostrata (Lake et al., 1995).
Marion Harbor, MA is an enclosed body of water with substantial boat traffic. Vineyard
Sound is an open body of water where eels used in the experimental exposures were
caught. Total P450 and b5 contents as well as CYP1A protein and EROD activity were
significantly greater in liver of eels from New Bedford Harbor (NBH) than in those from
Marion Harbor or Vineyard Sound (Table III).
Endothelium
Biochemical analysis: Heart and rete mirabile microsomes were biochemically
analyzed to examine the induction of CYP1A in endothelial cells. Endothelium represents
as much as 8-9% of the mass of the teleost heart (Stegeman et al., 1989), and the rete
mirabile is composed almost solely of endothelial cells (Krogh, 1959). In heart, CYP1A
protein and activity increased with increasing doses of BP and TCB (Table IV). As in
liver, similar CYP1A induction occurred with BNF and BP, while TCB treatment resulted
in a lesser CYP1A induction. Not only was CYP1A protein detectable in rete mirabile
(Figure 5), but EROD and CPR activity also were measurable (Table IV). Furthermore, in
eels collected from variously polluted sites, endothelial CYP1A content and activity was
elevated significantly in eels collected from NBH (Table V).
Immunohistochemical analysis: Immunohistochemical analyses were performed in
order to determine the dose-dependence of endothelial CYP1A induction in a variety of
organs. Across experiments, control eels which received corn oil had at most mild staining
of CYP1A in gill pillar cells, heart endothelial cells, and kidney endothelial cells (Figure 6).
No staining was observed in gill epithelium of control eels.
CYP1A was induced in endothelium in heart, kidney and gill by treatment with
BNF, BP or TCB, although the pattern of induction varied with the inducer (Figure 6).
Both BP and TCB induced dose-dependent increases in endothelial staining in gill, heart,
and kidney. Doses greater than 10 mg/kg of BP or TCB resulted in significant CYP1A
induction compared to that in controls. At 20 mg TCB/kg, CYP1A immunostaining also
was significantly greater than that in eels receiving 0.1 mg TCB/kg. CYP1A
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Figure 4. Correlation of BP and TCB concentration in eel liver with CYPIA induction. A)
Inducer concentration vs. EROD activity B) Inducer concentration vs. CYP1A content.
Inducer concentrations were determined as described in Figure 1. EROD activity and
CYPIA content were determined as described in Figure 3. All of the relationships shown
are correlated significantly (p<0.001).
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TABLE II[
Characterization of CYP1A protein and activity in liver microsomes from eels collected
from differentially polluted sites
Site EROD Activity CYP1A Total P450 b5
(pmol/min/mg) (pmol/mg) (nmol/mg) (nmol/mg)
New Bedford (n=16) 321 ± 119** 190 ± 92** 0.55 + 0.10* 0.36 ± 0.11"*
Marion Harbor (n=8) 116 + 28 13 + 3 0.35 + 0.08 0.14 ± 0.03
Vineyard Sound (n=10) 77 + 32 1 1 0.41 + 0.07 0.14 ± 0.12
Eel liver microsomes from eels collected in New Bedford Harbor, Marion Harbor and
Vineyard Sound were characterized for their cytochrome P450, b5 and CYP1A contents,
and CYP1A catalytic activity (EROD) as described under Methods. Values are means +
SD.
* - Significantly different from all other sites (p<0.05, Tukey-Kramer).
** - Significantly different from all other sites (p<0.01, Tukey-Kramer).
175
TABLE IV
Quantification of CYP1A content and activity in eel heart and rete mirabile following
treatment with model AhR agonists
Heart Rete mirabile
Treatment CYP1Aa EROD CYP1Ac EROD Reductase
Activityb Activityd Activitye
Control ND 2 ± 2 ND 0.1 8.9
BP 0.1 mg/kg ND 4 ± 2 0.2 0.2 18.0
BP 1 mg/kg 23 + 23 4 +2 1.4 0.5 11.3
BP 10 mg/kg 255 ± 143 13 ± 12 5.8 0.9 14.5
BNF 10 mg/kg 49 ± 49 9 ± 6 3.9 0.9 5.6
TCB 10 mg/kg 22 + 14 3 ± 3 0.7 0.4 33.8
Eels were injected IP with BNF, BP or TCB at the doses indicated and killed 8 days post-
injection. Eel heart and rete mirabile were characterized for their CYP1A content and
catalytic activity (EROD) as described under Methods. For heart, values are means ± SD
from 3-6 pools of 2-3 individual organs. For rete mirabile, each value is from a pool of 2-
3 individual organs.
a - Integrated density/mg microsomal protein.
b - Pmol resorufin formed/min/mg microsomal protein.
c - Integrated density measured in 80 gg of post-mitochondrial supernatant protein.
d - Pmol resorufin formed/min/mg post-mitochondrial supernatant protein.
e - Nmol/min/mg post-mitochondrial supernatant protein.
ND - Not detectable.
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Figure 5. Immunodetection of CYP1A in rete mirabile microsomes from eels treated with
BNF, BP and TCB. Eels were injected IP with BNF, BP or TCB at the doses indicated and
killed 8 days post-injection. Immunoblot analysis was performed as described in Figure 2,
with the exceptions of being transferred to nylon and visualized using enhanced
chemiluminescence. Lane 1: Scup CYP1A standard. Lane 2: Control. Lane 3: 1 mg
BP/kg. Lane 4: 0.01 mg BP/kg. Lane 5:10 mg BP/kg. Lane 6: 10 mg TCB/kg. Lane 7:
10 mg BNF/kg.
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TABLE V
Characterization of CYP1A protein and activity in heart and rete mirabile microsomes from
eels collected from differentially polluted sites
Site Organ EROD Activity CYP1A Endothelial CYP1A
(pmol/min/mg) (pmol/mg) (Stain Index)
New Bedford Heart 5.8 ± 2.8* 4.5 ± 1.7 10.1 ± 3.5*
n=11 Rete 1.9 ± 1.2* <.0 0 1a id
Marion Harbor Heart 1.0 ± 0.4 <.001 1.3 ± 1.8
n=-5 Rete 0.2 ± 0.1 <.001 rd
Vineyard Sound Heart 0.6 ± 0.5 <.001 0.2 ± 0.4
n=8 Rete 0.3 + 0.1 <.001 nd
Eel heart and rete mirabile microsomes from eels collected in New Bedford Harbor, Marion
Harbor and Vineyard Sound were characterized for their CYP1A content and CYP1A
catalytic activity (EROD) as described under Methods. Values are means ± SD.
* - Significantly different from all other sites (p<0.01, Tukey-Kramer).
a - Bands corresponding to CYP1A were visible in two samples, but were unquantifiable.
nd - Not determined
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immunostaining in BNF treated eels peaked at intermediate doses, which differed from that
resulting from BP or TCB treatment where staining increased to the highest dose.
Endothelial staining peaked at 1 mg BNF/kg in gill pillar cells and 5 mg BNF/kg in
ventricular and kidney endothelial cells.
Gill epithelial cells also were inducible for CYP1A; however, the response was
dependent upon the inducer (Figure 6). In BP and TCB-treated eels, gill epithelial staining
remained mild, even at the highest doses. While gill endothelial staining in eels treated with
doses greater than 5 mg BNF/kg decreased, the gill epithelial staining was induced and
continued to increase significantly with increasing dose.
CYPIA immunostaining in the rete mirabile: Immunohistochemical analysis of
CYP1A showed a dose-dependent induction in the endothelial cells of the rete mirabile
(Figure 7). All control and dosed fish showed significant positive staining in the pre-rete
arteries; however, the extent of penetration of staining into the rete itself differed with
inducer and dose. Rete from control fish had mild to strong staining in endothelial cells of
the pre-rete arteries only. BNF was most effective at inducing CYP1A in the endothelium
of the rete (Table VI). There was a dose-dependent increase in the CYP1A stain index in
the pre-rete arteries, with maximal staining reached by the 1 mg BNF/kg dose. Similarly,
the intensity of CYP1A staining in the heart-pole endothelium was dose-dependent. Doses
greater than 1 mg BNF/kg resulted in penetration of CYP1A staining into the mid-rete
region, and doses greater than 5 mg BNF/kg resulted in extension of penetration of
endothelial CYP1A staining into the vessels of the bladder pole. In BP-treated eels, the
CYP1A stain index in the pre-rete arteries was dose-dependent. Doses greater than 0.1 mg
BP/kg resulted in CYP1A staining in heart-pole endothelium, and the intensity of staining
increased with dose. A dose of 10 mg BP/kg resulted in CYPIA induction in the mid-rete.
While the CYP1A stain index in TCB-treated eels was dose-dependent, maximal staining
(i.e. a score of 16) was not reached in these eels. Doses greater than 1 mg/kg TCB resulted
in CYP1A staining in the heart-pole endothelium, and the intensity increased with dose.
TCB did not induce CYP1A staining in the mid-rete. With all of the inducers as the dose
increased, the proportion of eels with staining of retial CYP1A increased, evident most
clearly in the heart pole.
DISCUSSION
Previous studies have suggested that eels may be useful in biomonitoring of aquatic
pollution (van der Oost et al., 1996). However, the direct response of CYP1A in eels
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Figure 6. Immunohistochemical analysis of CYPIA protein in endothelium of eels treated
with BNF, BP and TCB. A) BNF-treated eels (n=3-10). B) BP-treated eels (n=4-8). C)
TCB-treated eels (n=3-15). Eels were injected IP with BNF, BP or TCB at the doses
indicated and killed 8 days post-injection. Tissues were dissected, embedded, sectioned and
immunohistochemically analyzed for CYP1A as described under Methods. Staining of
CYP1A was scored for intensity of staining (0=no stain, 1=mild stain, 2=moderate stain,
3=strong stain, 4=very strong stain) and for occurrence of staining (0=no cells, 1=rare
cells, 2=some cells, 3=many cells, 4=all cells staining). The stain index was computed by
multiplying the intensity and occurrence scores for a scale from 0-16. *-Significantly
different from control. a-Significantly different from control and 0.1 mg/kg. b.
Significantly different from control, 0.1 and 1 mg/kg. c-Significantly different from 1
mg/kg. d-Significantly different from 5 mg/kg. Significance was determined as p<0.05
(Tukey-Kramer).
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Figure 7. CYP1A immunostained sections of rete mirabile from eels treated with BNF.
Eels were injected IP with BNF at the doses indicated and killed 8 days post-injection. A)
Control (heart pole). B) 0.1 mg/kg (heart pole). C) 1 mg/kg (heart pole). D) 5 mg/kg
(heart pole). E) 5 mg/kg (bladder pole). The immunostaining procedure used is as
described by Smolowitz et al. (1991).
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TABLE VI
Immunohistochemical analysis of CYP1A induction following treatment with BNF, BP
and TCB in the rete mirabile of eels
Pre-rete Heart Pole Mid-rete Bladder Pole
Endothelium Endothelium Endothelium Endothelium
Chemical Dose Stain +/total* Intensity +/total +/total +/total
(mg/kg) Index
BNF 0 10 + 4 3/3 0 0/3 0/3 0/3
0.1 13 + 2 3/3 1 + 1 1/3 0/3 0/3
1 16 + 0 3/3 3 +1 2/3 1/3 0/3
5 16 ± 0 3/3 4 ± 1 3/3 3/3 2/3
10 16 + 0 9/9 3 ± 0 9/9 1/9 1/9
100 16 + 0 3/3 3 ± 0 3/3 3/3 2/3
BP 0 10 + 6 7/12 0 ± 0 4/12 0/12 0/12
0.1 10 + 2 4/4 1 + 1 3/4 0/4 0/4
1 15 ± 2 6/7 1 + 1 6/7 0/7 0/7
10 16 ± 0 6/6 2 ± 1 6/6 2/6 1/6
TCB 0 10 ± 4 5/5 0 ± 0 0/5 0/5 0/5
0.1 6 3 3/3 0 0/3 0/3 0/3
1 14 ± 3 3/3 2 ± 0 3/3 0/3 0/3
10 15 ± 3 12/12 1 ± 1 12/12 0/12 0/12
20 11 7 3/3 2 ± 0 3/3 0/3 0/3
Eels were injected IP with BNF, BP or TCB at the doses indicated and killed 8 days post-
injection. Rete mirabile were dissected, embedded, sectioned and immunohistochemically
analyzed for CYP1A as described under Methods. Staining of CYP1A was scored for
intensity of staining (0=no stain, 1=mild stain, 2=moderate stain, 3=strong stain, 4=very
strong stain) and for occurrence of staining (0=no cells, l=rare cells , 2=some cells,
3=many cells, 4=all cells staining). The stain index in computed by multiplying the
intensity and occurrence scores for a scale from 0-16.
* - Number of rete with positive staining over the total number analyzed.
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following treatment of AhR agonists has not been addressed. CYP1A in liver was
significantly induced by both halogenated and non-halogenated AhR agonists.
Furthermore, CYP1A induction in liver was correlated strongly with agonist concentration,
whether PAH (BP) or pHAH (TCB). In comparison with other species, eels are
moderately sensitive to CYP1A induction by AhR agonists.
CYP1A induction in endothelium could have multiple consequences. Previous
studies have suggested that endothelial CYP1A induction may alter the pharmacokinetics of
AhR agonists/CYP1A substrates (Smolowitz et al., 1991), affect vascular function (Pinto
et al., 1986; Pinto et al., 1987), and stimulate toxicity (Guiney et al., 1997). In this study
we evaluated the possible relationship between CYPlA induction in endothelium and the
pharmacokinetics of AhR agonists. CYP1A in endothelium responded in a dose-dependent
manner to treatment with AhR agonists and was highly inducible in heart, gill and kidney.
The rete mirabile was examined for CYP1A induction because it is an organ that is
composed almost solely of endothelial cells and may be a unique site in which to investigate
the response of endothelial CYPIA to AhR agonists in vivo. Induction of CYP1A in rete
mirabile could be observed in both immunohistochemical and biochemical assays. The
patterns of induction in this vascular bed are consistent with the extent of penetration of
inducer being limited at lower doses possibly by induction of CYP1A. The results also
confirm that capillary endothelial CYP1A is metabolically active.
Liver
Tissue Distribution of BP and TCB: Previously, studies determined that the tissue
distribution of highly lipophilic compounds, including pHAHs, is species specific. Cod
injected with 2,3,3',4,4'-pentachlorobiphenyl or 2,3,7,8-tetrachlorodibenzo-p-dioxin have
much greater concentrations of these chemicals in the liver than similarly treated rainbow
trout (Bernhoft et al., 1994; Hektoen et al., 1994). This difference has been attributed to
the fact that the main lipid store in cod is the liver, while in rainbow trout there are
peritoneal and subcutaneous lipid stores. In the present study, eels tended to have low
concentrations of both TCB and BP in the liver, though the liver did have greater
concentrations of both BP and TCB than any other organ examined. The low
concentrations of BP and TCB may be related to abundant peritoneal fat in these animals
(personal observation), which could limit the amount distributed to other organs. The
similarity in the concentrations of BP and TCB in most organs suggests that the
pharmacokinetics of these chemicals are similar in eels.
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Induction and Suppression of Eel Liver CYPIA: BP and BNF are model non-
halogenated AhR agonists, and TCB is a model halogenated AhR agonist. CYP1A can be
induced in a variety of fish by these AhR agonists (Gooch and Matsumura, 1983;
Melancon and Lech, 1983; Beyer et al., 1997; White et al., 1997a). In eels, an ED50 for
EROD activity of approximately 5 mg/kg for BNF, BP and TCB can be estimated from the
dose-response curves. Furthermore, both EROD activity and CYP1A content were highly
correlated with concentrations of BP and TCB in the liver. In comparison, the ED50 for
administered doses of TCB has been estimated at 0.03 mg/kg in chicken embryo (Poland
and Glover, 1977), 0.1 to 0.7 mg/kg in rainbow trout (Oncorhynchus mykiss) (Janz and
Metcalfe, 1991; Newsted et al., 1995) , 5.8 mg/kg in C57BL/6J mice (Poland and Glover,
1977), and 150 mg/kg in Wistar rats (Leece et al., 1985). In comparison to other species,
eels are moderately sensitive to CYP1A induction by model AhR agonists.
BNF and BP had greater efficacy in inducing CYP1A than TCB. The induction of
hepatic microsomal CYP1A content and catalytic activity was 2 to 3-fold greater in eels
dosed with BNF or BP than in those dosed with TCB, compared at a 10 mg/kg dose.
While TCB induced CYP1A in liver, a dose of 20 mg/kg did not produce a greater level of
induction than did a 10 mg/kg dose. Increasing doses of BNF or BP resulted in increased
induction of CYP1A in hepatic microsomes, with no decline in induction at administered
doses that far exceeded doses of TCB. The reason for this greater efficacy is not known
but might result from differences in pharmacokinetic distribution; however, the distribution
studies demonstrate that the concentrations of BP and TCB were similar in all organs but
spleen. The plateau in induction of CYP1A activity following treatment with high doses of
TCB also may result from inhibition of CYP1A, as TCB is a competitive inhibitor of
EROD activity (Gooch et al., 1989). However, there is a plateau in induction of both
protein and activity at the 20 mg/kg dose, suggesting that catalytic inhibition is not the only
contributing factor.
While TCB and other planar PCBs generally induce CYP1A, the rate of CYP1A
activity and the content of CYP1A protein decline sharply following in vivo exposure to
high doses of TCB, 3,3',4,4',5-pentachlorobiphenyl and 3,3',4,4',5,5'-
hexachlorobiphenyl in several species (Gooch et al., 1989; Sinclair et al., 1989; Newsted et
al., 1995; Stegeman et al., 1995). In the fish model, scup (Stenotomus chrysops), the
decline was shown to be largely specific for CYP1A, resulting from a loss of CYP1A
protein following transcription (White et al., 1997a). The mechanism was determined to be
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oxidative inactivation (Chapter 3). Inactivation of CYP1A during the metabolism of TCB
may explain in part the lack of increase in induction at the highest dose (See Appendix A).
Use of Eels as Biomonitoring Species: A previous study demonstrated the use of
feral eels (Anguilla anguilla) in biomonitoring aquatic pollution (van der Oost et al., 1996).
CYP1A content and activity were the most sensitive to environmental xenobiotics (van der
Oost et al., 1996) and were correlated with tissue levels of PCBs and organochlorine
pesticides (van der Oost et al., 1995). Although the relationship between AhR agonist
concentration and CYP1A induction is species dependent (Bernhoft et al., 1994; Hektoen et
al., 1994), in this study both BP and TCB concentrations were correlated with hepatic
CYP1A induction. In addition, eels collected from NBH, an EPA Superfund site, had
significantly elevated CYP1A levels compared to eels collected from other sites in the area.
These results suggest that the eel is a good candidate for use as a biomonitoring species.
Endothelium
CYP1A Induction in Endothelium: In most extra-hepatic organs, CYP1A can be
strongly induced in endothelium by AhR agonists (Smolowitz et al., 1991). In eels, the
immunohistochemical CYP1A signal was as strong in endothelial cells as in hepatocytes.
In other species it has been estimated that CYP1A could account for as much as 25% of the
endothelial cell microsomal protein in heart (Stegeman et al., 1982; Stegeman et al., 1989).
In this study, we observed a dose-dependent increase in endothelial CYP1A induction
following treatment of BNF, BP and TCB.
Investigation of endothelial CYP1A induction in vivo is complicated by two factors.
Most organs have multiple cell types which are inducible for CYP1A, and endothelial cells
represent a very small proportion of the mass of most organs. Fish heart has been used as
a model for CYP1A induction in endothelial cells. Although endothelium represents as
much as 8-9% of the mass of the teleost heart (Stegeman et al., 1989), that proportion is
less than in the rete mirabile, an organ composed almost solely of endothelial cells (Krogh,
1959). Thus, we deduced that the rete may be a unique site in which to study induction of
CYP1A in endothelial cells in vivo. Both experimental and environmental exposure to AhR
agonists resulted in induction of CYP1A in rete endothelial cells, detectable both
immunohistochemically and biochemically. Both CYP1A catalytic activity and reductase
activity were quantifiable in the rete, supporting conclusions that endothelial CYP1A is
catalytically active (Overby et al., 1992; Brittebo, 1994; Stegeman et al., 1995). We have
demonstrated that endothelial cells exposed to CYP1A inducers in vivo responded with
increasing CYP1A content and activity.
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Although immunohistochemical studies have suggested that CYP1A may be as
highly induced in endothelium as in hepatocytes, the catalytic activity of endothelial CYP1A
is very low in comparison to that in liver. As has been found for PAEC (Stegeman et al.,
1995), EROD rates in endothelial cells from induced eels are lower than that in liver of
uninduced eels. In comparison, the maximum EROD rate quantified in eel rete mirabile
was 3 pmol/min/mg microsomal protein and in PAEC was 25 pmol/min/mg total protein
(Stegeman et al., 1995). The low activity may result from a deficiency of CPR in
endothelial cells (Stegeman et al., 1982; Overby et al., 1992; Stegeman et al., 1995).
Augmentation with rat reductase increased the CYP1A catalytic rate in PAEC, suggesting
that there is not enough reductase to fully support the catalytic capacity of endothelial
CYP1A (Stegeman et al., 1995).
Significance of Endothelial CYP1A Induction: The limited catalytic capacity of
endothelial CYP1A raises the question of what significance CYP1A induction in
endothelium might have. Endothelium is thought to act as a protective barrier, and
induction of a metabolically inefficient CYP1A might contribute to the barrier function by
holding substrates in the active site rather than metabolizing them. CYP1A2 strongly binds
TCDD (Poland et al., 1989; Poland et al., 1989) and was shown to be responsible for the
sequestration of TCDD in rat liver (Diliberto, 1997). Binding of TCB to CYP1A also may
be inferred from inhibition studies using scup hepatic microsomes in which a Ki of 18-22
nM at low protein concentrations (Hahn and Stegeman, 1994) and a Ki of 0.2-0.3 jiM at
high protein concentrations (Gooch et al., 1989; Chapter 3) were measured.
Slowly metabolized substrates might be effectively "bound" to endothelial CYP1A,
resulting in sequestration in the endothelium that could limit the amount of inducer that can
penetrate to underlying tissues or distal regions (Stegeman et al., 1995). Results from this
study support the hypothesis that endothelial CYP1A might influence the pharmacokinetics
of AhR agonists. First, concentrations of BP and TCB in the rete mirabile were dose-
dependent and were greater than in the blood. Second, as the agonist dose increased,
penetration of CYP1A immunostaining into the rete increased. Third, CYP1A staining was
never seen in efferent rete vessels. The correlation of AhR agonist concentration with
endothelial CYP1A induction suggests that the AhR agonist is responsible for the
endothelial CYP1A induction. However, concentration of AhR agonists from the blood
and lack of efferent CYP1A induction suggest that endothelial CYP1A can effectively
remove the agonists from the circulation. In humans, placental endothelium taken from
smokers has elevated aryl hydrocarbon hydroxylase (AHH) activity, however the umbilical
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vein does not (Manchester et al., 1984). This suggests that the placental endothelium may
remove inducers from the blood, and as CYP1A2 induction in extra-hepatic tissues is
limited (Goldstein and Linko, 1984), the elevated AHH activity may indicate that CYP1A1
is responsible for that removal. In addition to controlling distal distribution of AhR
agonists, endothelial CYP1A may influence passage of AhR agonists to underlying tissues
as seen in the transition of CYP1A immunostaining from within the endothelial cells to
staining in cells underlying the endothelium high doses of BNF. Endothelial CYP1A may
limit the spread of AhR agonists following low dose exposures.
Despite the relatively low catalytic activity of endothelial CYP1A, its induction has
been correlated with overt toxicity. Guiney et al. (1997) found that the strongest CYP1A
induction occurs in the vascular endothelium of lake trout embryos exposed to TCDD, and
that this induction correlated with the toxic effects, culminating in mortality. Two potential
routes to this toxicity may be alteration in arachidonic acid (AA) metabolism and production
of reactive oxygen species (ROS). First, AA metabolites produced by P450s influence
vascular function by altering endothelial cell permeability (Ohnishi et al., 1992), vascular
tone (Harder et al., 1995), and cellular ion flux (Schwartzman et al., 1987; Campbell et al.,
1996), and stimulating angiogenesis (Harder et al., 1995). BNF and MC treatment of
canine coronary and rabbit pulmonary arteries leads to dose-dependent increases in AA
induced endothelium-dependent relaxations (Pinto et al., 1986; Pinto et al., 1987), which
can be reversed in the presence of general P450 inhibitors (Pinto et al., 1986) and 7-
ethoxyresorufin (Fulton et al., 1992; Fulton et al., 1995). Second, CYP1A binding of
slowly metabolized substrates and resulting release of ROS during catalytic uncoupling
(Chapters 3 and 4) in endothelium could be a mechanism of toxicity. Piperonyl butoxide, a
general CYP inhibitor, and N-acetylcysteine, an antioxidant, can protect against TCDD-
induced mortality in fish embryos (Cantrell et al., 1996). Furthermore, porcine pulmonary
endothelial cells respond to TCB treatment with increased CYP1A1 content and activity, as
well as ROS production and lipid peroxidation (Toborek et al., 1995).
We have demonstrated that American eels respond to both PAHs and a pHAH with
induction of hepatic and endothelial CYP1A. Liver CYP1A can be induced significantly by
multiple model AhR agonists, and in comparison with other species, eels are moderately
sensitive to CYP1A induction. That CYP1A induction is correlated strongly with inducer
concentration supports the conclusion that eels can be a useful biomonitor. Endothelial
CYP1A in eels is highly inducible and can respond to AhR agonists in a dose-dependent
manner. Further, induction of CYP1A in endothelium appears to be strong in eels collected
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from a notably polluted site. Our results support the hypothesis that endothelial CYP1A
can potentially sequester AhR agonists thereby modifying their pharmacokinetics. The
results of this study suggest that the rete mirabile can be used a model for the study of
CYPIA expression in endothelial cells in vivo and its role in the toxicity of AhR agonists.
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CHAPTER 8
Summary and Conclusions
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Arachidonic Acid Metabolism
The goal of these studies was to investigate cytochrome P450-related changes in a
process that is important to the function of endothelial cells. Only one previous preliminary
study had addressed CYP-mediated AA metabolism in fish (Zacharewski et al., 1996).
Scup liver microsomes produced all possible types of P450-derived AA metabolites: EETs,
DHETs, mid-chain HETEs and co-terminal HETEs. While liver microsomes from females
and males produced identical metabolite profiles, gravid females had much lower rates of
total AA metabolism. In fish, several CYP, including CYP1A, CYP2B, CYP2K and
CYP3A, have been shown to be hormonally regulated (Pajor et al., 1990; Gray et al.,
1991; Buhler et al., 1994), suggesting that these CYP might contribute to basal hepatic AA
metabolism. Antibodies against scup CYP1A and a scup CYP2B-like protein inhibited
liver microsomal AA metabolism, also suggesting that multiple CYP contribute to hepatic
AA metabolism. These studies provide the first evidence of EETs and DHETs as
endogenous constituents in teleost liver. Treatment of scup with the CYP1A inducer BP
increased both liver microsomal AA metabolism and endogenous hepatic EET content, with
a shift in EET regio- and enantioselectivity. While TCDD treatment did not significantly
affect liver microsomal AA metabolism, it did increase endogenous EET content and alter
EET regioselectivity. Kidney, gill and heart microsomes all metabolized AA, at rates 10 to
30-fold less than with liver. BP treatment did not alter total EET content in heart and
kidney; however there was a shift in favor of 14,15-EET. The predominant CYPs in
mammalian kidney are the CYP2Cs (Capdevila et al., 1992), and CYP2N2 is highly
expressed in heart of some fish (Oleksiak et al., 1998b). Therefore, CYP1A induction may
not significantly alter the CYP compliment in these organs. However, other studies have
shown that CYP1A-mediated AA metabolites can alter vasoactivity in blood vessels, as will
be discussed below. Thus, scup liver and extrahepatic organs metabolize AA via multiple
CYP forms to eicosanoids in vitro and in vivo. While AhR agonists alter metabolism of
AA in early diverging vertebrates expressing both CYP1A and AhR, the magnitude of
effects may depend upon the type of inducer.
Induction of CYP1A was correlated with changes in the regio- and stereochemistry
of endogenous EETs, suggesting that CYP1A-mediated metabolism of AA is regio- and
enantiospecific. Expressed CYP2P and CYP2N from F. heteroclitus also metabolize AA in
a regio- and stereospecific fashion (Oleksiak et al., 1998a; Oleksiak et al., 1998b).
Metabolism of AA by expressed or purified scup CYP1A is required to confirm the actual
metabolites produced by this CYP.
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Marine fish contain less AA and greater amounts of n-3 fatty acids (e.g.
eicosapentaenoic acid) than do mammals or freshwater fish, presumably due to differences
in diet and in ability to elongate fatty acids (Weber, 1990). In comparison to mammals,
amounts of endogenous AA metabolites and rates of microsomal AA metabolism were low
in scup. Fish oils are rich in eicosapentaenoic (EPA) and docosahexaenoic acids; thus
these fatty acids may be more readily available for metabolism in fish. Rat hepatic
microsomes metabolize n-3 fatty acids to products with regiochemistry similar to P450-
derived AA metabolites (VanRollins et al., 1984; VanRollins et al., 1988; VanRollins,
1990). EPA has been implicated in regulation of tight junction permeability, gene
expression and nitric oxide production (Achard et al., 1997; Okuda et al., 1997; Jiang et
al., 1998). Even though EPA metabolites appear to be less biologically active than their
AA-counterparts, they appear to contribute significantly to the maintenance of the
cardiovascular system in mammals (Weber, 1990). Investigation of the metabolism of
EPA by fish and the role of CYP-derived AA and EPA metabolites in cardiovascular, renal
and hepatic function in fish is required.
This is the first study to demonstrate alteration of endogenous AA metabolites
following treatment with a CYP inducer. Rifkind et al (1990) have raised the issue as to
whether TCDD-induced changes in AA metabolism exacerbate or ameliorate the toxicity of
TCDD. Rifkind et al (1994) argue that the effects of the AA metabolites produced by
CYP1As are compatible with the syndrome of TCDD toxicity (i.e. alterations in hormonal
regulation, fluid homeostasis, cell growth, and intermediary metabolism and increased
intracellular Ca2 +). However, it is also pointed out that some CYP-derived AA metabolites
could protect against TCDD toxicity through anti-mitogenic and edema-inhibition pathways
(Rifkind et al., 1990). Now that there is evidence for alterations in AA metabolism by AhR
agonists in vivo, an examination of how predominant CYP1A-derived metabolites might
contribute to pHAH toxicity is necessary.
PHAH-Simulated-CYPlA Inactivation
Previous studies in fish, birds and mammals have demonstrated induction,
inhibition and suppression of CYP1A by TCB. Here we defined the mechanism of CB-
stimulated CYP1A inactivation. In vitro inactivation of scup CYP1A activity by TCB was
time-dependent, NADPH-dependent, oxygen-dependent and irreversible. TCB increased
microsomal NADPH oxidation rates, and CYP1A inactivation was lessened by adding
cytochrome c. CYP1A inactivation was accompanied by loss of spectral P450 and variable
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loss of heme and/or appearance of P420. Rates of TCB metabolism were too slow to
support the rate of inactivation. Non-heme iron chelators, anti-oxidant enzymes, and ROS
scavengers had no influence on inactivation. Adding H202 enhanced TCB-dependent
inactivation, but only the enhancement was reversed by catalase. Inactivation was
accelerated by azide but not by hydroxylamine or aminotriazole, suggesting that the azide
effect is not dependent upon catalase. TCB also inactivated rat liver microsomal CYP1A;
although the rate of inactivation was slower than that seen with scup CYP1A. The results
indicate that TCB uncouples the catalytic cycle of CYP1A, ostensibly CYP1A1, resulting in
formation of ROS within the active site. Furthermore, we hypothesized that the attacking
species is OH*, formed by the interaction of the reduced heme iron with H202. The
inactivation of CYP1A was stimulated by CBs that are AhR agonists and possibly CYP1A
substrates, i.e. CBs 126 and 169. The mono-ortho CB 105 was less effective at
stimulating inactivation of CYP1A. The non-ortho CB 52 and the rapidly metabolized
CYP1A substrate BP did not stimulate inactivation. Inactivation of CYP1A was species-
specific and was correlated with the rate of TCB metabolism. Based on in vitro data, we
hypothesized that CB 126 would suppress CYP1A induction in vivo. CB 126 potently
induced CYP1A mRNA, protein and catalytic activity at low doses (0.01-0.1 mg/kg) and
induced CYP1A mRNA at a high dose (1 mg/kg) but suppressed induction of CYP1A
protein and catalytic activity at that high dose. The suppression of CYP1A induction was
organ-dependent, with hepatic CYP1A being most susceptible to inactivation.
Species differences in TCB metabolism and CYP1A inactivation suggest
differences in the topology of the substrate access channel or the active site of homologous
CYP1As. Such differences may favor metabolism of TCB by rat CYP1A1 and retention of
ROS by scup CYP1A. Structural differences between scup CYP1A and rat CYP1A1 have
been suggested by results from antibody studies. Only 1 of 9 antibodies raised against
scup CYP1A recognize rat CYP1A1, and 2 of 10 antibodies raised against rat CYP1A1
recognize scup CYP1A (Klotz et al., 1986). In addition, even though polyclonal
antibodies raised against scup CYP1A inhibit EROD activity in teleost microsomes, they do
not inhibit EROD activity in BNF-treated rat liver microsomes (Stegeman et al., 1985).
Modeling studies are planned to determine if TCB "fits" differently into CYP1A active sites
from various species. Aligned amino acid sequences show both similarities and differences
in residues in the vicinity of the CYP1A active site and considered involved in substrate
binding (Figure 1) (Lewis and Lake, 1996). Only a small change in molecular size allows
the binding and metabolism of BP but prevents the binding of benzo[e]pyrene (Lewis et
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al., 1994). This sieve effect has been attributed two phenylalanine residues (Phe 201 and
Phe 243, using P4 5 0cam nomenclature) that have a coplanar orientation (Lewis et al.,
1994); this may be a site important to determining differences between the scup and rat
proteins.
The consequences of suppression of CYP1A are unknown at this time. Studies of
a CYP1A-deficient animal model are required, but this tool has not been developed as of
yet. However, studies are beginning to recognize the regulation of AhR activation by
CYP1A1 in a mammalian system. Studies in Hepa-1 cells have shown that the c37 mutant,
which lacks CYP1A1 activity, has a constitutively activated AhR (Chang and Puga, 1998).
Similarly, inhibition of CYP1A1 activity by ANF in the wild-type Hepa-1 also results in
activation of the AhR. Chang and Puga (Chang and Puga, 1998) have hypothesized that an
endogenous CYP1A substrate is responsible for the constitutive activation of the AhR.
Metabolism of the substrate converts it to an inactive product; therefore, if CYP1A is not
present or is inhibited the substrate will remain active resulting in the constitutive activation
of the AhR. The endogenous ligands of the AhR have been suggested to be eicosanoids,
compounds which also can be metabolized by CYP1A (Capdevila et al., 1990; Nebert,
1994). Thus, it is possible that the suppression of CYP1A resulting from inactivation
mediated by coplanar PCBs may alter the homeostasis of the AhR. Considering that the
AhR now is recognized to participate in control of cell cycle progression (Ma and Whitlock,
1996; Weiss et al., 1996), perturbation of AhR homeostasis may have physiologically
important consequences.
PHAH-Stimulated ROS Production
Adding TCB to scup or rat liver microsomes containing CYP1A, but not control
microsomes, stimulated formation of ROS; formation rates correlated with native CYP1A
content. Use of multiple techniques confirmed that both 02-' and H202 were produced by
scup CYP1A. Expressed human CYP1As differed in their production of ROS. In the
presence of NADPH alone, CYP1A2 microsomes oxidized DCDFDA and HE at rates 5-
fold greater than the rates obtained with CYP1A1 microsomes. Considering that CYP1A2
has been shown to be reduced in the absence of substrate (Guengerich and Johnson,
1997), this result is not surprising. However, another recent study reported that NADPH-
stimulated ROS production by human CYP1A1 was greater than that by CYP1A2
(Puntarulo and Cederbaum, 1998). Addition of TCB+NADPH stimulated ROS production
by the human CYP1A1 microsomes, but decreased ROS production by the CYP1A2
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Figure 1. An alignment between CYP1A sequences demonstrating similarities and
differences between amino acids in the vicinity of the CYP1A active site. A, B, C -
involved in hydrogen bonding. D -Involved in limiting the size of the substrate binding
site. E - Involved in t-n stacking with aromatic rings on substrates. F - Involved in
hydrogen bonding by CYP1A1. G - Involved in hydrogen bonding by CYP1A2. H -
Possibly involved in discrimination of CYP1A1 and CYP1A2 substrates. I - Possibly
involved in t-t stacking with substrates and limiting the size of the substrate binding site.
J - Possibly involved in substrate binding interactions or in limiting the size of the binding
site. K - Involved in t-n stacking with aromatic rings on substrates. Designations of
active site amino acids are from (Lewis and Lake, 1996). Sequences were retrieved by
GenBank accession numbers K03191 (human CYP1A1), Y00071 (mouse CYP1A1),
K02246 (rat CYP1A1), U14162 (scup CYP1A), M21310 (trout CYP1A1), and X99453
(chicken CYP1A4).
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microsomes. Therefore, the data suggest that pHAH-stimulated ROS production is a result
of the interaction with CYP1A1 in mammals. ROS formed by uncoupling of CYP1A could
attack any member of the cellular machinery, including proteins (Davies, 1987; Stadtman
and Berlett, 1991), lipids (Girotti, 1985) and nucleotides (Breen and Murphy, 1995). CBs
have been shown to stimulate oxidative stress in this study as well as others (Stohs et al.,
1990; Buchmann et al., 1991; Toborek et al., 1995; Park et al., 1996), and ROS
production was shown to be both AhR-dependent (Faux et al., 1992; Alsharif et al., 1994;
Park et al., 1996) and limited to microsomal and mitochondrial sources (Wahba et al.,
1989). Uncoupling of CYP1A fits the criteria for the source of pHAH-stimulated ROS
production.
Beyond inactivating CYP1A protein, oxygen and ROS may be important regulators
of CYP1A. Oxidative stress has been shown to downregulate CYPs. While BNF
substantially induced CYP1A1 and CYP1A2 mRNA expression in hepatocytes isolated
from rats, co-treatment with H202 reduced transcription rates by 50% and 70%,
respectively (Barker et al., 1994). Oxidizing conditions decrease DNA binding of purified
AhR (Ireland et al., 1995). Unlike other redox-sensitive transcriptions factors, the AhR
does not contain conserved cysteines in its basic regions; however both the AhR and
ARNT contain conserved cys-arg motifs in the PAS domain. In contrast, hyperoxia has
been found to induce CYP1A expression in both mice (Gonder et al., 1985) and sheep
(Hazinski et al., 1995). On the other hand, hypoxia also may influence CYP1A induction.
Activated hypoxia inducible factor-la out competes dioxin-activated AhR for binding of
ARNT, resulting in reduced AhR-DNA binding (Gradin et al., 1996). A greater
understanding of the regulation of the AhR and CYP1A by oxygen is required.
NF-rB in a Teleost
The goal of these studies was develop an assay with which we could analyze the
physiological effect of the production of ROS during the uncoupling of CYP1A by pHAH.
Even though analysis of antioxidant enzymes and oxidative damage are difficult to
interpret, I initially attempted to measure an oxidative DNA adduct 8-hydroxy-
deoxyguanosine. This was abandoned due to the difficult nature of isolating DNA from
scup. I turned to looking for a redox sensitive transcription factor whose activation I could
use as a sensitive indicator of oxidative stress. First, this required finding a probe that
would recognize such a protein in fish and then confirming its specificity. Thus, I have
demonstrated for the first time that members of the Rel family of proteins are present in a
198
teleost. An NF-KB consensus sequence bound at least 3 proteins in scup liver, kidney and
heart, two of which potentially correspond with mammalian p50 and RelA. An antibody to
mammalian p50 immunoprecipitated the =50 kD binding protein in all 3 organs. In EMSAs
the band-shifts were specifically competed by NF-KB binding oligonucleotides and not by
the AhR DRE. Second, I attempted to use activation of NF-kB/DNA binding as an
indicator of oxidative stress following treatment with two AhR agonists. An NF-kB
consensus sequence was bound by nuclear proteins from untreated scup. BP did not
increase the activation of NF-kB, and PeCB activated NF-KB in only 1 of 2 experiments.
While, we have confirmed the presence of the Rel family of proteins in a teleost,
interpretation of the effects of AhR agonists on NF-KB activation is difficult. This is not
necessarily surprising considering the conflicting results seen in cell culture (Yao et al.,
1995; Tian et al., 1998; Shneider et al., submitted). Sequencing of members of the Rel
family of proteins from scup is occurring as I write. This will confirm further the
biochemical results which show that this family of proteins is present in a teleost. The
identification, the distributions, the regulation and the functions of Rel family proteins in
teleosts, as well as determining the relationship of teleost Rel proteins to mammalian, avian
and amphibian Rel proteins, all remain questions for another thesis. Use of primary cell
culture or the Hepa-expressed scup CYP1A system may reduce the confounding effects
seen in vivo.
CYPlA in Endothelium
Endothelial cells may be a particularly sensitive target for PAHs and pHAHs. We
have shown that CYP1A can be strongly induced in this cell type by several model AhR
agonists. Induction of endothelial CYP1A is dose-dependent in multiple organs, and both
cardiac endothelial CYP1A in microvascular endothelial CYP1A were metabolically active.
In the rete mirabile, greater doses of inducers were associated with increasing penetration
of induction. In addition, a transition from endothelial to epithelial staining occurred in the
gill, heart and kidney at high doses of BNF. We conclude that the penetration of
endothelial cell CYP1A expression in the vessels of the rete mirabile reflects greater
concentrations of inducer reaching the distal circulation. The results are consistent with the
hypothesis that endothelial cell CYP1A may participate in removal of AhR agonist/CYP1A
substrates from the circulation.
We have shown that AA metabolism is altered by AhR agonists, and others have
shown that P450-derived AA metabolites can affect endothelial cell function. Even though
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endothelial cells represent up to 8-9% of the mass of the teleost heart (Stegeman et al.,
1989), changes in CYP1A status may not have changed the CYP compliment of the heart
as a whole, and thus we saw little change in AA metabolism following BP treatment.
However, considering that CYP1A can represent up to 25% of endothelial microsomal
protein (Stegeman et al., 1982) and the ability of CYP1A-induction to alter AA metabolism
in an CYP1A-rich organ (i.e. liver), it is likely that changes in CYP1A-content in
endothelial cells may have a profound effect on AA metabolism. For instance, BNF and
MC treatment of canine coronary and rabbit pulmonary arteries leads to dose-dependent
increases in AA induced endothelium-dependent relaxations (Pinto et al., 1986; Pinto et al.,
1987). Studies on AA metabolism in cultured endothelial cells treated with AhR agonists
would be required to answer this question definitively.
ROS play an important role in the normal physiology of endothelial cells, as well as
participate in endothelial cell pathology. Endothelial cells produce nitric oxide (NO) as a
paracrine factor which stimulates relaxation in vascular smooth muscle cells, and ROS are
second messengers in shear flow induced gene expression (Chien et al., 1998; Hsieh et al.,
1998). Endothelial cells also commonly encounter ROS produced by activated neutrophils
(Baboir, 1978). However, ROS also have been implicated in atherosclerosis.
Peroxidation of low density lipoproteins has been suggested to attract adhering monocytes
(Halliwell, 1993), and ROS induce the transcription of vascular cell adhesion molecule-1
whose promoter contains an NF-icB consensus binding sequence (Weber et al., 1994;
Alexander, 1995). Treatment of endothelial cells with ROS can result in alterations of
many physiological process including stimulation of release of intracellular Ca+2 stores,
release of polyunsaturated fatty acids via activation of phospholipases A2, C and D,
platelet-activating factor, protein phosphorylation and prostanoid synthesis, inhibition of
agonist induced Ca + 2 flux and inositol triphosphate liberation, depletion of ATP, NAD+
and reduced glutathione, accumulation of lysophopholipids, induction of c-myc and c-fos
expression and alteration of vascular barrier function (Vane et al., 1990; Vercellotti et al.,
1991; Elliot et al., 1992; Schilling and Elliot, 1992; Barchowsky et al., 1994; Natarajan,
1995). Considering the substantial potential for CYP1A induction in endothelial cells
(Stegeman et al., 1982), the production of ROS during CYP1A uncoupling, the evidence
of oxidative stress following CB treatment in culture (Toborek et al., 1995) and the
correlation of early life-stage mortality stimulated by TCDD with endothelial CYP and ROS
(Cantrell et al., 1996), ROS production stimulated by pHAHs may be an important initiator
of endothelial cell pathology.
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Appendix A
3,3',4,4'-Tetrachlorobiphenyl Metabolism in Fish, Bird and Reptile
Species and its Relationship with Cytochrome P4501A Inactivation and
Reactive Oxygen Production
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ABSTRACT
Previous work in the fish model scup (Stenotomus chrysops) demonstrated that
during the association of planar polychlorinated biphenyls with the CYP1A active site,
reactive oxygen species (ROS) are produced as a result of catalytic uncoupling, culminating
in oxidative inactivation of the enzyme. Here, we investigated 3,3',4',4-tetrachloro-
biphenyl (TCB) metabolism and its relationship to CYP1A catalytic activity, CYP1A
inactivation and ROS production liver microsomes from a series of fish (Anguilla rostrata,
Fundulus heteroclitus, Psuedopleuronectes americanus, and Raja erinacea), bird (Gallus
domesticus, Larus argentatus and Phalacrocorax auritus ) and reptile (Chrysemys picta)
species. For all species examined, TCB metabolism represented a very small proportion of
the CYP1A catalytic activity, ethoxyresorufin O-deethylation (EROD); however, it was
correlated strongly with EROD activity in all species except flounder. The rate of CYP1A
inactivation varied between species. Chicken hepatic CYP1A was most susceptible to
inactivation; however eel, flounder, killifish and cormorant liver microsomes all had
significant decreases in EROD activity following incubation with TCB and NADPH.
Inactivation was correlated negatively with TCB metabolism in the bird species (r2=0.992,
p<0.05). ROS production by liver microsomes also was species dependent. In chicken
and turtle liver microsomes, NADPH alone stimulated a high rate of ROS production, both
H202 and 02-*. In both fish and bird species, NADPH-stimulated ROS production was
correlated positively with EROD activity (r2 =0.770-0.845, p<0.05 and r2 =0.952-0.959,
p<0.05, respectively). TCB stimulated H202 production in liver microsomes of flounder,
cormorant and gull; however, TCB decreased H202 production in the chicken liver
microsomes. TCB stimulated 02-* production in liver microsomes of flounder, killifish,
cormorant and gull. Compared to the model species scup, only chicken had rates of ROS
production and CYP1A inactivation as high. CYP1A inactivation appears to be dependent
in part on the rate at which species metabolize TCB.
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INTRODUCTION
Polychlorinated biphenyls are ubiquitous in the global environment and present in
tissues of fish, birds and mammals (see (Risebrough et al., 1968; McFarland and Clark,
1989)). Congeners that lack substitution at ortho sites (e.g. 3,3',4,4'-tetrachlorobiphenyl)
can achieve a planar conformation similar to that of 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) (Safe et al., 1985). These planar halogenated aromatic hydrocarbons (pHAH)
promote hepatocellular carcinoma, immunotoxicity, wasting syndrome and reproductive,
endocrine and developmental toxicity (as reviewed in (Safe, 1994)). PHAH alter the
expression of a number of genes, including cytochrome P4501A (CYP1A) genes, by
activating the aryl hydrocarbon receptor (AhR) (Hankinson, 1995).
3,3',4'4,-Tetrachlorobiphenyl (TCB) induces CYP1A in a wide range of fish
(Franklin et al., 1980; Melancon and Lech, 1983; Gooch et al., 1989; Monosson and
Stegeman, 1991; Tyle et al., 1991; Lindstrom-Seppa et al., 1994; Newsted et al., 1995;
Otto and Moon, 1995; Huuskonen et al., 1996; Sleiderlink and Boon, 1996; White et al.,
1997a), bird (Dubois et al., 1995; Kennedy et al., 1996; Lorenzen et al., 1997), reptile
(Schwen and Mannering, 1982; Jewell et al., 1989; Yawetz et al., 1998) and amphibian
(Marty et al., 1992) species; however sensitivity to induction is species specific. In
comparison, the ED50 calculated from 7-ethoxyresorufin O-deethylation (EROD) induction
for administered doses of TCB has been estimated at 0.03 mg/kg in chicken embryo (Poland
and Glover, 1977), 0.1 to 0.7 mg/kg in rainbow trout (Oncorhynchus mykiss) (Janz and
Metcalfe, 1991; Newsted et al., 1995), 5 mg/kg in American eel (Anguilla rostrata) (Chapter
7), 5.8 mg/kg in C57BL/6J mice (Poland and Glover, 1977), and 150 mg/kg in Wistar rats
(Leece et al., 1985). The EC50s for EROD induction by TCB in hepatocytes cultured from
a number of bird species range over 4 orders of magnitude (Dubois et al., 1995; Kennedy et
al., 1996; Lorenzen et al., 1997). Furthermore, in bird species, the susceptibility to CYP1A
induction has been correlated with susceptibility to toxicity (Brunstrom and Reutergardh,
1986; Brunstrom, 1988; Brunstrom and Lund, 1988; Dubois et al., 1995; Kennedy et al.,
1996; Lorenzen et al., 1997).
One possible route to toxicity is the metabolic activation of CYP1A substrates to
reactive derivatives. That CYP1A1 is responsible for the metabolism of TCB has been
established in rats (Ishida et al., 1991). Correlations of CYP1A catalytic activity and TCB
metabolism support the conclusion that CYP1A4 metabolizes TCB in birds (Murk et al.,
1994) and CYP1A metabolizes TCB in a fish (White et al., 1997b). Although rates of
microsomal TCB metabolism in birds approach that seen in mammals, TCB metabolism is
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extremely slow in fish (Borlakoglu and Wilkins, 1993; Murk et al., 1994; White et al.,
1997b). However, whether efficiently metabolized or not, bioactivation has not been
found to be a significant avenue to pHAH toxicity (Safe, 1992).
Another route to toxicity may be stimulation of oxygen activation. TCB significantly
increases the rate of ROS production by hepatic CYP1A in the fish model scup (Stenotomus
chrysops) (Chapter 3). We have hypothesized that the production of ROS during catalytic
uncoupling by TCB results in the formation and attack of OH., leading to the inactivation of
CYP1A (Chapter 3). This may be the mechanism by which pHAH stimulate oxidative
stress (Faux et al., 1992; Alsharif et al., 1994; Park et al., 1996), as well as the mechanism
of CYP1A protein loss following exposure to high doses of TCB seen in vivo in fish
(Gooch et al., 1989; Newsted et al., 1995; White et al., 1997a) and in cultured hepatocytes
of chickens and endothelial cells of pigs (Lambrecht et al., 1988; Sinclair et al., 1989;
Stegeman et al., 1995).
Previous work has demonstrated a disparity in both TCB metabolism and TCB-
stimulated inactivation of CYP1A in scup and rats (Chapter 3), which suggested that the
rate of inactivation may be related to the rate of TCB metabolism. Therefore, we
investigated the relationship between TCB metabolism and inactivation of CYP1A in vitro,
in a variety of fish, bird and reptile species. In addition, the potential for ROS production
by liver microsomes of these species was examined. Within species groups, inactivation of
CYP1A appears to be correlated negatively with the rate of TCB metabolism. The potential
to produce ROS was correlated positively with CYP1A catalytic activity.
MATERIALS AND METHODS
Chemicals: 2',7'-Dichlorodihydrofluorescein diacetate, 7-ethoxyresorufin, and
dihydroethidium were purchased from Molecular Probes (Eugene, OR). 3,3',4,4'-
Tetrachlorobiphenyl and 2,3,7,8-tetrachlorodibenzofuran were purchased from Ultra
Scientific (N. Providence, RI). 3,3',4,4'-tetrachlorobiphenyl-Ring-UL- 1 4 C (52.1
mCi/mmol) was purchased from Pathfinder (St. Louis, MO). Analysis of the 14 C-
3,3',4,4'-TCB by GC/ECD and GC/MS revealed no hydrophobic contaminants (>99%
pure); small amounts of polar contaminants were removed by dissolving the TCB in hexane
and extracting twice with NaOH. All other reagents were purchased from Sigma (St.
Louis, MO).
Animals: Killifish (Fundulus heteroclitus ) were caught in Scorton Creek, MA, in
June, 1996 and used in experiments in July, 1996. Killifish were held in flow-through
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seawater tanks at 14'C and maintained on a diet of TetraMin large flake food. Killifish
ranged in size from 9 to 21 g. Eight fish each were injected intraperitoneally with corn oil
or a solution of 2,3,7,8-tetrachlorodibenzofuran (10 nmollkg), a potent CYP1A inducer.
Seven days following injection the fish were killed by decapitation. Livers were removed,
and microsomes were made immediately. In each dose group, livers were pooled in twos
to form 4 samples per group. Liver microsomes from benzo[a]pyrene treated eels
(Anguilla rostrata) were prepared and characterized previously (Chapter 7). Flounder
(Pseudopleuronectes americanus) and skate (Raja erinacea) liver samples were from
animals environmentally exposed to halogenated and non-halogenated aromatic pollutants
in Boston Harbor, MA. Chicken (Gallus domesticus), double crested cormorant
(Phalacrocorax auritus), and herring gull (Larus argentatus) livers, both control and
3,3',4,4',5-pentachlorobiphenyl-treated, were generous gifts of Lori Feyk (Michigan State
University). Microsomes from TCB- and 3-naphthoflavone-treated turtles (Chrysemys
picta) were prepared and characterized previously (Yawetz et al., 1998).
Microsome preparation: Microsomes were prepared from livers by differential
centrifugation as before (Stegeman et al., 1979). Pellets were resuspended in buffer (50
mM TRIS, pH 7.4, 1 mM dithiothrietol, 1 mM EDTA, 20% glycerol) and frozen in liquid
N2 until use. Protein content was determined using the bicinchoninic acid method (Smith
et al., 1985), using bovine serum albumin as a standard.
Western blotting for CYPIA quantification: Immunoblotting procedures were
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal
proteins (10-80 gg/lane) were resolved on 12% SDS-PAGE gels and electrophoretically
transferred to nylon or nitrocellulose (1 gm) membrane. The primary antibody was the
mouse monoclonal antibody 1-12-3 (Park et al., 1986), raised against scup P450E
(CYP1A; (Morrison et al., 1995)). MAb 1-12-3 is highly specific for CYP1A in fish and
CYP1A1 in mammals but recognizes both CYP1A4 and CYP1A5 in chicken. The
secondary antibody was alkaline phosphatase linked goat anti-mouse IgG (Biorad,
Hercules, CA). The immunoreactive proteins on nitrocellulose membrane were visualized
using nitro blue tetrazolium and 5-bromo-4-chloro-3-indoyl-phosphate (NBT/BCIP). The
immunoreactive proteins on nylon membranes were visualized using enhanced
chemiluminescence (Tropix, Bedford, MA). CYP1A content was quantified by
densitometric analysis of video images (NIH Image, 1.60b5). Where appropriate, the
CYP1A values are relative, reported as scup CYP1A equivalents.
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Enzyme assays: Microsomal ethoxyresorufin O-deethylation (EROD) was
determined fluorometrically as before (Hahn et al., 1993), using a Cytofluor 2300
(Millipore) multiwell plate reader. TCB metabolism was assessed using the assay of
Schnellman et al. (Schnellman et al., 1983), as modified by White et al., (1997b).
Radioactivity was determined by liquid scintillation counting on a Beckman LS5000TD
counter.
In vitro studies of CYPIA inactivation: The procedure was as described in Chapter
3 except that 0.1-0.3 mg of microsomal protein was used in each reaction mixture.
Inactivation was calculated by comparing EROD activity at 30 minutes in reaction mixtures
containing TCB alone to that in reaction mixtures containing TCB+NADPH.
Peroxide and superoxide formation: H202 and 02-s formation were determined as
described in Chapter 3.
Statistics: Statistics were calculated using Microsoft Excel (Microsoft, Inc.,
Redmond, WA) and Stat-View for Macintosh (Abacus Concepts, Inc., Berkeley, CA). A
Student's t-test was used to analyze inactivation (TCB vs. TCB+NADPH) and ROS
production (NADPH vs. TCB+NADPH). To examine correlations between EROD
activity, TCB metabolism, inactivation and ROS production, linear regression analyses
were performed.
RESULTS
CYP1A content, EROD activity and TCB metabolism were determined in liver
microsomes from bird, fish and reptile species in order to examine their relationship. The
rate of TCB metabolism was very low in all species, compared to the rate of EROD (Table
1). When TCB metabolism was represented as a percentage of EROD activity, species
varied widely in their rates of TCB metabolism. In the bird and turtle species, TCB
metabolism represented a greater proportion of EROD activity than it did in fish (Table 1).
However, in all species but flounder, the rate of TCB metabolism was correlated strongly
with EROD activity (Table 1).
We examined the same fish, bird and reptile species for TCB-stimulated inactivation
of CYP1A which has been described in the marine fish scup (White et al., 1997a; Chapter
3). To determine the level of inactivation, the rate of EROD activity in hepatic microsomal
reaction mixtures containing TCB+NADPH was compared to that in reaction mixtures
containing only TCB following a 30 minute incubation. CYP1A inactivation was highly
variable between species (Figure 1). Of the fish species, no one had as great a loss of
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TABLE 1I
Comparison of CYP1A content, EROD activity and TCB metabolism in liver microsomes from bird, fish and reptile species
Species n Treatment CYPIA EROD TCB Metabolism TCB Metabolism TCB Metabolism
Activity as a % of EROD vs. EROD
(pmol/mg) (pmol/min/mg) (pmol/min/mg) r2  p<
Fish
Eel (A. rostrata)a 4 Control 1 ± 1 59 ± 26 0.12 ± 0.03 0.2 ± 0.1 0.930 0.001
4 Induced 51± 7 466 ± 194 0.65 ± 0.12
Flounder (P.americanus) 5 Environment 22 + 7 112 + 21 0.14 ± 0.02 0.1 ± 0.0 0.000
Killifish (F.heteroclitus) 4 Control 3+ 1 566 + 240 0.12 ± 0.02 0.0 ± 0.0 0.915 0.001
4 Induced 21 + 8 1385 + 290 0.23 ± 0.07
Scup (S. chrysops)b 7 Induced 380 ± 150 4837 + 924 0.34 ± 0.08 0.0 ± 0.0
Skate (R. erinacea ) 3-4 Environment 5 ± 1 201 ± 84 0.09 ± 0.04 0.1 ± 0.1 1.000 0.05
Birds
Chicken (G. domesticus) 2 Control 1 , 2 131 , 480 0.4 , 0.7 0.3 ± 0.1 0.840 0.005
7 Induced 19 ± 5 3658 ± 1568 10.9 + 2.9
Cormorant (P. auritus) 4 Control 3± 1 182 ± 64 2.2 ± 2.1 0.9 ± 0.6 0.922 0.001
3 Induced 28 + 3 1734 ± 729 12.8 ± 8.0
Gull (Largentatus) 3-6 Control 3+ 1 65 ± 44 0.5 + 0.2 1.3 ± 0.5 0.978 0.001
Induced 25 +2 337 + 114 5.8 ± 2.5
Reptile
Turtle (C. picta) c 4 Induced 463 + 171 80 ± 23 2.5 ± 0.7 3.2 ± 0.4 0.861 0.05
a - CYPIA content and activity data from Chapter 7. b - All data from Chapter 3. c - CYP1A content and activity data from (Yawetz et al., in press).
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Figure 1. TCB-stimulated inactivation of hepatic microsomal CYP1A (EROD activity).
Microsomes were incubated at 2 mg/mi in buffer (50 mM TRIS, 0.1 mM EDTA, pH 7.6)
with combinations of the following additions: acetone (5 gl), NADPH (1.8 mM), and TCB
(1.7 gM). Aliquots were removed from reaction mixtures at times zero, 10, 20 and 30
minutes and assayed for EROD fluorometrically over 5 minutes. Data shown here are from
the 30 minute time point. EROD was constant in microsomes incubated with acetone or
NADPH. Following an initial loss of EROD upon addition of TCB, EROD remained
constant. There were linear losses of EROD during incubation with NADPH and TCB.
Data are means ± SD. 3-8 sets of microsomes. *Statistically different from the
corresponding TCB incubation analyzed at 30 minutes (Student t-Test, p<0.01).
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activity due to inactivation as the model species scup; although there were statistically
significant losses of EROD activity in eel, flounder and killifish liver microsomes (Figure
1). Of the bird species, chicken appeared to be highly sensitive to CYP1A inactivation
(Figure 1). There was no inactivation of CYP1A in turtle liver microsomes (Figure 1).
There was no significant relationship between the rate of TCB metabolism normalized for
EROD activity and competitive inhibition of EROD activity by TCB (data not shown).
However, both fish and bird species demonstrated a negative relationship between
inactivation and TCB metabolism, with the relationship in the bird species being statistically
significant (Figure 2).
Previous results in scup have demonstrated that TCB stimulates the production of
ROS in liver microsomes, and it was hypothesized that those ROS may attack the protein
resulting in inactivation (Chapter 3). Therefore, we examined ROS production in liver
microsomes from the species analyzed in the inactivation assays. H202 and 02-*
production were measured by monitoring the oxidation of 2',7'-dichlorodihydrofluorescein
diacetate (DCDFDA) to dichlorofluorescein (DCF) and dihydroethidium (HE) to ethidium,
respectively. DCDFDA and HE oxidation were stimulated significantly by NADPH alone
in chicken and turtle liver microsomes (Figure 3). In both fish and bird species, NADPH
stimulated ROS production was correlated positively with EROD activity (Figure 4). TCB
stimulated H202 production in flounder, cormorant and gull liver microsomes; however,
TCB decreased H202 production in chicken liver microsomes. TCB increased 02-"
production in the flounder, killifish, cormorant and gull liver microsomes. These increases
in ROS production were not of the same magnitude as was seen in scup (Figure 3).
DISCUSSION
Planar HAHs are ubiquitous environmental contaminants that are known to be
highly toxic (Safe, 1994). TCB both induces and suppresses the induction of CYP1A in
several species (Lambrecht et al., 1988; Sinclair et al., 1989; Newsted et al., 1995;
Stegeman et al., 1995; White et al., 1997a). Loss of CYP1A during incubation of scup
liver microsomes with TCB+NADPH has been attributed to the formation and attack of
ROS and may be involved in the decline in CYP1A seen in vivo (Chapter 3). In these
studies we examined the inactivation of CYP1A and its relationship to TCB metabolism and
ROS production in a variety of fish, bird, and reptile species. For all species examined,
TCB metabolism represented a very small proportion of the CYP1A catalytic activity;
however, it was correlated strongly with EROD activity, except in flounder. Susceptibility
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Figure 2. Correlation of TCB metabolism with inactivation of CYPlA catalytic activity.
A) Fish liver microsomes. B) Bird liver microsomes. TCB metabolism has been
normalized to the EROD activity in the microsomes.
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to inactivation varied among species with chicken being most sensitive but with eel,
flounder, killifish and cormorant also having significant inactivation. Inactivation appeared
to be negatively correlated with TCB metabolism. In both fish and bird species, NADPH-
stimulated ROS production was positively correlated with EROD activity. TCB further
stimulated ROS production in liver microsomes of flounder, killifish, cormorant and gull;
however, TCB decreased ROS production in the chicken liver microsomes. Compared to
scup, only chicken had rates of ROS production and CYP1A inactivation as high. CYP1A
inactivation appear to be dependent in part on the rate at which species metabolize TCB.
TCB Metabolism: This study and others have shown that fish do not metabolize
chlorobiphenyls (CB) as readily as birds or mammals. A recent study confirmed that TCB
is metabolized by the marine fish scup both in vivo and in vitro (White et al., 1997b).
Here, all species of fish examined metabolized TCB at a rate of less than 1 pmol/min/mg
which represented between 0.01 and 0.2% of the EROD activity in these species. These
very low rates of metabolism may be the reason why some studies have failed to detect CB
metabolism in fish (Hutzinger et al., 1972; Herbst et al., 1978; Murk et al., 1994).
However, selective loss of CB congeners in fish species indicated that biotransformation
occurs in fish; selective loss of coplanar congeners TCB and 3,3',4,4',5-
pentachlorobiphenyl (Niimi and Oliver, 1983; de Boer et al., 1993) and non-coplanar
congeners 2,2',5,5'-tetrachlorobiphenyl, 2,2',4,5,5'-pentachlorobiphenyl and
2,2',3,5,5',6-hexachlorobiphenyl (Boon et al., 1989; Elskus et al., 1994) has been
described. Furthermore, trace amounts of metabolites of di- to pentachlorobiphenyls have
been detected in several fish species (Metcalf et al., 1975; Sanborn et al., 1975; Melancon
and Lech, 1976; Hinz and Matsumura, 1977; Herbst et al., 1978). Birds have been shown
to metabolize a number of di- to pentachlorobiphenyls both in vitro (Borlakoglu and
Wilkins, 1993) and by the selective loss of specific congeners (Borlakoglu et al., 1990).
Analysis of congener composition following either environmental or experimental exposure
to complex CB mixtures suggested that only congeners with at least one pair of adjacent
unsubstituted meta-para carbons were metabolized by birds (Borlakoglu et al., 1990;
Rozemeijer et al., 1991). However, liver microsomes from eider duck (Somateria
mollissima) and common tern (Sterna hirundo) metabolize TCB at significant rates (0.6-1.4
and 21-47 pmol/min/mg, representing 2.9 and 4.0% of EROD activity) (Murk et al.,
1994). Furthermore, all of the bird species in this study metabolized TCB at rates between
0.4 and 12.8 pmol/min/mg which represented 0.3 to 1.3% of the EROD activity in these
samples. TCB metabolism in liver microsomes from rats induced for CYP1A ranged from
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Figure 3. TCB-stimulated ROS production in liver microsomes. A) H202 production as
assessed by oxidation of DCDFDA to DCF. B) 02-' production as assessed by oxidation
of HE to ethidium. In a 48-well plate, approximately 0.1 mg of microsomal protein was
diluted to 160 p.l with HBSS containing 5 pM DCDFDA and 7.5 pM HE (final
concentrations). Some reaction mixtures contained 200 units SOD. Following a fifteen
minute incubation at 30"C, 1.7 nmol TCB in acetone or 5 pl acetone was added. Reactions
were initiated with NADPH (1.7 mM). The rates of DCF and ethidium production were
monitored fluorometrically over 5 minutes. Calculations were made using DCF and
ethidium bromide as standards. Data are the means ± S. D. from 3-8 sets of microsomes.
*Statistically different from the corresponding NADPH+acetone incubation (p<0.05,
Student's t-Test).
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Figure 4. Correlation of ROS production with CYPIA catalytic activity. A) Fish liver
microsomes. B) Bird liver microsomes.
microsomes. B) Bird liver microsomes.
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18-91 pmol/min/mg, representing 4% of EROD activity (Ishida et al., 1991; Murk et al.,
1994).
Previous studies have determined the metabolite profiles of TCB in various species.
In scup treated with 0.1 mg TCB/kg, 5-hydroxy-3,3',4,4'-tetrachlorobiphenyl (5-OH-
TCB) is the predominant metabolite in bile, constituting 85% of all metabolites, while 4-
hydroxy-3,3',4',5-tetrachlorobiphenyl (4-OH-TCB) constitutes 13% of the total (White et
al., 1997b). This distribution appears to be dependent upon dose of TCB, with a dose of 5
mg TCB/kg resulting in a profile with similar amounts of 4-OH-TCB and 5-OH-TCB
(White et al., 1997b). 5-OH-TCB is the predominant metabolite in bile of chickens
(Klasson Wehler et al., 1990) and is the predominant metabolite produced by liver
microsomes of the common tern and eider duck (Murk et al., 1994). In feces of mice and
rats, 4-OH-TCB and 5-OH-TCB occur in nearly equal amounts (Yoshimura et al., 1987;
Klasson Wehler et al., 1989).
CYP1As appear to be responsible for the metabolism of TCB. For most species in
this study, TCB metabolism was correlated strongly with EROD activity. EROD activity is
associated with CYP1A in fish (Klotz et al., 1983), CYP1A4 in birds (Rifkind et al.,
1994), and CYP1A1 in mammals (Nerurkar et al., 1993). Induction and inhibition studies
in scup have suggested that CYP1A is responsible for TCB metabolism in the fish scup
(White et al., 1997b). Interestingly, the flounder showed no relationship between EROD
activity and TCB metabolism. This may have resulted in part from the fact that a small
number of samples with very similar TCB metabolism rates were analyzed. However,
other studies have demonstrated a lack of CYP1A-like metabolism of CB congeners in
flounder (Brown, 1992; Elskus et al., 1994). Along with the chicken, cormorant and gull
examined in this study, positive correlation of EROD activity and TCB metabolism also has
been demonstrated for the common tern and eider duck (Murk et al., 1994). In rats it is
known that CYP1A1 metabolizes congeners with adjacent, unsubstituted ortho-meta
carbons (Ishida et al., 1991).
TCB-Stimulated CYPIA Inactivation: TCB-mediated inactivation of CYP1A was
described first in scup, where the phenomenon is quite strong (White et al., 1997a).
Uncoupling of electron transfer and oxygen activation from mono-oxygenation during the
interaction of TCB with CYP1A results in the release of ROS, either H202 and 02-*, from
the heme iron. H202 can be converted to the extremely reactive OH. by the Fenton
reaction with the reduced heme iron acting as the catalyst. That OH* can attack the protein
and disable it (Chapter 3. This oxidative mechanism of inactivation is hypothesized to
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occur during the in vitro metabolism of TCB and to be responsible for the loss of CYPIA
protein in scup following exposure to a high dose of TCB (White et al., 1997a).
Furthermore, in vitro oxidative inactivation is stimulated by several slowly metabolized CB
congeners that are CYP1A substrates, including 2,3,3',4,4'-pentachlorobiphenyl,
3,3',4,4',5-pentachlorobiphenyl (PeCB) and 3,3',4,4',5,5'-hexachlorobiphenyl (Chapter
4).
Results from this study and others suggest that pHAH stimulated oxidative
inactivation may occur in species other than scup. While CYP1A mRNA remains elevated
in rainbow trout exposed to high doses of PeCB, CYP1A activity and protein both decrease
at high doses (Newsted et al., 1995). Similarly, studies of cultured cells have
demonstrated that chick embryo hepatocytes and porcine aorta endothelial cells exposed to
high doses of TCB show losses of both EROD activity and CYP1A protein (Lambrecht et
al., 1988; Sinclair et al., 1989; Stegeman et al., 1995). Studies of inactivation of CYP1A
in liver microsomes of fish and birds show that the extent of TCB-mediated inactivation of
CYP1A is species specific and may be related to the rate at which TCB is metabolized. A
greater rate of TCB metabolism was correlated with a lesser rate of inactivation and a lesser
rate of ROS production. A greater rate of TCB metabolism may reduce the extent of
catalytic uncoupling thereby reducing the rate of production of ROS which could attack the
protein.
However, data from the chicken do not fit this explanation entirely. Chickens have
a greater concentration of AhR, are more sensitive to CYP1A induction and are more
susceptible to CB toxicity than other bird species (Brunstrom, 1988; Brunstrom and Lund,
1988; Dubois et al., 1995; Kennedy et al., 1996). While chicken liver microsomes had
both one of the lowest rates of TCB metabolism and the greatest rate of inactivation, TCB
did not enhance the production of ROS. Chicken liver microsomes had high levels of ROS
production in the presence of NADPH alone with a slight reduction in the presence of
TCB. Similarly, human CYP1A2 produced ROS at a high rate with NADPH alone, and
the rate decreased substantially in the presence of TCB (Chapter 3). Unlike mammalian
CYP1A1 and CYP1A2 (Dragnev et al., 1995), chicken CYP1A4 and CYP1A5 are induced
in almost equal amounts by pHAH (Sinclair et al., 1997). As CYP1AS possesses
characteristics more like CYP1A2, then it may contribute more to the general production of
ROS seen with NADPH alone. However, ROS production decreases only slightly in the
presence of TCB in the chicken microsomes. While ROS production by CYP1A5 may
decrease in the presence of TCB, the interaction of CYP1A4 with TCB may increase ROS
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production, finally resulting in the inactivation of CYP1A4. Studies with purified chicken
CYP1As would be required to support this hypothesis.
PCB-Stimulated ROS Production: Evidence from studies in fish, birds and
mammals indicate that CBs stimulate oxidative stress. Aroclor 1254 treatment stimulates
hepatic lipid peroxidation in chickens, rats and guinea pigs (Combs and Scott, 1975; Kato
et al., 1981; Dogra et al., 1988). Studies in fish have demonstrated an increase in
antioxidant enzyme activity following exposure to TCB and PeCB (Otto and Moon, 1995;
Palace et al., 1996). PeCB stimulates lipid peroxidation in kestrels (Hoffman et al., 1996),
and TCB increases ROS production and lipid peroxidation in porcine pulmonary
endothelial cells (Toborek et al., 1995).
Results from in vitro studies supports the hypothesis that pHAH stimulate ROS
production through their interaction with CYP1A. While the extent of stimulation varied,
TCB stimulated ROS production in a number of the species examined here. Previously,
CYP1A from scup and rat were shown to produce ROS during their interaction with planar
CB congeners (Chapter 4). Oxidation of bilirubin in chicken and rat liver microsomes was
suggested to occur as a result of ROS formed during uncoupling of the CYP1A catalytic
cycle by non-ortho CB congeners (Sinclair et al., 1986; DeMatteis et al., 1989). In rats,
bilirubin oxidation has been shown to be catalyzed by CYP1A1 (DeMatteis et al., 1991).
Thus, the correlation of CYP1A induction and oxidative stress may indicate that CYP1A
induced through the AhR could be the immediate source of ROS in vivo.
Reptiles and Cytochromes P450: Information on CYP induction and CB
metabolism in reptiles is scare. In both turtles and alligators, two bands are recognized by
a polyclonal anti-mouse or anti-rat CYP1A1 (Jewell et al., 1989; Yawetz et al., 1998). 3-
Methylcholanthrene induced the slower migrating band in alligators (Jewell et al., 1989)
and induced total P450, benzo[a]pyrene hydroxylase activity, and p-nitrophenetol 0-
deethylase activity in snakes (Schwen and Mannering, 1982). In the turtle, BNF, TCB and
2,3,3',4,4'-pentachlorobiphenyl also induced the slower migrating band (Yawetz et al.,
1998). While EROD activities were low, they were correlated with the content of MAb-1-
12-3 cross-reactive protein (Jewell et al., 1989; Yawetz et al., 1998). Furthermore, aryl
hydrocarbon hydroxylase rates were substantial. We show here that a turtle species can
metabolize TCB at rates comparable to those seen in birds. This study is the first to
demonstrate a correlation between EROD activity and TCB metabolism in a reptile. Similar
to the chicken, the oxidase activity in turtle liver microsomes was substantial.
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Initial studies in scup and rat suggested that not all species are equally susceptible to
TCB mediated CYP1A inactivation. Here, we examined the relationship of the TCB
metabolism to TCB-mediated inactivation of CYP1A and ROS production in a variety of
species. Within groups of species, CYP1A inactivation appears to be negatively correlated
with TCB metabolism. This supports earlier conclusions that TCB-mediated inactivation
results from catalytic uncoupling and formation and attack of ROS. The results also
demonstrate that ROS are produced by a variety of species. Formation of ROS by CYP1A
may be linked to overt toxicity though damage to membranes (Bagchi et al., 1989;
Simonian and Coyle, 1996), proteins (Davies, 1987; Kyle et al., 1989), and nuclei acids
(Floyd et al., 1988; Simonian and Coyle, 1996) and through modification of the regulation
of genes involved in several signal transduction pathways (Flohe et al., 1997). The
stimulation of ROS production by pHAH may represent a pathway of toxicity that is
common among diverse species.
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